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Abstract 
The UK has the highest rate of stillbirth in the developed world and there are more 
than three million stillbirths worldwide each year. With over 30 different 
classification systems, the rate of unexplained stillbirth varies from 15-60% despite 
postmortem investigation being undertaken in a number of cases.  The primary 
aims of this project were to use a unique autopsy database to examine a large well 
characterised series of stillbirth autopsies to assess specific causes of death, 
relationships between fetal maceration, intrauterine and postmortem interval on 
cause of death and fetal intrauterine growth restriction as well as producing 
evidence based guidelines for autopsy practise and investigating the potential role 
of novel techniques in future stillbirth autopsy. 
The analysis of more than 1000 intrauterine and intrapartum fetal deaths revealed 
that two thirds had an unexplained cause of death. Internal examination of the 
fetuses provided a definitive cause of death in 1% of cases; 19% of the overall 
causes of death could have been diagnosed from review of the clinical 
circumstances and a further 18% by placental macroscopic and microscopic 
examination. Significant associations were found between increasing maceration 
and Small for Gestational Age (SGA) fetuses and that using birthweight or 
bodyweight alone erroneously overestimate the role of SGA as an underlying factor 
in stillbirth causation. Other investigations such as modified organ weight ratios 
may contribute to determining cause of death.  Proteomic experiments proved that 
in principle significantly different amounts and types proteins could be successfully 
extracted from formalin fixed paraffin embedded stillbirth fetal tissue in different 
case groups, suggesting a possible future investigation into the causation of 
stillbirth.
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1.0 Background 
 
The stillborn (definition) Act 1992 defines stillborn as a child that has issued forth 
from its mother after the 24
th
 week of pregnancy and that did not at any time after 
being completely expelled from its mother breathe or show any signs of life (1). 
Intrauterine death can be defined a fetus with no sign of life in utero (2).  
In 2012 there were 729,674 births in England and Wales of which 3,558 were 
stillborn, a rate of 4.9 stillbirths per 1000 births (3). Depending on which 
classification system is used, 15-60% of all stillbirths remain unexplained, despite 
postmortem examinations being undertaken by trained professionals in a number of 
cases (4, 5). Stillbirth is 10 times more common than sudden infant death syndrome 
and is nearly five times more common than infant deaths related to congenital 
anomalies (6).  
Globally, stillbirth has a large public health impact and specific causes of death 
include congenital abnormalities, ascending infection, placental abruption, placental 
insufficiency and complications of labour (5, 7-28). There are an estimated 1.02 
million intrapartum stillbirths each year and a total of at least 3.2 million stillbirths 
worldwide although these numbers may be underestimates due to under-reporting, 
and inconsistent definitions (29-32). The majority of stillbirths occur in low to 
middle income countries and approximately half occur at home, causing the deaths 
to be uncounted and unnamed (6, 33-43).  Household surveys are often the only way 
of collecting data on child mortality; however their expense limits the number of 
reviews to one every five years in most countries making their ability to look at rapid 
change in mortality limited (33). Verbal autopsy methods are used to collect data 
through the use of questionnaires that are given to the remaining family members 
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after the death of the fetus (13, 34). Data is often not collected in those fetal losses 
under 28 weeks gestation in most developing countries or in those fetuses that weigh 
less than 1000g further limiting data collection (6). 
 
Figure 1 Obesity prevalence in Adults (16 years+) 1993 – 2012.  Copyright © 2016, Re-used with 
permission of the Health and Social Care Information Centre. All rights reserved. (44) 
Epidemiological associations include a parity of zero or greater than 3; maternal 
ethnicity (particularly black mothers), consanguineous marriage, advanced maternal 
age and maternal obesity (45-60). These findings are worrying since the national rate 
of obesity in the United Kingdom is rising (44) (Figure 1). Other associations 
include smoking; maternal Diabetes Mellitus; maternal hypertension; history of 
antenatal vaginal bleeding, maternal cholestasis and fetal intrauterine growth 
restriction (IUGR) (48, 49, 51, 52, 61-82).  It has been suggested that unrecognised 
intrauterine growth restriction may be a major contributing factor, suggesting that 
some deaths of normally formed stillborn fetuses could be avoided if fetal growth 
disturbances were detected and interventions performed. 75% of fetuses with 
intrauterine growth restriction are not recognised until after delivery and this rises to 
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85% in low risk pregnancies. The majority of our data on ‘IUGR’ comes from 
surrogate data based on small for gestational age (SGA) fetuses, assessing the weight 
of liveborn infants or stillborns (83-85).  
Awareness of the improvement in detecting SGA antenatally, of which a proportion 
will be IUGR, is now recognised (86-92). Using a birthweight of <10
th
 percentile for 
the  diagnosis of SGA and taking into account maternal ethnicity, weight, parity, 
gestational age of the fetus and fetal gender, one study reported that 52% of the 
stillbirths were SGA (93). 
Studies have also highlighted the role of ethnicity and stillbirth, reporting that Black 
and Asian women have twice the odds of stillbirth compared to white women even 
after adjusting for age, parity, deprivation, obesity, hypertension and diabetes; 
mothers who were native to South Asia also have an increased risk of antepartum 
stillbirth in late pregnancy (37 -42 weeks gestation) compared to other women in the 
Australian population (94, 95).  
Maternal Age is a risk factor for fetal loss with women between the ages of 30-34 
having a 27% greater risk compared to mothers between the ages of 25-29, after 
adjusting for parity, ethnicity, body mass index, maternal co-morbidities and 
deprivation (96). Women aged over 40 years at the time of delivery also have an 
increased risk of stillbirth (RR 1.83), independent of parity and adjusting for 
socioeconomic status (97). 
The day of a person’s birth is the day of ones greatest risk of death until one reaches 
old age  but despite this and all the associated risk factors discussed above, stillbirths 
are not currently recorded in the Millennium Development Goal (MDG) for child 
survival or the Global Burden of disease metrics which is also likely  to be another 
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reason for the underestimation of the total number of stillbirths worldwide (29, 30, 
98).  
In 2011 a series of high profile papers was published which highlighted the global 
burden of stillbirth. ‘Stillbirths: why they matter’ presented a survey of 2,490 health 
professionals in 135 countries and 1,127 parents in 32 countries (99). This 
highlighted several important issues. Mothers who had experienced a stillbirth were 
often subjected to stigma and marginalisation in communities that would blame the 
death on the mothers own sins, evil spirits and destiny with little bereavement 
support, particularly in Sub-Saharan Africa (99). One in two mothers were unable to 
grieve in public due to stigma attached to stillbirth and this experience was not 
limited to Africa but was also found throughout parts of Europe, Russia and South 
America (Figure 2)(99). 
 
Figure 2 Percentages of stigma felt by grieving mothers of stillborn infants (Permission to reproduce 
this figure has been granted by Elsevier through Copyright Clearance Centre)  (99) 
Low income countries, showed a much higher degree of detachment to the stillborn 
fetus than more developed countries with the overall survey finding that four out of 
every five fetuses that were stillborn had been disposed of without a name and 
without any ritual recognition of the passing of life; 75% had not been held or 
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dressed and one quarter were not seen by the mother or family members (99). A 
disparity in stillbirth rates globally was found with an inverse association with sex 
equality such as secondary education and reproductive control (Figure 3) (99). 
 
Figure 3 Stillbirth rates plotted against indicators of disparity in income and sex equality 
(Permission to reproduce this figure has been granted by Elsevier through Copyright Clearance 
Centre) (99) 
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Seventy percent of those people completing the survey in high burden areas agreed 
that stillbirth prevention needed prioritising (99). A lack of knowledge on the causes 
of stillbirth combined with limited evidence of preventability means that much more 
data collection on the rates and causes of stillbirths together with any preventable 
strategies is needed in order to convince more health professionals that stillbirth 
should be as highly prioritised as preventing infant and maternal deaths (99). The 
lasting message was that stillbirths need visible leaders for both local communities 
and on the wider international platform to encourage the United Nations to include 
stillbirth in their global health policy (99).  
‘Stillbirths: Where? When? Why? How to make the data count’, highlighted the 
invisibility of stillbirth; how stillbirth is not on the Millennium Development Goals, 
or in the Global Burden of Disease metrics, as fore mentioned nor is data compiled 
by the United Nations (100). 
‘Stillbirths: what difference can we make and at what cost’ was a systematic review 
of randomised trials and observational studies of interventions which could reduce 
the burden of stillbirth, particularly in low and middle-income countries (101). 98% 
of the 2.65 million stillbirths worldwide occur in low-middle income countries (101). 
The review found that the main causes of stillbirth in these settings were; childbirth 
complications, maternal infections in pregnancy (e.g. syphilis), maternal disorders 
(particularly hypertension), maternal under nutrition, fetal growth restriction and 
congenital abnormalities. The authors reviewed 35 possible interventions that may 
reduce stillbirth, 10 of which were highly recommended by the paper for 
implementation. These included; periconceptional folic acid fortification, insecticide 
–treated bed nets or intermittent preventative treatment for malaria prevention, 
syphilis detection and treatment, detection and management of hypertensive disease 
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of pregnancy, detection and management of diabetes in pregnancy, detection and 
management of fetal growth restriction, routine induction to prevent post-term 
pregnancies, skilled care at birth, basic emergency obstetric care and comprehensive 
emergency obstetric care (101). 
In high income countries, less than 10% of all stillbirths are intrapartum and there is 
good access to high quality care compared to low and middle income countries 
where there are an estimated 46% of women giving birth without skilled assistance 
(101, 102). Using the Lives Saved Tool the authors found that if there was 99% use 
of these 10 recommendations, 45% of stillbirths could be prevented (101). The 
authors finally highlighted the need for further data collection on the gestational age 
of the stillbirth and whether the death was ante or intrapartum- a similar plea to that 
of the first stillbirth series paper (99, 101).  
‘Stillbirths: how can health systems deliver for mothers and babies’ focused on how 
the recommendations outlined above could be implemented and ‘Stillbirths: the way 
forward in high income countries’ highlighted that the UK has one of the highest 
stillbirth rates in high income countries, recognises that there are modifiable risk 
factors for stillbirth  and suggests the need for further data collection and a thorough 
investigation of the death is necessary including placental histopathology and 
autopsy (103, 104). The authors agree that there needs to be a consensus on the 
definition and classification of stillbirth in order to further our knowledge and data 
collection together with research into the underlying mechanisms of stillbirth and 
how it can be detected; thoughts echoed by other literature (104-107). 
In the United Kingdom, SANDs, the stillbirth and neonatal death charity, shares the 
thoughts above and offers support to those affected by the death of a baby. The 
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charity aims to promote research into the field and helps to fund research 
programmes such as this project (108). The charity was founded in 1978 by two 
bereaved parents (108). Over the course of the last 30 years the Charity has made 
great progress in the recognition of the grief caused by stillbirth and the medical and 
legal documentation of the death and postmortem in the UK. (108).  
1.1 Classification systems for perinatal deaths and stillbirth  
 
As highlighted in the Lancet series, the classification of stillbirth varies globally as 
do the terms used to describe it such as birth asphyxia, fresh stillbirth, intrauterine 
stillbirth and delivery-related perinatal death, making the collation of data more 
difficult (104, 107, 109, 110). 
Over the last 60 years there have been many attempts to classify stillbirths. In 1954 
the Aberdeen classification system was developed after stillbirths first became 
notifiable in Scotland in 1940 (111, 112). Figure 4 displays the Aberdeen 
classification of stillbirth which is based more on obstetric findings and 
complications than findings at postmortem (113). 
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OBSTETRIC (Aberdeen) CLASSIFICATION 
Categories at the head of the list take priority over those lower down.  Only ONE answer applies – it is the lowest 
numbered category that adequately describes the death.   
Code Category 
 Congenital anomaly:- any structural or genetic defect incompatible with life or potentially treatable   but 
causing death 
1 Neural tube defects 
2 Other anomalies 
 Isoimmunisation:- death ascribable to blood group incompatibility 
3 Due to Rhesus (D) antigen 
4 Due to other antigens 
 Pre-eclampsia 
5 Without APH 
6 Complicated by APH 
 Antepartum Haemorrhage (APH) 
7 With placenta praevia 
8 With placental abruption 
9 APH of uncertain origin 
 Mechanical  
10 Cord prolapse or compression with vertex or face presentation 
11 Other vertex or face presentation 
12 Breech presentation 
13 Oblique or compound presentation, uterine rupture etc. 
 Maternal disorder 
14 Maternal hypertensive disease 
15 Other maternal disease 
16 Maternal infection 
 Miscellaneous 
17 Neonatal infection 
18 Other neonatal disease 
19 Specific fetal conditions 
 Unexplained 
20 Equal or greater than 2.5kg 
21 Less than 2.5kg 
22 Unclassifiable 
Figure 4 Aberdeen classification of stillbirth (113) 
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In 1980, the Wigglesworth classification system was created in an attempt to 
simplify and unify professional’s opinions about cause of death with the purpose of 
this classification to subdivide cases into groups with clear implications for clinical 
management (4). 
The Wigglesworth system is based on major groups of pathophysiological 
abnormalities/conditions of the fetus defined as; 
1. Normally formed macerated (Stillbirth) 
2. Congenital malformation (Stillbirth or neonatal death) 
3. Conditions associated with immunity (Neonatal death) 
4. Asphyxial conditions developing in labour (Fresh stillbirth/neonatal death) 
5. Specific conditions other than the above (4) 
This classification system has several flaws. Firstly, it covers both stillbirths and 
neonatal deaths, two separate entities. Secondly a normally formed but macerated 
fetus is not a cause of death and this classification does not help to distinguish those 
fetuses that died before or during labour (4). The classification system may help 
clinicians understand areas of deficit within their clinical practise, but it does not 
provide a pathological cause of death.  
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Classification system according to 
relevant 
condition at death (ReCoDe) 
 
Group A: Fetus 
1. Lethal congenital anomaly 
2. Infection 
2.1 Chronic 
2.2 Acute 
3. Non-immune hydrops 
4. Isoimmunisation 
5. Fetomaternal haemorrhage 
6. Twin-twin transfusion 
7. Fetal growth restriction* 
 
Group B: Umbilical cord 
1. Prolapse 
2. Constricting loop or knot† 
3. Velamentous insertion 
4. Other 
 
Group C: Placenta 
1. Abruption 
2. Praevia 
3. Vasa praevia 
4. Other “placental insufficiency”‡ 
5. Other 
 
Group D: Amniotic fluid 
1. Chorioamnionitis 
2. Oligohydramnios† 
3. Polyhydramnios† 
4. Other 
 
Group E: Uterus 
1. Rupture 
2. Uterine anomalies 
3. Other 
 
Group F: Mother 
1. Diabetes 
2. Thyroid diseases 
3. Essential hypertension 
4. Hypertensive diseases in 
pregnancy 
5. Lupus or antiphospholipid 
syndrome 
6. Cholestasis 
7. Drug misuse 
8. Other 
 
Group G: Intrapartum 
1. Asphyxia 
2. Birth trauma 
 
Group H: Trauma 
1. External 
2. Iatrogenic 
Group I: Unclassified 
1. No relevant condition identified 
2. No information available 
* < 10th customised weight for 
gestational age centile. 
†If severe enough to be considered 
relevant. 
In 2005 an article was published on a further 
classification system for stillbirth,  ReCoDe an 
acronym for Relevant Condition at Death (5) (Figure 
5). The aim of this system was to establish what 
conditions are associated with death not necessarily 
the mechanisms(5). It classifies fetal growth 
restriction as a fetus below the 10
th
 customised 
centile (5). Using registry data of over 2500 cases of 
stillbirths over a 7 year period in the UK, the study 
demonstrated that when the Wigglesworth 
classification system, the fetal and neonatal 
classification system and the revised obstetric 
(Aberdeen) classification systems were used, the 
cause of death was unexplained in 66.2%, 66.2% 
and 52.7% respectively. 
Using the ReCoDe classification, only 15.2% of 
cases were unexplained and the majority (43%) fell 
into the category of fetal growth restriction (5). This 
study highlighted the need for further investigation 
into the association between fetal growth restriction 
and stillbirth, particularly when 57.7% of 
Wigglesworth’s unexplained cases were found to be 
growth restricted in the ReCoDe study (5). 
The ReCoDe system appears more comprehensive 
Figure 5 ReCoDe Stillbirth Classification (Permission to reproduce this figure has been granted by BMJ 
Publishing Group Ltd) (5) 
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but does not necessarily address why the fetus died or what went wrong and has a 
major emphasis on fetal weight as a defining factor for IUGR, which is likely 
erroneous (See Chapter 5).  
In 2009, Causes Of Death and Associated Conditions, classification was published 
(114). CODAC was developed to follow the concepts within the International 
Classification of disease (ICD) and contains ten main categories; intrapartum events, 
infections, congenital abnormalities, unknown causes of death, termination of 
pregnancy, fetal, cord, placental, maternal, conditions relevant to the neonatal period 
(114). 
In full, CODAC contains 94 subcategories which are then further specified into 577 
categories (114). The system is designed to accommodate both the main cause of 
death as well as two associated conditions and combines both the clinical and 
pathological causes of stillbirth (114).  
 A review of six stillbirth classification systems, the Amended Aberdeen, the 
Extended Wigglesworth, PSANZ-PDC (Perinatal Society of Australia and New 
Zealand – Perinatal Death Classification), ReCoDe, Tulip and CODAC reported that 
three of the systems (Tulip, Wigglesworth and Aberdeen) focussed on identifying a 
single underlying cause of death; CODAC and PSANZ-PDC tried to find the cause 
of death and any associated conditions on secondary and tertiary levels; and ReCoDe 
aimed to find a relevant condition and /or a cause of death (115). Only the ReCoDe 
system was designed for exclusive use in stillbirths (115). Three measures of 
outcome were used (InfoKeep: A scoring system to measure the extent to which the 
classification teams agreed that important information to aid in the understanding of 
the death was conserved and retrievable after classification ; Ease Score: which 
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measured the extent to which the classification team agreed that it was easy to 
identify the relevant category in the classification system; Inter-observer reliability: 
inter-observer agreement beyond chance for the main classification categories was 
assessed using the unweighted kappa statistic (115)).  
 
  
Figure 6 Retention of important information (InfoKeep) and ease of use (Ease) scores by 
classification systems. (Permission to reproduce this figure has been granted; the article is an open 
access article with unrestricted use of its content) (115) 
Teams assessed 857 cases of stillbirth (115). Infokeep scores were significantly 
different across the classifications (p<0.01; Figure 6) due to low scores in both the 
Wigglesworth and Aberdeen classifications. The Ease of use scores were similar and 
significantly different across the classifications (p<0.01) with CODAC having the 
highest score and Wigglesworth the lowest (115). 
The Aberdeen and Wigglesworth classifications had the worst inter-observer 
reliability with kappa values of 0.35 and 0.25 respectively. Tulip had the best inter-
observer reliability with a kappa value of 0.74 (115). 
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The proportion of unexplained stillbirth deaths varied greatly between the 
classification systems but was not statistically significant (p=0.38). The CODAC 
system had the least amount of unexplained deaths and the Wigglesworth and 
Aberdeen systems had the most unexplained deaths (115). 
This review suggested that the Extended Wigglesworth and the Amended Aberdeen 
classification systems should no longer be used to classify stillbirths (115). The best 
performing system was CODAC (115). No one system was a perfect fit and their 
correct and appropriate use in both developing and developed countries remains a 
challenge.   
Perinatal pathologists, paediatricians, obstetricians and public health professionals 
need a united classification system that can be used throughout the world simply, 
effectively, confidently and accurately to continue to improve research into the cause 
of stillbirth. Furthermore, it should be recognised that different classification systems 
may be required for different purposes; for example, the assessment of underlying 
pathophysiological mechanisms versus identifying deficiencies in clinical care. 
1.2 The importance of the placenta 
The placenta and the umbilical cord are essential for intrauterine life and therefore, 
unsurprisingly, each classification system discussed above has a section available for 
causes of death associated with or caused by abnormalities of the placenta (116). 
Abnormalities at a macroscopic, microscopic and/or molecular level (including 
infections) within the arteries, veins, villi or umbilical cord can fatally disrupt blood 
and nutrient flow to the developing fetus (116-137). Abnormalities can include, 
ascending genital tract infections in which firstly there is a Maternal Inflammatory 
Response (MIR) followed by a Fetal Inflammatory Response (FIR) although a FIR is 
not always seen in early preterm stillbirth (138, 139).  The innate immune system 
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responds with neutrophils (140). In the FIR leukocytes migrate from fetal vessels in 
the umbilical cord to the chorionic plate (funisitis). FIR increases with gestational 
age and the severity of MIR (141). Histologically ascending genital tract infection is 
associated with polymorphonuclear leucocytic infiltration of the extraplacental 
membranes, the intervillous space and finally the chorionic plate (142). Thrombi can 
form in chorionic vessels due to the activation of endothelial cells which can 
embolize into the fetus (142). Exposure to infection can cause preterm delivery, 
hypoxia and death (142, 143). Abnormalities can present secondary to 
haematogenous infections such as Toxoplasmosis and cytomegalovirus (144). 
 
Hypertension and Pre-eclampsia/Eclampsia can also lead to placental abnormalities 
of which the former affects around 5-8% of pregnancies (144, 145). A large 
population based study of 57 million singleton live and stillbirths found that 
pregnancy induced hypertension is associated with increased risk of stillbirth with a 
higher risk in second order plus pregnancies than  in mothers who are primigravida 
(145, 146). Pre-eclampsia can be defined as maternal endothelial dysfunction with 
clinical hypertension, oedema and proteinuria and is associated with increased risk of 
stillbirth (117, 147).  
 
Placental Abruption, defined as the complete or partial separation of a normally 
implanted placenta before delivery can cause fetal death, severe haemorrhage, need 
for blood transfusions, emergency hysterectomy, disseminated intravascular 
coagulopathy and renal failure and is a recognised cause of stillbirth, especially in 
the third trimester (148).  
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Specific pathologies only diagnosable on histological examination associated with 
growth restriction and fetal death, such as massive perivillous fibrin deposition, can 
also occur as well as the spectrum of changes associated with maternal vascular 
malperfusion including those previously known as uteroplacental vascular disease 
(149, 150). 
 
Placental abnormalities are therefore believed to be a common cause of death in 
stillbirth, (151).  A review of placental pathology in association with stillbirth 
reported that the placental pathology was associated with stillbirth in anywhere from 
11 - 65% of cases. Placental abruption was the most frequently identified placental 
cause of stillbirth. Diagnostic criteria and nomenclature for placental abnormalities 
varied between studies thus making observations rather subjective and increasing the 
risk of observer bias and inter-observer variability (152). Again the lack of an 
adequate evidence base for interpretation of histological findings is evident together 
with a lack of any definitive and accurate classification of the cause of death of 
stillbirth.  
At present there are no clinically useful first or second-trimester tests of placental 
function to reliably predict stillbirth, although uterine artery Doppler indices and 
maternal serum PAPP-A levels appear to be promising candidates for early detection 
of placental dysfunction (153). Placental examination in stillbirth autopsy is advised 
and histological analysis has clinical value, however; improved communication 
between scientists, clinicians and pathologists and advanced research is still needed 
to explore further the role of the placenta in stillbirth (154-156).  
Cord insertion and placental disc shape, in livebirths, have been reviewed in large 
scale studies and it is reported that the cord is more typically eccentric than central 
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and the placental disc elliptical rather than round. No differences were seen 
comparing groups of normal pregnancies to those with pre-eclampsia, pregnancy 
induced hypertension, gestational diabetes mellitus or small for gestational age as 
well as those with specific placental histological abnormalities (157, 158). However, 
such studies have not been completed in relation to or in comparison to stillbirth.  
1.3 Current postmortem investigation is stillbirth 
There are currently no evidence based guidelines in the United Kingdom of the 
pathological investigation of stillbirth; recommendations from the Royal College of 
Pathologists exist, which are based on expert opinion (159). There are no statutory 
requirements to investigate intrauterine death and the parents of a stillborn infant can 
either consent to a full or limited autopsy or decline autopsy examination. 
Autopsy uptake after stillbirth has been falling in the UK over the last 10-20 years 
and now ranges from only 40-50% (160). The discussion  between the health 
professional and parents regarding autopsies usually only occurs once, several hours 
after the stillbirth, through verbal communication with little written information 
about autopsy being available to parents (160). It has been recognised that emotional 
distress and perceived lack of rapport between the health professional and the family 
may be barriers in gaining consent for stillbirth autopsy together with the health 
professionals own perception of autopsy; a lack of appropriate training to gain 
parental consent for autopsy (particularly in cases with cultural diversity) and the 
history of organ retention by some hospitals (160-162). Parents may refuse autopsy 
in fearing that their child will be mutilated by the procedure; that they want their 
child to rest peacefully after its death; and sometimes religious and cultural beliefs 
about autopsies and the need to bury the dead quickly mean parents decline autopsy 
(162-165). Improved training and the use of more senior health professionals (i.e. 
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Consultant Obstetricians rather than juniors or midwives) and the support and 
availability of perinatal pathology services appear to help improve stillbirth autopsy 
uptake (166). 
Full autopsy consists of an external and an internal examination with the weighing 
and sampling of organ tissue and the placenta for histological analysis. 
Evidence of fetal maceration, the process of fetaltissue changes due to immersion in 
fluid after intrauterine death, has rarely been investigated or analysed in the context 
of cause of death in stillbirth, but is frequently commented on during external 
examination of a fetus at autopsy (167).   Maceration can be defined as mild, 
moderate or severe based on the degree skin slippage/peeling, effusions within 
serous cavities and fetal mummification but little is reported about any effects of 
maceration on the overall weight of a fetus, individual organ weights or the ability to 
assign a cause of death (167). Only one previous study has reported that weights of 
the liver, thymus and spleen were markedly lighter with increasing maceration in 
perinatal autopsy cases (168). It is assumed that maceration worsens the longer the 
time period between intrauterine death and delivery (Intrauterine interval, IUI) but 
this is based on conjecture highlighting the necessity of assessing both maceration 
and IUI.  
Autopsies are also not completed immediately after death and postmortem interval 
(PMI) can vary from one day to several weeks, depending on individual 
circumstances. The effects of postmortem interval on fetal weight, organ weight or 
cause of death have not been previously systematically investigated.  
Fetal brain to liver weight ratio (in grams) is used in clinical pathology practise as a 
marker for fetal growth restriction. However, this is based on two small historical 
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studies, neither of which provide data on pathological mechanism of death or 
possible effects of maceration, IUI or PMI (169, 170).  
Histological examination of fetal tissue samples for a wide range of organs is also 
recommended in Royal College guidance however, there are no studies which have 
examined in any detail, the usefulness of such histological examination or the 
correlation between positive histological findings and cause of death. Thymus 
histology is recommended in stillbirth autopsies to assess for accelerated involution 
which has been suggested to be an indicator of prenatal stress and IUGR (171, 172).  
Involution is graded using the Van Baarlen Grading scale, however this assessment 
is essentially subjective and relies on consistent reporting from perinatal pathologists 
making judgements on the degree of lymphodepletion and shrinkage of the cortex, 
without the use of measurements, with great potential for bias (173). 
Other investigations such as fetal radiographs, Magnetic Resonance Imaging (MRI) 
Computered Tomography (CT) and microbiological and virological sampling and 
are also recommended based on expert opinion (159, 174). 
Genetic testing is also recommended, in the appropriate setting, at stillbirth autopsy, 
however, antenatal ultrasound scanning has greatly advanced over the last 20 years 
and now plays a vital role in detecting fetal congenital abnormalities, particularly in 
the second trimester (175). Many of these cases may now be terminated by parental 
choice thus limiting the need for genetic analysis and confirmation of results at 
autopsy, however autopsy can provide additional information in up to 30% of these 
cases (175).  
If congenital abnormalities are discovered macroscopically at autopsy the reporting 
pathologist will usually ask for genetic analysis of fetal tissue. At present 
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cytogenetics and karyotyping can be undertaken on a fresh placental sample (1cm
3
) 
from the fetal aspect of the placenta and thus needs to be collected prior to the 
placenta being placed in formalin (175, 176). DNA from organ tissue samples can 
also be helpful and important as karyotyping can differ between the fetus and its 
placenta: DNA can still be extracted from such fresh tissue 3-5 days after delivery 
(175, 176). Abnormal fetal karyotypes have been reported in stillbirths at similar 
proportions to liveborns, the majority being 45X, trisomy 21, trisomy 18 and trisomy 
13, however standard karyotyping can fail in up to 50% of cases and cannot detect 
abnormalities less than 5 megabases (176). New laboratory techniques such as 
Comparative Genomic Hybridization (CGH), which does not rely on tissue culture 
and appears to have a higher success rate than conventional karyotyping, could lead 
to greater detection of genetic abnormalities in stillbirth due to its ability to evaluate 
the whole genome for microdeletions 1 megabase or smaller (176-178). However, 
CGH may be more useful in detecting abnormalities in miscarriage than stillbirth 
with detection rates as low as 13% in specific stillbirth populations with known 
congenital abnormalities and CGH is still significantly more expensive than 
conventional karyotyping (179-181). 
It is only recently been hypothesized that single gene mutations (particularly in NOS, 
HIF-1, Klotho and TNF – alpha) and missense mutations associated with LQTS 
susceptibility may account for a proportion of currently unexplained stillbirths (182, 
183). Initial studies have found no significant data in regards to single gene 
mutations but a small percentage (3.3% ) of a selection of unexplained fetal deaths 
(91 cases) had missense mutations associated with LQTS susceptibility and 8% of 
cases had genetic variants leading to dysfunctional LQTS-0 associated ion channels 
in vitro, suggesting there may be a cohort of unexplained stillbirths with genetic 
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abnormalities that could directly or indirectly lead to death (182, 183). More research 
is required in this area with a greater cohort of patients to further establish the role 
and importance of genetics in unexplained stillbirth. 
1.4 The project 
The primary aims of this project are therefore to use a unique autopsy database 
with pre-defined and objective criteria for all fields to examine a large well 
characterised series of stillbirth autopsies to: 
1. Analyse specific causes of death in stillbirth, including in depth analysis of 
death associated with specific and non-specific placental pathology  
2. Assess for possible relationships between fetal maceration, intrauterine interval 
and postmortem interval on body and organs weights with detailed analysis of 
fetuses found to be IUGR/ SGA  
3. Assess the clinical usefulness of histological analysis of fetal tissue 
4. Review and analyse the role of thymic involution in stillbirth autopsy practise 
5. Investigate the potential role of new novel techniques in future stillbirth 
autopsy investigation 
6. Produce evidence based guidance for stillbirth autopsy practise. 
This is the largest study of its kind and the only one in which, rather than using 
autopsy findings based on subjective interpretation, all data fields have predefined, 
objective criteria with pathological findings clearly distinct from interpretation. In 
addition to providing an evidence base for practice, it will identify areas for further 
research in stillbirth.  
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2.0 The database 
During previous research at Great Ormond Street Hospital an objective Microsoft 
Access Database, named the Rapid Study Database was designed for the input of 
postmortem data in cases of Sudden Unexpected Infant Death (184). Although 
extensive the database did not have areas designed for the input of specific details 
such as antenatal and delivery history, which are vital when investigating stillbirth. 
Modifications to the database were therefore required in order to collect and analyse 
data from stillbirth and miscarriage postmortems.  
 
2.1 Modifications to the database 
Eight new tables were created and added to the existing database to improve data 
entry in the most objective manner possible (Table 1). Modifications to the database 
took two months.  Appendix 1 describes in detail, the process of creating the new 
tables and intergrating them as forms into the rapid study database.  After 
modifications there were over 400 fields of entry for each case in the database.  
New Table and Form heading Details entered in the form 
Antenatal Details  Maternal blood tests 
 12 and 20 week Ultrasound scan 
report findings including Doppler 
results.  
 Space to record any evidence of pre-
eclampsia, Diabetes Mellitus and 
other ultrasound scan reports. 
 Maternal body mass index   
 Gestation of intrauterine death. 
 Free text box for any further 
information 
Delivery Details  Mode of delivery 
 If caesarean, why this was undertaken 
 Details of any intrapartum events  
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 Degree of fetal maceration 
Placenta  Type of placenta (single or multiple) 
 Placental weight (trimmed) 
 Cord length, vessels and coiling 
 Macroscopic and microscopic 
description for cord, membranes and 
placental disc 
 Free text boxes for further 
information. 
 
Consent  Type of consent for the postmortem 
including if consent was given for 
histological analysis and research of 
tissue. 
Cause of death  There are four tables within this form  
1. Cause of death e.g. ascending 
infection 
2. Abnormalities e.g. of the cord, 
placenta or organ 
3. Pathologists opinion of the cause 
of death (free text) and separate 
entry area for cause of death 
assigned during analysis for this 
research 
4. Quick classification system of 
those cases with Diabetes 
Mellitus/ obesity/ previous fetal 
loss.  
Table 1 Details of new tables and forms entered into the database. 
 
2.2 Data Entry 
Over a six month period, postmortem and antenatal details available for all stillbirth 
(>24 weeks), early (<20 weeks) and late (20-24 weeks) intrauterine deaths, dating 
from 2005 – 2013 (inclusive), from their paper records stored at Great Ormond 
Street Hospital, London were entered onto the database. (The term ‘Miscarriage’ will 
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be used throughout this thesis for ease of all pre-viable intrauterine deaths to 
distinguish them from stillbirth at 24 weeks of gestation and beyond). This gave a 
total of 817 cases. Despite Great Ormond Street Hospital being a tertiary referral 
centre for Paediatric deaths and complex anomalies, all stillbirth cases used in this 
study were referred from local District General Hospitals in the surrounding region 
as part of an existing service level agreements in which Great Ormond Street 
hospital was the regional referral centre for stillbirth autopsies. The data is therefore 
likely to be a valid representation of stillbirths one would expect from any other 
region in the UK since perinatal pathology services are regionalised. Data was 
collected and documented on second trimester intrauterine deaths (miscarriages) in 
addition to third trimester stillbirths to allow for comparison of associated findings 
between the different gestational ages at death and as a point of interest since 
minimal research has previously been completed on miscarriage autopsy findings 
compared to stillbirth. Further data was collected from St Georges Hospital, London 
to include 247 third trimester stillbirths (from the years 2012 and 2013) in order to 
increase the number of third trimester stillbirths within the study since stillbirths 
were not routinely examined at Great Ormond Street Hospital in the early years of 
the study. Due to the nature of the database, cases from the year 2012 from St 
Georges were coded on the database with a PM number of 21Pxxx and the 2013 
cases as 31Pxxx.   
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 Figure 7 Screen shot of the antenatal details form in the database 
The data entered for each case was obtained from the postmortem pack, which 
included the completed, typed autopsy report as authorised by a specialist Consultant 
Paediatric Pathologist, the completed consent form for the autopsy, a copy of the 
antenatal history and a completed perinatal death form to include the nature of the 
death (e.g. intrapartum or intrauterine) and surrounding circumstances. The 
completeness of the information in the postmortem pack was very variable and thus 
a potential limiting factor in this study. Not all cases contained maternal 
demographic information or a detailed review of the antenatal history. Any 
information provided was entered onto the database and in those cases without the 
information provided data fields were left blank or filled in with the appropriate 
dropdown option of “Not given”.  However, the aim of the current study was to 
determine the relative contribution of aspects of the autopsy as available to the 
pathologist at the time of the procedure, therefore the information provided is exactly 
comparable to routine clinical care. Data entry was standardised using two protocols; 
one designed previously for the original database and a second that was designed 
specifically for data entry into the new tables/forms (Appendix 2) (184). Cases in 
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which the fetus received resuscitation immediately after delivery but did not have 
any signs of life were included in the study. Cases were excluded if the fetus gained 
or re-gained signs of life after resuscitation and in which an extremely premature 
fetus was delivered alive but survived without any intervention for a limited amount 
of time (usually less than 1 hour).  
Once entered all the data was analysed through queries and statistical tests run 
through Microsoft Access, Excel, Graph Pad Prism and Stats Direct. Any statistical 
test within this thesis can be viewed in detail in Appendix 3. Statistical tests used 
included, Mann Witney, Regression Analysis, Chi Squared and ROC Curves. Each 
of the results chapters contain a separate Methods sections which describe any 
additional methods used for specific analysis.   
 
2.3 Histology and Laboratory Work 
Histology and laboratory work account for a small part of the project and therefore 
the specific methods are discussed in the relevant Chapters (Chapters 9 and 10).  
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3.0 Background 
 
There are an estimated 1.02 million intrapartum stillbirths each year and a total of at 
least 3.2 million stillbirths worldwide (30). In 2013 there were 781,932 births in the 
United Kingdom of which 3,286 were stillborn, calculating a rate of 4.2 stillbirths 
per 1000 births (185). 
Epidemiological associations include a parity of zero or greater than 3; mothers of 
African, African –Caribbean, Indian or Pakistani ethnicity and mothers with a body 
mass index over 30 (52, 186). Studies in London and Australia further highlight the 
role of ethnicity in stillbirth reporting that black and Asian women have twice the 
odds of stillbirth compared to white women even after adjusting for age, parity, 
deprivation, obesity, hypertension and diabetes and that mothers who were native to 
South Asia have an increased risk of antepartum stillbirth in late pregnancy (37 -42 
weeks gestation) compared to other women in an Australian population (94, 95).  
Other associations include smoking; maternal Diabetes Mellitus; history of antenatal 
vaginal bleeding and raised maternal age; women between the ages of 30-34 have a 
27% greater risk of stillbirth (and other obstetric events) compared to mothers 
between the ages of 25-29, after adjusting for parity, ethnicity, body mass index, 
maternal co-morbidities and deprivation (52, 96). Women aged over 40 years also 
have an increased risk of stillbirth (97, 187).  
In view of the many maternal demographic associations to stillbirths, this chapter 
will provide an overview of the demographics of this study’s population (both 
maternal and fetal), to allow for comparison with national and published statistics.  
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3.1 Methods 
The Microsoft Access Autopsy Database was used to collate postmortem and 
antenatal details available for all stillbirths, early and late miscarriage from 2005 – 
2013 from Great Ormond Street Hospital and St George’s Hospital, London.  Data 
was analysed through queries and statistical tests run using Microsoft Access, Excel, 
Graph Pad Prism and Stats Direct. Statistical tests can be viewed in detail in 
Appendix 3.  
3.2 Results  
3.2.1 Total population 
Data was collected from 1,064 individual autopsy reports, from fetuses with 
intrauterine and intrapartum death delivered from 12 weeks gestation to term. Table 
2 shows the total number of cases in each death category; early miscarriage, late 
miscarriage and stillbirth.  
  
Early 
miscarriage Late miscarriage Stillbirth Total 
Total Number of cases 246 (23%) 179 (17%) 639 (60%) 1064 
Table 2 Number of cases for each category of death in the overall study population 
The majority of the cases are third trimester stillbirths. Table 3 shows the 
distribution of all cases dependant on whether the death was intrauterine (more or 
less than 24 hours) or intrapartum (known or fresh) for the total number of cases. 
Tables 4-6 show the distribution in the timing of death i.e. intrauterine or 
intrapartum, for each death category. In both the Early Miscarriage and Stillbirth 
categories the most common type of death was intrauterine with retention of the 
fetus for more than 24 hours in utero. In the late miscarriage group the most common 
type of death was a fresh intrapartum death.  
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Intrauterine 
death < 24 hours 
Intrauterine 
death > 24 
hours 
Intrapartum 
death – known 
 
Intrapartum 
death – fresh 
 
Total 
 
Total 
Number of 
cases 138  (13%) 628  (59%) 29  (3%) 269  (25%) 1064 
Table 3 Total cases split into different types of deaths 
Table 4 Type of death in early miscarriage 
 
  
Intrauterine 
death < 24 
hours 
Intrauterine 
death> 24 
hours 
Intrapartum 
death - known 
Intrapartum 
death - fresh 
Total 
 
Late 
miscarriage 21 (12%) 71 (39%) 6 (3%) 81 (45%) 179 
Table 5 Type of death in Late miscarriage 
 
 
  
Intrauterine 
death < 24 
hours 
Intrauterine 
death> 24 
hours 
Intrapartum 
death - known 
Intrapartum 
death - fresh Total 
Stillbirth 92 (14%) 430 (67%) 18 (29%) 99 (15%) 639 
Table 6 Type of death in stillbirth 
 
  
Intrauterine 
death < 24 
hours 
Intrauterine 
death> 24 
hours 
Intrapartum 
death - known 
 
Intrapartum 
death - fresh 
 
Total 
 
Early 
miscarriage 25 (10%) 127 (52%) 5 (2%) 89 (36%) 246 
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Figure 8 The percentage of each death type within each death category 
3.2.2 Seasonal distribution of cases 
 Season 
 
Total number of cases 
Spring 
239 (23%) 
Summer 
330 (31%) 
Autumn 
260 (25%) 
Winter 
229 (22%) 
Totals:  
 
1058 
No information provided 
 
6 
Table 7 Seasonal distribution of cases 
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 Season Early Miscarriage Late Miscarriage Stillbirth 
Spring 53 (22%) 46 (26%) 140 (22%) 
Summer 75 (31%) 54 (30%) 201 (32%) 
Autumn 64 (26%) 39 (22%) 157 (25%) 
Winter 52 (21%) 40 (22%) 137 (22%) 
Totals:  244 179 635 
No information 
provided 2 0 4 
Table 8 Seasonal distribution of cases within each death category  
 
There was a non-significant peak in deliveries in the summer months.   
 
 
Figure 9 Seasonal distribution of cases in each death category 
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3.2.3 Fetal Gender 
Fetal Gender Number of cases 
Male 569 (53%) 
Female 466 (44%) 
Unknown at PM / no information 
given 29 (3%) 
Total:  1064 
Table 9 Fetal gender within the total population studied.  
 
Fetal Gender 
 
Early miscarriage Late miscarriage Stillbirth 
Male 
 
 
129 (52%) 92 (51%) 348 (54%) 
Female 
 
 
101 (41%) 80 (45%) 285 (45%) 
Unknown at PM / no 
imformation given 
 
 
16 (7%) 
7 (4%) 6 (1) 
Total:  
 
 
246 179 639 
Table 10 Fetal Gender by death category 
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Figure 10 Fetal Gender within each death category  (excluding unknowns). There is a similar 
distribution of gender between categories of death but overall a greater number of male fetuses (not 
significant). 
There was no significant difference in the proportion of male to female fetuses 
between the miscarriage and the stillbirth categories (z = 0.0003, p = 0.10). There 
was also no significant difference between the observed and expected number of 
males and females in both miscarriage and stillbirth (z = 0.38, p = 0.70 and z=0.36, 
p=0.72 respectively).  
3.2.4 Maternal Age 
Maternal Age (years) Study population 
14 and under  1 (<1%) 
15-19  43 (4%) 
20-24  131 (13%) 
25-29  241 (23%) 
30-34  330 (32%) 
35-39  209 (20%) 
40-44  80 (8%) 
45-49  4 (<1%) 
50 and over  0 
Total 1039 
No Information given 25 
Table 11 Maternal age in the study population 
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Figure 11 Distribution of maternal age  
 
 
Maternal Age (years) Early miscarriage Late miscarriage Stillbirth 
14 and under  1(<1%) 0 (0%) 0 (0%) 
15-19  7 (3%) 4 (2%) 32 (5%) 
20-24  31 (13%) 20 (11%) 80 (13%) 
25-29  47 (20%) 37 (21%) 157 (25%) 
30-34  69 (29%) 66 (37%) 195 (31%) 
35-39  62 (26%) 31 (18%) 116 (19%) 
40-44  23 (10%) 17 (10%) 40 (6%) 
45-49  0 (0%) 2 (1%) 2 (<1%) 
50 and over  0 (0%) 0 (0%) 0(0%) 
Total 240 177 622 
Unknown  6 2 17 
 Table 12 Maternal age distribution by death category 
 
0
5
10
15
20
25
30
35
14 and
under
15-19 20-24 25-29 30-34 35-39 40-44 45-49 50 and
over
P
er
ce
n
ta
g
e 
o
f 
ca
se
s 
Maternal Age (years) 
% Study
population
Autopsy Investigation in Stillbirth 
 
59 
 
 
Figure 12 Maternal age distribution by death category (excluding not givens) 
There is a peak of mothers in the age group 31-45 years who experience a fetal loss.  
The mean maternal age of the population studied is 31 years. There is no significant 
difference in the maternal age distribution between the stillbirth and miscarriage 
groups. 
National information and data regarding the antenatal period, labour details and 
some postpartum details are collected by the Health and Social Care Information 
centre in the UK (188). For the purposes of this study data from the years 2012/2013 
from this resource has been used as control data against the study population.  
Data can be compared between the national distribution of maternal age (for all 
pregnancies) with the distribution of maternal age from this study’s population as a 
whole (miscarriages and stillbirths). 
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Table 13 Maternal age distribution for national data and study population 
Maternal Age National Data 2012 Study population 
14 and under  223 (<1%) 1 (<1%) 
15-19  30,650 (5%) 43 (4%) 
20-24  120,302 (18%) 131 (12%) 
25-29  185,856 (28%) 241 (23%) 
30-34  196,593 (29%) 330 (31%) 
35-39  102,775 (15%) 209 (20%) 
40-44  24,342 (4%) 80 (8%) 
45-49  1,343 (<1%) 4 (<1%) 
50 and over  114 (<1%) 0 (<1%) 
unknown  9,057 (1%) 25 (2%) 
Total: 671,255 1064 
 
 
There is a significant difference in the distribution of the maternal ages of the two 
populations (p = 0.0012) with women within the study being significantly older than the 
general population of women in all pregnancies nationally. (Table 13, Figure 13).  
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Figure 13 Distribution of maternal age, national data and study population 
The two populations can be compared further, looking at the distribution of maternal 
age for both stillbirths and miscarriages separately, between the national data and the 
study population. 
When comparing the national data for stillbirths with the study’s stillbirth population 
(see table 14) there is no significant difference in the maternal age distribution (p= 
0.16).  However compared to the overall national maternal age distribution the 
study’s stillbirth population is significantly older (p = 0.0003). These data 
demonstrate that women suffering intrauterine death are, on average, older than the 
overall maternity population but importantly demonstrate that the current study 
population is representative of the national population of women suffering stillbirth. 
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Maternal Age National data – stillbirths Study population - stillbirths 
14 and under  0 (0%) 0 (0%) 
15-19  183 (6%) 32 (5%) 
20-24  614 (19%) 80 (13%) 
25-29  882 (27%) 157 (25%) 
30-34  873 (27%) 195 (31%) 
35-39  476 (15%) 116 (18%) 
40-44  147 (5%) 40 (6%) 
45-49  13 (0%) 2 (0%) 
50 and over  1 (0%) 0(0%) 
No Information  31 (31%) 17 (3%) 
Total:  3,220 639 
Table 14 Maternal age distribution for both the national data and the study population of stillbirths.  
 
Figure 14 Maternal age distribution for stillbirths in the national data and study population 
(Excluding unknowns) 
When comparing the national data for maternal age in those with miscarriages 
against the study’s population of miscarriages (early and late) there was a significant 
difference in the distribution of maternal age (p= 0.0008). The study’s population is 
significantly older than the national population of women who had miscarriages and 
significantly older than all pregnant mothers (p<0.0001).  
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Maternal Age National data - miscarriages             Study population - miscarriages 
14 and under  34 (0%) 1 (<1%) 
15-19  1959 (5%) 11 (3%) 
20-24  5842 (15%) 51 (12%) 
25-29  8589 (22%) 84 (21%) 
30-34  9809 (25%) 135 (32%) 
35-39  7635 (19%) 93 (21%) 
40-44  3845 (10%) 40 (9%) 
45-49  366 (1%) 2 (<1 %) 
50 and over  609 (2%) 0 (<1 %) 
Unknown 1112 (3%) 8 (<1%) 
Totals:  39800 425 
Table 15 Distribution of maternal age for national data and study population 
 
Figure 15 Distribution of maternal age for both the national data for miscarriage and study 
population of miscarriage (Excluding unknowns) 
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3.2.5 Maternal Ethnicity  
Ethnicity Number of cases (Study population) 
Not Given 313 (29%) 
White, British 276 (26%) 
White, Irish 7 (1%) 
White, Other/NOS 186 (17%) 
Mixed, White and Black 
Caribbean 9 (1%) 
Mixed, White and Black 
African 1 (<1%) 
Mixed, White and Asian 0 (<1%) 
Mixed, Other/NOS 5 (<1%) 
Asian/Asian British, Indian 21 (2%) 
Asian/Asian British, Pakistani 6 (1%) 
Asian/Asian British, 
Bangladeshi 2 (<1%) 
Asian/Asian British, 
Other/NOS 29 (3%) 
Black/Black British,Caribbean 43 (4%) 
Black/Black British, African 149 (14%) 
Black/Black British, 
Other/NOS 14 (1%) 
Chinese 3 (<1%) 
Total: 1064 
Table 16 Maternal ethnicity in the study population  
 
Autopsy Investigation in Stillbirth 
 
65 
 
 
Figure 16 Maternal ethnicity in the study population (excluding unknowns) 
 
The ethnic groups are simplified below into White, Asian, Black, Oriental/other and 
Mixed (excluding not givens) and each death category. (Table 17) 
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Maternal 
Ethnicity 
Early 
Miscarriage 
Late 
miscarriage Stillbirth Total: 
White 87 ( 54%) 71 (53%) 311 (68%) 469 (62%) 
Asian 14 (9%) 10 (7%) 34 (7%) 58 (8%) 
Black 55 (34%) 52 (39%) 99 (22%) 206 (27%) 
Oriental/Other 2 (1%) 0 (0%) 1 90%) 3 (0%) 
Mixed 3 (2%) 2 (1%) 10 (2%) 15 (2%) 
Total: 161 135 455 751  
Table 17 Maternal ethnicity by death category (Excluding not givens) 
 
Figure 17 Maternal ethnicity for each death category (excluding not givens) 
For each death category the largest proportions of death, as displayed in Figure 17 
are to the white mothers, followed by black mothers. Statistically, when comparing 
miscarriages to stillbirths: 
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 White mothers are significantly overrepresented in the stillbirths compared to 
the miscarriages group compared to non-white mother (z= 4.08, p <0.0001).  
 Black mothers are significantly overrepresented in the miscarriages compared 
to stillbirth groups when compared to non-black mothers (z= 3.94, p 
<0.0001). 
 White mothers have a significantly greater proportion of stillbirths than black 
mothers (z= 4.47, p <0.0001)  
 Black mothers have a significantly greater proportion of miscarriages than 
white mothers (z= 4.47, p <0.0001) 
 There is no significance between mothers who are Asian versus Non- Asian 
and mothers of Mixed Ethnicity versus other ethnicity.  
Using the national HSCIC data (188) as controls, a comparison can be made between 
the proportion of cases of each ethnicity (Table 18, Figure 18). 
Maternal Ethnicity  National data Study population 
Asian         71,131 (11%) 58 (5%) 
Black         33,105 (5%) 206 (19%) 
Chinese / Other 24,204 (4%) 3 (< 1%) 
White         482,095 (72%) 469 (44%) 
Mixed         10,091 (2%) 15 (1%) 
Not Stated    39,453 (6%) 0 (0%) 
Unknown       11,176 (2%) 313 (29%) 
Total:  671,255 1064 
Table 18 Maternal ethnicity for both the national data and the study population.  
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Figure 18 Maternal ethnicity within the national data and the study population. (Excluding 
unknowns) 
There is greater proportion of unknown maternal ethnicities in the study population 
but overall the most represented ethnic group is white.  
Black mothers, are significantly overrepresented in the study population (z = 28.06, 
p <0.0001). 
 
3.2.6 Maternal Body Mass Index (BMI)  
The body mass index of the mothers was defined as:  
 BMI underweight= <18 
 BMI normal = 18- 24  
 BMI overweight = 25-29 
 BMI obese = >30 (189) 
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Body Mass Index (BMI) Number / percentage of cases 
BMI underweight 5 (<1%) 
BMI normal 152 (14%) 
BMI overweight 167 (16%) 
BMI obese 143 (13%) 
BMI not given 597 (56%) 
Total: 1064 
Table 19 Maternal BMI in study population 
Body Mass Index (BMI) Early miscarriage Late miscarriage Stillbirth 
BMI underweight 1 (<1%) 0 (0%) 4 (1%) 
BMI normal 42 (17%) 25 (14%) 85 (13%) 
BMI overweight 43 (17%) 34 (19%) 90 (14%) 
BMI obese 41 (17%) 20 (11%) 82 (13%) 
BMI not given 119 (48%) 100 (56%) 378 (59%) 
Totals: 246 179 639 
Table 20 Maternal BMI within each death category 
Unfortunately more than half of the study’s population had no reported maternal 
Body Mass Index (BMI) in their antenatal notes or history as shown in Table 20, 
Figure 19 represents the same data with the exclusion of the unknown BMIs. In both 
the early miscarriage and stillbirth groups the majority of the study’s population of 
mothers had normal BMIs. For Late miscarriage there was a slightly higher 
proportion of overweight mothers and no underweight mothers.  
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Figure 19 Maternal BMI within each death category.   
There are no significant differences between the miscarriage and stillbirth groups 
when comparing body mass index. 
Using national data from the Health Survey for England 2012, HSCIC (190) as 
controls, the study population is significantly more overweight (z= 2.996, p = 
0.0027) and more obese (z= 3.920, p <0.0001) than the total population of women of 
childbearing age confirming obesity is a risk factor for fetal loss (Table 21 and 
Figure20). 
(National figures for obesity had to be taken from women of a child bearing age 
between 25- 34 years from the year 2012 as no data is currently available covering 
the body mass index of all pregnant mothers in the United Kingdom). 
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Maternal Body Mass 
Index 
National data for all women aged 25 - 34 in 
2012 
Study population 
 
Underweight  11 (2%) 5 (1%) 
Normal  275 (49.9%) 152 (33%) 
Overweight  149 (27%) 167 (36%) 
Obese  116 (21.2%) 143 (31%) 
Total 551 467 
 
 
 
 
Figure 20 Maternal BMI in the study population and the national population of women (between the 
ages of 25-34 years in 2012) 
These data confirm that maternal overweight and obesity is associated with increased 
risk for felt loss, but interestingly this risk appears similar for intrauterine death at all 
gestational ages and is not restricted to late third trimester stillbirth.  
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 Table 21 Maternal BMI in the study population and the national population of women (between the 
ages of 25-34 years in 2012) 
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3.2.7 Maternal Smoking 
Maternal smoking status  Total number of cases 
Not given 364 
Smoker 111(16%) 
Non-smoker 589 (84%) 
Total: 1064 
Table 22 Maternal smoking status during pregnancy (percentages exclude not givens) 
 Maternal smoking 
status 
Early Miscarriage 
 
Late Miscarriage 
 
Stillbirth 
 
Not given 96 61 207 
Yes smoker 18 (12%) 17(14%) 76 (18%) 
Non-smoker 132 (88%) 101 (86) 356 (82%) 
Total: 246 179 639 
Table 23 Maternal smoking status by death category during pregnancy (percentages exclude not 
givens)  
The majority of the mothers in the study population were non-smokers but of those 
that did smoke, the majority had stillbirths rather than miscarriages. No further 
analysis of these cases has been performed due to the small numbers and potential 
issues relating to self- reporting of use. 
3.2.8 Maternal Drugs and Alcohol  
 Maternal illicit drug use Total Number of cases 
Not given 594 
Illicit Drugs 17 (4%) 
No Illicit drugs 453 (96%) 
Total: 1064 
Table 24 Maternal illicit drug use during pregnancy (percentages exclude not givens) 
 Maternal Illicit drug use Early miscarriage Late miscarriage Stillbirth 
Not given 168 100 326 
Illicit Drugs 2 (3%) 2 (3%) 13 (4%) 
No illicit drugs 76 (97%) 77 (37%) 300 (96%) 
Total:  246 179 639 
Table 25 Maternal illicit drug use by death category during pregnancy (percentages exclude not 
givens) 
 
Autopsy Investigation in Stillbirth 
 
73 
 
 
 Maternal alcohol use Total number of cases 
Not given 492 
Drank Alcohol 32 (6%) 
No Alcohol 540 (94%) 
Total: 1064 
Table 26 Maternal alcohol use during pregnancy (percentages exclude not givens) 
Maternal Alcohol use  Early miscarriage Late miscarriage Stillbirth 
Not given 125 81 286 
Drank alcohol 6 (5%) 8 (8%) 18 (5%) 
No alcohol 115(95%) 90 (92%) 335 (95%) 
Total: 246 179 639 
Table 27 Maternal alcohol use, by death category during pregnancy (Percentages exclude not givens) 
A very small proportion of mothers drank alcohol or took illicit drugs within our 
population.  No further analysis of these cases has been completed. 
3.2.9 Previous Maternal obstetric history 
Past Maternal Obstetric History Total number of cases 
Primigravida 356 (68%) 
G1+P0 168 (32%) 
Total: 524 
Table 28 Mothers with a past obstetric history of being either primigravida or having one or more 
pregnancies but no live births (G1+P0)  
One third (356/1064) of the mothers in the total study population were primigravida 
and a smaller proportion (16%) had experienced at least one previous pregnancy but 
had no live births. Their losses included miscarriages, stillbirths, terminations and 
ectopic pregnancies.  
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Previous Maternal obstetric 
history 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
Total 
Primigravida 55 (56%) 54 (60%) 247(74%) 
 
356 
G1+P0 44 (44%) 36 (40%) 88 (26%) 
 
168 
Total: 99 90 335 
 
524 
Table 29 Mothers with a past obstetric history of being either primigravida or having one or more 
pregnancies but no live births (G1+P0) in relation to the type of death experienced in most recent 
pregnancy.  
When comparing miscarriages to stillbirths: 
 Mothers had a significantly greater proportion of stillbirths than miscarriages 
if they were primigravida, (z =4.38, p <0.0001) compared to mothers who 
were not primigravida.  
 Mothers had a significantly greater proportion of miscarriages if they were 
G1+P0 (z = 3.78, p < 0.0002) compared to those mothers who were 
primigravida. 
3.2.10 Relevant gynaecological history  
Maternal Gynae History Number of cases 
History of Maternal fibroids 45 (4%) 
History of Bicornate uterus 7 (1%) 
History of Polycystic ovaries 18 (2%) 
PV bleeding( this pregnancy) 70 (7%) 
Previous cervical History 11 (1%) 
IVF pregnancy (this pregnancy) 39 (4%) 
Other gynae history 14 (1%) 
No gynae history/ no history given 860 (81%) 
Total: 1064 
Table 30 Mothers with relevant gynaecology history. 
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A small proportion of the total number of cases had relevant gynaecological history. 
However, certain gynaecological features were associated with differences in 
presentation group. Specifically:  
 Mothers with fibroids were significantly overrepresented in the miscarriage 
group compared to the stillbirth group (z = 3.74, p = 0.0002). 
 Mothers with a history of PV bleeding during the pregnancy were 
significantly overrepresented in the miscarriage group compared to the 
stillbirth group ( z= 3.55 p =0.0004)  
 IVF pregnancies were significantly overrepresented in the miscarriage group 
compared to the stillbirth group (z=3.81, p = 0.0001).  
Maternal Gynae 
History Early miscarriage Late  miscarriage Stillbirth 
History of Maternal 
fibroids 16 (7%) 14 (8%) 15 (2%) 
History of Bicornate 
uterus 1 (<1%) 2 (1%) 4 (1%) 
H/O Polycystic ovaries 1 (<1%) 7 (4%) 10 (2%) 
PV bleeding( this 
pregnancy) 26 (11%) 16 (9%) 28 (4%) 
Previous cervical 
History 3 (1%) 3 (2%) 5 (1%) 
IVF pregnancy (this 
pregnancy) 16 (7%) 11 (6%) 12 (2%) 
Other gynae history 7 (3%) 2 (1%) 5 (1%) 
No gynae history/ no 
history given 192 (78%) 124 (69%) 560 (88%) 
Total:  246 179 639 
Table 31 Mothers with relevant gynaecological histories in each death category 
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Figure 21 Mothers with relevant gynaecological histories in each death category. 
 
3.2.11 IVF Pregnancies 
Table 32 IVF pregnancies for each death category 
A greater proportion of IVF pregnancies ended in miscarriage than stillbirth.  
3.2.12 Diabetes Mellitus (IDDM, GDM) 
DM – Diabetes Mellitus 
IDDM – Insulin Dependent Diabetes Mellitus 
GDM – Gestational Diabetes Mellitus 
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Maternal Diabetic History Total Number of cases in study population 
Not information given 19 (2%) 
No DM 982 (92%) 
Known DM 26 (2%) 
 IDDM 18 
 Non-IDDM 8 
GDM 37 (3%) 
 Non-insulin dependent GDM 14 
 Insulin – dependent GDM 6 
 GDM no info on meds given 17 
Total:  1064 
Table 33 Mothers with diabetes mellitus in the study population 
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 Maternal Diabetic History 
Early 
miscarriage 
Late 
 miscarriage Stillbirth 
No Information given 6 3 10 
No DM 231 (96%) 169 (96%) 582 (92%) 
Known DM 3 (1) 4 (2%) 19 (3%) 
 IDDM 2 3 13 
 Non-IDDM 1 1 6 
Gestational DM 6 (3%) 3 (2%) 28 (5%) 
 Non-Insulin 
dependent GDM 3 2 9 
 Insulin dependent 
GDM 1 1 4 
 GDM no info given 
on meds 2 0 15 
Total: 240 176 629 
Table 34 Mothers within each death category with Diabetes Mellitus/ Gestational Diabetes. 
 
When comparing the number of women who had any form of diabetes in pregnancy 
against those who did not, stillbirths were significantly overrepresented compared to 
miscarriages (z=2.41, p=0.02). 
There were no statistical differences between stillbirth and miscarriages groups when 
comparing any form of diabetes mellitus with any form of gestational diabetes 
mellitus. 
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Figure 22 Diabetes Mellitus in different death categories 
When comparing the study data against the national data for diabetes mellitus the 
study population had a greater proportion of mothers with some form of diabetes 
mellitus (odds ratio = 1.4).  
Population 
 
Number of cases of Diabetes 
Mellitus during Pregnancy 
Total number of 
pregnancies 
National data 28686 (4%) 671255 
Study population (incl. DM and GDM) 63 (6%) 1064 
Table 35 Diabetes mellitus during pregnancy in the study population and the national data 
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3.2.13 Maternal Hypertension 
Blood Pressure (BP) 
 
 
Total Number of cases 
Not information given 
 
 
19 (2%) 
Normal BP 
 
 
959 (90%) 
Hypertension 
 
 
86 (8%) 
 Chronic 
 
 
25 
 Pregnancy induced 
 
 
35 
 Pre-eclampsia 
 
 
26 
Total:  
 
 
1064 
 
Table 36 Blood pressure findings in the study population 
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Blood Pressure 
 
Early miscarriage 
 
Late miscarriage 
 
Stillbirth 
 
Not given 2 (1%) 0 (0%) 17 (3%) 
Normal BP 236 (96%) 170 (94%) 553 (87%) 
Hypertension 8 (3%) 9 (5%) 69 (11%) 
 Chronic 2 4 19 
 Pregnancy 
induced 6 4 25 
 Pre-eclampsia 0 1 25 
Total 246 179 639 
Table 37 Maternal blood pressure findings within each death category. 
 Women with hypertension were significantly overrepresented in the 
stillbirths compared to the miscarriage groups (z= 4.09, p <0.0001).  
 There was no difference in the proportions of mothers with chronic or 
pregnancy induced hypertension. 
 Women suffering from pre-eclampsia were significantly overrepresented in 
the stillbirths compared to the miscarriage groups (in comparison to both 
chronic hypertension and pregnancy induced hypertension; p =0.050 and p 
=0.017 respectively). 
When comparing the study data with national data on hypertension in pregnancy, no 
significant difference was found in the proportion of women in the study population 
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with hypertension  (excluding pre-eclampsia and eclampsia) compared to those in 
the general pregnant population (z= 0.94 p = 0.35).  
  
Number of cases of 
hypertension (excluding 
eclampsia) 
Total number of 
pregnancies 
National Data 34244 (5%) 671255 
Study population 60 (6%) 1045 
Table 38 Any form of maternal hypertension in pregnancy (excluding pre-eclampsia) in the study 
population and the national data 
3.2.14 Maternal Infection  
Maternal Infection 
 
 
Total number of cases in our population 
No infection 
 
 
 
 
957 (90%) 
Other 
 
 
 
 
23 (2%) 
UTI 
 
 
 
 
43 (4%) 
Vaginal Infection 
 
 
 
 
22 (2%) 
HIV Positive 
 
 
 
 
10 (1%) 
Syphilis 
 
 
 
 
4 (<1%) 
Hep B Positive 
 
 
 
 
5 (<1%) 
Total:  
 
 
1064 
Table 39 Maternal infections within study population 
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Table 40 Maternal infections within each death category 
The majority of mothers in the study did not have any infection during pregnancy. 
The most common type of infection, when present, was urinary tract. No significant 
difference in the proportion of infected mothers was found between the miscarriage 
and stillbirth groups (z = 1.71, p = 0.09). 
 
Maternal Infection 
 
 
 Early Miscarriage 
 
 
Late Miscarriage 
 
 
 Stillbirth 
 
 
No infection 222 (90%) 152 (85%) 583 (91%) 
Other  2 (1%) 5 (3%) 16 (3%) 
UTI  15 (2%) 10 (6%) 18 (3%) 
Vaginal Infection  4(2%) 5 (3%) 13 (2%) 
HIV Positive  2 (1%) 4 (2%) 4 (1%) 
Syphilis 0 (0%) 1 (1%) 3 (<1%) 
Hep B Positive 1 (<1%) 2 (1%) 2 (<1%) 
Total:  246 179 639 
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3.2.15 Multiple pregnancies 
50 individual fetal deaths were from twin pregnancies; 3 fetuses were from triplet 
pregnancies (from 2 cases) (53 deaths in total out of 1064; 5%). 
 
 Early 
Miscarriage 
Late 
Miscarriage 
Stillbirth Total number of 
individual twin 
losses 
Number of 
individual twin 
losses 
9 (17%) 15 (28%) 29 (55%) 53 
Table 41 The number and percentage of individual twin losses for each death category 
 
There is currently no usable data on the rate of individual intrauterine/intrapartum 
fetal deaths in twin pregnancies to allow a comparison to the current national 
population.   
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3.3 Discussion  
The study population was composed of 639 stillbirths, 179 late miscarriages and 246 
early miscarriages, totalling 1,064 autopsies for evaluation. The majority of deaths 
(766, 72%) were antepartum of which 82% had an intrauterine retention time of at 
least 24 hours. There were more male fetuses in the study population, but this was 
not statistically significant. 
The maternal demographics of the study population were explored in great detail. 
Firstly, it was found that the study population (in total and separately for both 
miscarriages and stillbirths) was significantly older than the distribution of all 
pregnancies nationally, in keeping with published literature; an interesting find as 
2011 saw the largest percentage increase in fertility in women 40 years and older 
since 2001 in England and Wales (52, 97, 191).  The finding confirms the 
association of increasing maternal age with increased risk of intrauterine demise.  
Secondly, the majority of mothers in the study population were white but black 
mothers were significantly overrepresented in the study population compared to data 
from national statistics, in keeping with published data that stillbirth risk is increased 
in mothers of African or Asian ethnicity (94, 95, 186, 192). Furthermore, among 
women who suffer an intrauterine death, white mothers appeared more predisposed 
to stillbirth and black mothers to miscarriage the possible causes of which are 
explored in other chapters.  
The mothers in the study population were also significantly more overweight and 
obese than the unselected national population (indicating that overweight is 
associated with intrauterine death risk) but interestingly there was no significant 
difference in BMI between mothers of miscarriages and stillbirths. This suggests that 
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a raised maternal BMI is associated similarly with both fetal loss and stillbirth across 
all gestations (49, 52).  
The majority of mothers in the study population were primigravida (another known 
association to stillbirth) and the primigravida mothers in the present study were more 
likely to have a stillbirth than miscarriage (49, 52). However those mothers with an 
obstetric history of vaginal bleeding during pregnancy, uterine fibroids, in vitro 
fertilization or history of a previous fetal loss, termination or ectopic pregnancy were 
more likely affected by miscarriage.  
Within the present study, most mothers were non-smokers, did not drink alcohol or 
take illicit drugs during their pregnancy and did not suffer from infection. Of the 
small number of mothers who suffered from some form of diabetes or hypertension 
during pregnancy, these mothers had significantly more stillbirths than miscarriages. 
Mothers with pre-eclampsia also had significantly more stillbirths than miscarriages 
in comparison to mothers with either chronic hypertension or pregnancy induced 
hypertension. 
In conclusion, this chapter confirms the known associations to stillbirth and 
miscarriage of rising maternal age, increased maternal BMI, maternal ethnicity, 
diabetes and hypertension but also provides new data suggesting; 
1. White mothers appear more predisposed to stillbirth and black mothers to 
miscarriage 
2. A raised maternal BMI is associated with fetal loss but not significantly more 
associated with a miscarriage or a stillbirth loss  
3. Mothers who are primigravida appear more predisposed to stillbirth than 
miscarriage 
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4. Mother with an obstetric history of vaginal bleeding during pregnancy, 
uterine fibroids and in vitro fertilization are more predisposed to miscarriages 
than stillbirth 
Further research is recommended to analyse the scientific and clinical reasons for 
such demographic associations with miscarriage and stillbirth and measures that 
could be taken to address such factors. 
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4.0 Background 
The underlying aim of autopsy investigation of stillbirth is to determine the cause 
and mechanism of death, for parental closure, management of subsequent 
pregnancies and development of potential future interventions. Over the last 60 years 
there have been many attempts to classify the causes of death in stillbirths but 
according to which classification system is used, (of which there are over 30 (193)), 
15-60% of all stillbirths remain unexplained, despite postmortem examinations being 
undertaken by trained professionals in specialist centres (4, 5). Four of the most 
well-known classification systems include; 
1. The Aberdeen system, predominantly based on obstetric findings and clinical 
history rather than the findings at autopsy (111-113)  
2. The Wigglesworth system which subdivides cases into general groups with 
clear implications for clinical management (4) 
3. Relevant Condition at Death (ReCoDe) system which aims to identify 
underlying risk factors, not necessarily mechanisms and incorporates growth 
restriction as a cause of death (5) 
4. Causes of death and associated conditions system (CODAC), which is 
designed to accommodate both the main cause of death as well as associated 
conditions and combines both the clinical and pathological causes of 
stillbirth (114).  
A review article published in 2009 evaluated the use of the above classification 
systems, as well as others such as the PSANZ-PDC (Perinatal Society of Australia 
and New Zealand – Perinatal Death Classification) and TULIP, and recommended 
that The Extended Wigglesworth and the Amended Aberdeen classification systems 
should no longer be used. The best performing system in terms of ease of use, inter-
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observer agreement and achieving the lowest rate of “unexplained” causes was 
CODAC followed by PSANZ-PDC and ReCoDe (115). However, all of these 
systems are highly subjective and allow for observer bias, making accurate 
comparisons between systems challenging. Furthermore, whilst it is tempting to 
suggest that reducing “unexplained” cases is beneficial, this is only the case if there 
is clear evidence that the “cause” assigned is correct; in most systems this is not the 
case as many “causes” of death are based on associations and risk factors and may 
therefore be spurious.  
 
4.1 Chapter aims  
The aim of this chapter is therefore to use a large dataset, from two specialist centres, 
to eliminate observer bias as far as possible, by objectively assigning causes and 
classifications of death in each case based on predetermined criteria, to facilitate the 
analysis and review of: 
1. The causes of death within stillbirth  and intrauterine death populations, 
2. The associations of maternal demographic features with cause of fetal death 
including, 
a. Maternal ethnicity 
b. Maternal age 
c. Maternal BMI 
d. Maternal Diabetes 
e. Maternal Hypertension. 
3. The effects of maceration and postmortem interval on assigned cause of 
death 
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4. A comparison of the distribution of causes of death with a well-known 
classification system, ReCoDe.  
5. Evidence to determine the frequency with which autopsy reliably provides a 
definite cause of death in stillbirth. 
 
4.2 Methods 
The Microsoft Access Autopsy Database was used to collate postmortem and 
antenatal details available for all stillbirths, early and late miscarriage from 2005 – 
2013 from Great Ormond Street Hospital and St George’s Hospital, London.  Data 
was analysed through queries and statistical tests run using Microsoft Access, Excel, 
Graph Pad Prism and Stats Direct. Statistical tests can be viewed in detail in 
Appendix 3.  
 
4.3 Classifying causes of death  
For the purposes of this study, predetermined criteria were used to assign an 
objective cause of death to each case based on the antenatal details provided and 
autopsy findings. As far as possible, definitions of causes of death were based on 
objective and documented findings, listed below. (See Appendix 4 for details of the 
‘other’ causes of death assigned by the original pathologist that were then reassigned 
to specific, objective causes of death). 
 Abruption: Definite clinical history of abruption +/- concurrent placental or 
autopsy findings 
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 Ascending Infection: Histologically proven chorioamnionitis +/- funisitis+/- 
fetal pneumonia (it is accepted that in such cases it may be impossible to 
determine whether ascending infection was primary or secondary). 
 
 Birth Trauma: A documented complication that occurred during delivery 
leading to fatal intrapartum events, with consistent, if non-diagnostic autopsy 
findings e.g. shoulder dystocia. 
 
 Congenital abnormalities: Congenital abnormalities documented antenatally 
or at autopsy, which likely accounted for the death.  
 Feto-Maternal Haemorrhage (FMH): Documented abnormal Kleihauer test, 
with our without autopsy features consistent with severe FMH.  
 
 Infection: Documented systemic maternal infection associated with fetal 
death. 
 
 Known cord accident: Witnessed and recorded cord complication during 
delivery – e.g. cord prolapse (the simple finding of a cord knot or abnormal 
coiling at autopsy in the absence of specific clinical history or other findings 
were not included in this category; see below). 
 
 Known IUGR: IUGR detected antenatally and with no other specific cause of 
death found at autopsy 
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 Placenta: Significant placental pathology confirmed with definite or 
unequivocal abnormal histological features which likely caused the death e.g. 
severe uteroplacental malperfusion, chronic histiocytic intervillositis 
(placental histological changes of uncertain significance were not recorded 
here; see below).  
 
 Pre-term: Likely cervical incompetence/ idiopathic severe preterm labour 
resulting in intrapartum death from antenatal history 
 
 Twin complication: Documented complication of twinning e.g. twin to twin 
transfusion syndrome 
 
 Unexplained lesion, baby*: Unexplained cause of death but with the presence 
of  a fetal finding of unknown significance e.g. mild intraventricular 
haemorrhage 
 
 Unexplained lesion, clinical*: Unexplained cause of death, but with the 
presence of a clinical risk factor of unknown significance in the specific case 
e.g. maternal cholestasis 
 
 Unexplained lesion, cord*: Unexplained cause of death, but with the 
presence of a cord finding of unknown significance e.g. true cord knot but 
with no thrombosis or other pathological findings. 
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 Unexplained lesion, Placenta*: Unexplained cause of death, but with the 
presence of placental findings of unknown significance e.g. increased 
syncytial knots but without changes of severe malperfusion, intervillous 
thrombus etc. 
 
 Unexplained obese: Unexplained cause of death, but with the presence of 
documented maternal obesity (BMI>30).  
 
 
 Unexplained post-term: Unexplained cause of death, but the presence of 
documented post-term delivery (post 41 weeks).  
 
 Unexplained with previous fetal loss: Unexplained cause of death, but with 
the presence of a maternal history of previous fetal loss.  
 
 Unexplained with Diabetes: Unexplained cause of death, but with the 
presence of some form of diabetes Mellitus (either Diabetes Mellitus or 
Gestational Diabetes).. 
 
 
 Unexplained, IUGR: Unexplained cause of death, with no history of antenatal 
IUGR but the presence of definite IUGR diagnosed at autopsy. This category 
does not include those Small for Gestational Age cases found during analysis 
based purely on biometry with no associated histological abnormalities - 
these results are to be discussed separately in Chapter 5.  
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 Unexplained, unexplained: No cause of death found at autopsy, no abnormal 
placental findings and no clinical risk factor associations. 
 
 Unexplained all: No cause of death found based on antenatal history and 
autopsy findings. This category encompasses all of the “unexplained” causes 
of death listed above. 
 
* In the simplified classification system these groups were placed together into the unexplained lesion 
category. 
 
 
The effects of growth restriction and fetuses that are small for gestational age (SGA) 
are discussed in detail in Chapter 5. SGA is only considered in this chapter when 
comparing causes of death in the current study population using this classification 
with the ReCoDe classification system.  
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4.4 Causes of death 
4.4.1 Cause of Death: overall, all cases (miscarriage and stillbirth) 
 Cause of death- all cases 
 
Number / percentage of 
cases 
Abruption 38 (4%) 
Ascending Infection 176 (17%) 
Birth trauma 7 (1%) 
Congenital abnormalities 50 (5%) 
Feto-maternal Haemorrhage 6 (1%) 
Infection 13 (1%) 
Known cord accident 4 (<1%) 
Known IUGR 18 (2%) 
Placenta 56 (5%) 
Pre-eclampsia 16 (2%) 
Preterm 4 (<1%) 
Twin Complication 21 (2%) 
Unexplained (all) 655 (62%) 
 Unexplained lesion, baby 20 (2%) 
 Unexplained lesion, clinical 16 (2%) 
 Unexplained lesion, cord 13 (1%) 
 Unexplained lesion, Placenta 78 (7%) 
 Unexplained obese 45 (4%) 
 Unexplained obese and post-term 5 (<1%) 
 Unexplained Obese and previous fetal loss 26 (2%) 
 Unexplained obese and GDM 5 (<1%) 
 Unexplained obese and IDDM 2 (<1%) 
 Unexplained post-term 29 (3%) 
 Unexplained, previous fetal loss 100 (19%) 
 Unexplained, unexplained 292 (27%) 
 Unexplained with GDM 14 (1%) 
 Unexplained with IDDM 7 (1%) 
 Unexplained with GDM and previous fetal loss 1 (<1%) 
 Unexplained with IDDM and previous fetal loss 1 (<1%) 
 Unexplained with IUGR at PM 1 (<1%) 
Total: 1064 
Table 42 All causes of death in the total study population 
The most common category was unexplained (63%), with 44% of these cases being 
unexplained, unexplained.  The second most common cause of death overall was 
ascending infection (17%), but this includes midtrimester miscarriages. 
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Simplified Cause of death- Overall Number / percentage of cases 
Abruption 38 (4%) 
Ascending Infection 176 (17%) 
Birth trauma 7 (1%) 
Congenital abnormalities 50 (5%) 
Feto-maternal Haemorrhage 6 (1%) 
Infection 13 (1%) 
Known cord accident 4 (<1%) 
Known IUGR 18 (2%) 
Placenta 56 (5%) 
Pre-eclampsia 16 (2%) 
Preterm 4 (<1%) 
Twin Complication 21 (2%) 
Unexplained (all) 655 (62%) 
 Unexplained lesion 127 (12%) 
 Unexplained obese 83 (8%) 
 Unexplained post-term 29 (3%) 
 Unexplained, previous fetal loss 100 (9%) 
 Unexplained, unexplained 292 (27%) 
 Unexplained with Diabetes 24 (2%) 
 Unexplained with IUGR at PM 1 (<1%) 
Total: 1064 
Table 43 Simplified overall causes of death 
Figure 23 All causes of death 
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4.4.2 Cause of death Early Miscarriage 
Cause of death – Early miscarriage Number of cases 
Abruption 3 (1%) 
Ascending Infection 58 (24%) 
Birth trauma 0 (0%) 
Congenital abnormalities 9 (4%) 
Feto-maternal Haemorrhage 0 (0%) 
Infection 0 (0%) 
Known cord accident 1 (<1%) 
Known IUGR 4 (2%) 
Placenta 1 (<1%) 
Pre-eclampsia 0 (0%) 
Preterm 0 (0%) 
Twin Complication 8 (3%) 
Unexplained (all) 162 (66%) 
 Unexplained lesion, baby 1 (<1%) 
 Unexplained lesion, clinical 1 (<1%) 
 Unexplained lesion, cord 1 (<1%) 
 Unexplained lesion, Placenta 16 (7%) 
 Unexplained obese 13 (5%) 
 Unexplained obese and post-term 0 (0%) 
 Unexplained Obese and previous fetal loss 14 (6%) 
 Unexplained obese and GDM 0 (0%) 
 Unexplained obese and IDDM 0 (0%) 
 Unexplained post-term 0 (0%) 
 Unexplained, previous fetal loss 43 (17%) 
 Unexplained unexplained 69 (28%) 
 Unexplained with GDM 1 (<1%) 
 Unexplained with IDDM 2 (1%) 
 Unexplained with GDM and previous fetal loss 1 (<1%) 
 Unexplained with IDDM and previous fetal loss 0 (0%) 
 Unexplained with IUGR 0 (0%) 
Total: 246 
Table 44 Cause of death in cases of early miscarriage 
 
.  
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Simplified Cause of death – Early miscarriage Number of cases 
Abruption 3 (1%) 
Ascending Infection 58 (24%) 
Birth trauma 0 (0%) 
Congenital abnormalities 9 (4%) 
Feto-maternal Haemorrhage 0 (0%) 
Infection 0 (0%) 
Known cord accident 1 (<1%) 
Known IUGR 4 (2%) 
Placenta 1 (<1%) 
Pre-eclampsia 0 (0%) 
Preterm 0 (0%) 
Twin Complication 8 (3%) 
Unexplained (all) 162 (66%) 
 Unexplained lesion 19 (8%) 
 Unexplained obese 27 (11%) 
 Unexplained post-term 0 (0%) 
 Unexplained, previous fetal loss 43 (17%) 
 Unexplained unexplained 70 (28%) 
 Unexplained with Diabetes 4 (2%) 
 Unexplained with IUGR 0 (0%) 
Total: 246 
Table 45 Simplified cause of death early miscarriage 
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4.4.3 Cause of death Late Miscarriage 
Cause of death – Late miscarriage Number of cases 
Abruption 5 (3%) 
Ascending Infection 59 (33%) 
Birth trauma 0 (0%) 
Congenital abnormalities 5 (3%) 
Feto-maternal Haemorrhage 0 (0%) 
Infection 1 (1%) 
Known cord accident 1 (1%) 
Known IUGR 5 (3%) 
Placenta 4 (2%) 
Pre-eclampsia 0 (0%) 
Preterm 3 (2%) 
Twin Complication 4 (2%) 
Unexplained (all) 92 (51%) 
 Unexplained lesion, baby 5 (3%) 
 Unexplained lesion, clinical 0 (0%) 
 Unexplained lesion, cord 0 (0%) 
 Unexplained lesion, Placenta 5 (3%) 
 Unexplained obese 6 (3%) 
 Unexplained obese and post-term 0 (0%) 
 Unexplained Obese and previous fetal loss 2 (1%) 
 Unexplained obese and GDM 0 (0%) 
 Unexplained obese and IDDM 1 (1%) 
 Unexplained post-term 0 (0%) 
 Unexplained, previous fetal loss 16 (9%) 
 Unexplained unexplained 54 (30%) 
 Unexplained with GDM 1 (1%) 
 Unexplained with IDDM 2 (1%) 
 Unexplained with GDM and previous fetal loss 0 (0%) 
 Unexplained with IDDM and previous fetal loss 0 (0%) 
 Unexplained with IUGR 0 (0%) 
Total:  179 
Table 46 Causes of death in cases of late miscarriage 
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Simplified Cause of death – Late miscarriage Number of cases 
Abruption 5 (3%) 
Ascending Infection 59 (33%) 
Birth trauma 0 (0%) 
Congenital abnormalities 5 (3%) 
Feto-maternal Haemorrhage 0 (0%) 
Infection 1 (1%) 
Known cord accident 1 (1%) 
Known IUGR 5 (3%) 
Placenta 4 (2%) 
Pre-eclampsia 0 (0%) 
Preterm 3 (2%) 
Twin Complication 4 (2%) 
Unexplained (all) 92 (51%) 
 Unexplained lesion 10 (6%) 
 Unexplained obese 9 (5%) 
 Unexplained post-term 0 (0%) 
 Unexplained, previous SB 16 (9%) 
 Unexplained unexplained 54 (31%) 
 Unexplained with Diabetes 3 (1%) 
 Unexplained with IUGR 0 (0%) 
 Total: 179 
Table 47 Simplified cause of death, late miscarriage 
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4.4.4 Cause of death Stillbirth 
Cause of death - Stillbirth Number of cases 
Abruption 30 (5%) 
Ascending Infection 59 (9%) 
Birth trauma 7 (1%) 
Congenital abnormalities 36 (6%) 
Feto-maternal Haemorrhage 6 (1%) 
Infection 12 (2%) 
Known cord accident 2 (<1%) 
Known IUGR 9 (1%) 
Placenta 51 (8%) 
Pre-eclampsia 16 (3%) 
Preterm 1 (<1%) 
Twin Complication 9 (<1%) 
Unexplained (all) 401 (63%) 
 Unexplained lesion, baby 14 (2%) 
 Unexplained lesion, clinical 15 (2%) 
 Unexplained lesion, cord 12 (2%) 
 Unexplained lesion, Placenta 57 (9%) 
 Unexplained obese 26 (4%) 
 Unexplained obese and post-term 5 (1%) 
 Unexplained Obese and previous fetal loss 10 (2%) 
 Unexplained obese and GDM 5 (1%) 
 Unexplained obese and IDDM 1 (<1%) 
 Unexplained post-term 29 (5%) 
 Unexplained, previous fetal loss 41 (6%) 
 Unexplained unexplained 169 (26%) 
 Unexplained with GDM 12 (2%) 
 Unexplained with IDDM 3 (<1%) 
 Unexplained with GDM and previous fetal loss 0 (0%) 
 Unexplained with IDDM and previous fetal loss 1 (<1%) 
 Unexplained with IUGR 1 (<1%) 
Total: 639 
Table 48 Causes of death for cases of stillbirth 
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Simplified Cause of death - Stillbirth Number of cases 
Abruption 30 (5%) 
Ascending Infection 59 (9%) 
Birth trauma 7 (1%) 
Congenital abnormalities 36 (6%) 
Feto-maternal Haemorrhage 6 (1%) 
Infection 12 (2%) 
Known cord accident 2 (<1%) 
Known IUGR 9 (1%) 
Placenta 51 (8%) 
Pre-eclampsia 16 (3%) 
Preterm 1 (<1%) 
Twin Complication 9 (1%) 
Unexplained (all) 401 (63%) 
 Unexplained lesion 98 (15%) 
 Unexplained obese 47 (7%) 
 Unexplained post-term 29 (5%) 
 Unexplained, previous SB 41 (6%) 
 Unexplained unexplained 169 (26%) 
 Unexplained with Diabetes 16 (3%) 
 Unexplained with IUGR 1 (<1%) 
Total: 639 
Table 49 Simplified Cause of death, stillbirth  
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Figure 24 Simplified Cause of death, stillbirth 
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4.4.5 Comparison of miscarriage and stillbirth causes of death 
 
 
Figure 25 Simplified causes of death in cases of miscarriage and stillbirth 
 
Unexplained, unexplained cases represented the largest category in both cohorts. 
Placental abruption, maternal infection, placental abnormalities and unexplained 
cases with lesions were statistically more common in stillbirths (z=2.421, p= 0.0155; 
z= 2.389, p =0.0169; z=4.725, p<0.0001; z=4.32, p<0.0001 respectively). 
Ascending Infection and unexplained death with a previous history of fetal loss were 
statistically more common in miscarriages (z=7.867, p <0.0001 and z= 4.088, p<0.0001 
respectively). 
There were no other significant differences between the remaining causes of death.  
There were only 24 cases (19 antepartum and five intrapartum deaths) in which there 
were no significant clinical findings such as overweight, obese or underweight BMI; 
cholestasis; maternal hypertension; diabetes mellitus; previous history of fetal loss or 
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termination of pregnancy; abnormal cervical smears or treatment to the cervix and no 
other significant maternal past medical history. Of these 24 cases there were: 
 Nine miscarriages 
 15 stillbirths 
The causes of death in the 15 cases of stillbirth are detailed below (Table 50). 
Cause of death Number of cases 
Ascending infection 4 (17%) 
Placenta 1 (4%) 
Unexplained 19 (79%) 
Total:  24 
Table 50 Causes of death in cases with no significant antenatal history 
These findings suggest that if there is no significant clinical history, an autopsy is 
unlikely to yield a positive finding in nearly 80% of cases and in the remaining 20% 
the cause of death will be found on examination of the placenta.  
 
4.4.6 Limited versus complete autopsy 
 
81 cases within the study had a limited autopsy. Table 51 details the degree of 
limitation and shows that in most cases the majority still had an unexplained death. 
In total, 63% of all limited postmortems had an unexplained death; the same as the 
overall percentage of unexplained death (62%) and thus for the analysis below all 
autopsies (both limited and complete) have been examined as one group.  
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Number of 
cases 
Number of unexplained 
causes of death 
% unexplained of 
those with limited 
PM 
Limited to 
Abdomen, chest 
and head 1 1 100 
No Brain 
examination 9 4 44 
Limited to 
external+/- MRI+/- 
Placenta 52 37 71 
Limited to chest 
and abdomen 4 1 25 
Limited other 7 4 57 
Laproscopic 
autopsy+/- MRI 7 3 43 
No histology to be 
taken 1 1 100 
Total: 81 51 63 
Table 51 Unexplained causes of death in limited autopsies 
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4.5 Maternal Ethnicity and Cause of Death 
4.5.1 Maternal ethnicity and cause of death in all cases 
Cause of death - all White 
Mixed/ 
oriental Asian Black Total: 
Abruption 15 (3%) 0 (0%) 5 (9%) 7 (3%) 27 (4%) 
Ascending Infection 48 (10%) 3 (17%) 12 (21%) 
69 
(33%) 
132 
(18%) 
Birth trauma 2 (<1%) 0 (0%) 1 (2%) 0 (0%) 3 (<1%) 
Congenital abnormalities 18 (4%) 0 (0%) 2 (3%) 7 (3%) 27 (4%) 
Feto-maternal 
Haemorrhage 3 (1%) 1 (6%) 0 (0%) 0 (0%) 4 (1%) 
Infection 6 (1%) 2 (11%) 0 (0%) 1 (<1%) 9 (1%) 
Known cord accident 3 (1%) 0 (0%) 0 (0%) 1 (<1%) 4 (1%) 
Known IUGR 10 (2%) 0 (0%) 3 (5%) 2 (1%) 15 (2%) 
Placenta 35(7%) 0 (0%) 3 (5%) 7 (7%) 45 (6%) 
Pre-eclampsia 5 (1%) 0 (0%) 0 (0%) 5 (2%) 10 (1%) 
Preterm 0 (0%) 0 (0%) 0 (0%) 3 (1%) 3 (<1%) 
Twin Complication 9 (2%) 0 (0%) 0 (0%) 2 (1%) 11 (1%) 
Unexplained (all) 315 (67%) 12 (67%) 32 (55%) 
103 
(50%) 
 
462(61%) 
Total 
469 
(62%) 18 (2%) 58 (8%) 
207 
(28%) 752 
Table 52 Cause of death, (all cases) by maternal ethnicity 
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Figure 26 Cause of death by maternal ethnicity 
 
The majority of cases were unexplained for all ethnic groups, followed by ascending 
infection. 
Black and Asian mothers had significantly greater proportion of ascending infection 
than white mothers (z=7.352, p<0.0001 and z=2.365, p = 0.08 respectively) 
White mothers had significantly greater proportion of unexplained deaths than all 
other ethnicities (z=4.101, p<0.0001) but the same proportion of unexplained deaths 
as mothers of oriental/mixed ethnicity.  
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4.5.2 Maternal ethnicity and cause of death in cases of early miscarriage 
Cause of death – Early 
Miscarriage White 
Mixed/ 
oriental Asian Black Total: 
Abruption 2 (2%) 0 (0%) 0 (0%) 0 (0%) 2 (1%) 
Ascending Infection 10 (11%) 1 (20%) 5 (36%) 
24 
(44%) 
40 
(25%) 
Birth trauma 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Congenital abnormalities 2 (2%) 0 (0%) 0 (0%) 1 (2%) 3 (2%) 
Feto-maternal Haemorrhage 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Infection 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Known cord accident 1 (1%) 0 (0%) 0 (0%) 0 (0%) 1 (1%) 
Known IUGR 1 (1%) 0 (0%) 1 (7%) 1 (2%) 3 (2%) 
Placenta 0 (0%) 0 (0%) 0 (0%) 
1 (2%) 
1 (1%) 
Pre-eclampsia 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Preterm 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Twin Complication 2 (2%) 0 (0%) 0 (0%) 2 (4%) 4 (2%) 
Unexplained (all) 69 (79%) 
   4 (80%) 8 (57%) 
26 
(47%) 
107 
(66%) 
Total 87 5 14 55 161 
Table 53 Cause of death in early miscarriage by maternal Ethnicity – excludes 85 unknown 
ethnicities 
 
Autopsy Investigation in Stillbirth 
 
112 
 
4.5.3 Maternal ethnicity and cause of death in cases of late miscarriage 
Cause of death – late miscarriage White 
Mixed/ 
oriental Asian Black Total 
Abruption 2 (3%) 0 (0%) 1 (10%) 1 (2%) 4 (3%) 
Ascending Infection 
18 
(25%) 
2 
(100%) 4 (40%) 
25 
(48%) 
49 
(36%) 
Birth trauma 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Congenital abnormalities 3 (4%) 0 (0%) 0 (0%) 0 (0%) 3( 2%) 
Feto-maternal Haemorrhage 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Infection 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Known cord accident 0 (0%) 0 (0%) 0 (0%) 1 (2%) 1 (1%) 
Known IUGR 4 (6%) 0 (0%) 1 (10%) 0 (0%) 5 (4%) 
Placenta 1 (1%) 0 (0%) 0 (0%) 0 (0%) 1(1%) 
Pre-eclampsia 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Preterm 0 (0%) 0 (0%) 0 (0%) 
2 (4%) 
2 (1%) 
Twin Complication 2 (3%) 0 (0%) 0 (0%) 0 (0%) 2 (1%) 
Unexplained (all) 
41 
(58%) 0 (0%) 4 (40%) 
23 
(44%) 
68 
(50%) 
Total 71 2 10 52 135 
Table 54 Cause of death in late miscarriage by maternal Ethnicity – excludes 45 unknown ethnicities 
.  
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4.5.4 Maternal ethnicity and cause of death in cases of stillbirth 
Cause of death –Stillbirth White 
Mixed/ 
Oriental Asian Black Total 
Abruption 11 (4%) 0 (0%) 4 (12%) 6 (6%) 21 (5%) 
Ascending Infection 20 (6%) 0 (0%) 3 (9%) 
20 
(20%) 43 (9%) 
Birth trauma 2 (1%) 0 (0%) 1 (3%) 0 (0%) 3 (1%) 
Congenital abnormalities 13 (4%) 0 (0%) 2 (6%) 6 (6%) 21 (5%) 
Feto-maternal Haemorrhage 3 (1%) 
1 (9%) 
0 (0%) 0 (0%) 4 (1%) 
Infection 6 (2%) 2 (18%) 0 (0%) 1 (1%) 9 (2%) 
Known cord accident 2 (1%) 0 (0%) 0 (0%) 0 (0%) 2 (<1%) 
Known IUGR 5 (2%) 0 (0%) 1 (3%) 0 (0%) 6 (1%) 
Placenta 34 (11%) 0 (0%) 3 (9%) 6 (6%) 43 (9%) 
Pre-eclampsia 5 (2%) 0 (0%) 0 (0%) 5 (5%) 10 (2%) 
Preterm 0 (0%) 0 (0%) 0 (0%) 1 (1%) 1 (<1%) 
Twin Complication 5 (2%) 0 (0%) 0 (0%) 0 (0%) 5 (1%) 
Unexplained (all) 
205 
(66%) 8 (73%) 
20 
(59%) 
54 
(55%) 
287 
(63%) 
Total:  311 11 34 99 455 
Table 55 Cause of death in stillbirth by maternal ethnicity – excludes 184 unknown ethnicities 
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4.6 Maternal Age and cause of death 
4.6.1 Maternal age and cause of death all cases  
Cause of 
death 
 
 
Maternal age less 
than and equal to 35 
years 
 
 
Maternal age 36 -40 
years 
 
 
Maternal age 
more than or 
equal to 41 years 
 
Total 
 
 
Abruption 28 (4%) 7 (4%) 1 (2%) 
36 
(3%) 
Ascending 
infection 130 (16%) 36 (19%) 8 (17%) 
174 
(17%) 
Birth Trauma 6 (1%) 0 (0%) 0 (0%) 6 (1%) 
Congenital 
abnormalities 39 (5%) 6 (3%) 4 (8%) 
49 
(5%) 
Feto-maternal 
Hameorrhage 4 (1%) 1 (1%) 1 (2%) 6 (1%) 
Infection 11 (1%) 1 (1%) 1 (2%) 
13 
(1%) 
Known cord 
accident 4 (1%) 0 (0%) 0 (0%) 
4 
(<1%) 
Known 
IUGR 14 (2%) 3 (2%) 1 (2%) 
18 
(2%) 
Placenta 42 (5%) 8 (4%) 6 (13%) 
56 
(5%) 
Pre-
eclampsia 14 (2%) 2 (1%) 0 (0%) 
16 
(2%) 
Pre-term 4 (1%) 0 (0%) 0 (0%) 
4 
(<1%) 
Twin 
complication
s 16 (2%) 4 (2%) 1 (2%) 
21 
(2%) 
Unexplained 
(all) 486 (61%) 125 (65%) 25 (52%) 
636 
(61%) 
Total:  798 (77%) 193 (19%) 48 (5%) 1039 
Table 56 Cause of death by maternal age (Excludes 26 cases with  no maternal age) 
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Figure 27 Maternal age and cause of death 
The majority of the study population (77%) had a maternal age less than or equal to 
age 35 years. The most common cause of death remained unexplained (not 
significantly different between age groups z= 1.329, p =0.1835), followed by 
ascending infection. Mothers over the age of 40 had a significantly greater 
proportion of placental causes of death than mothers <40 years of age (z=2.234, 
p=0.0255).  
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4.6.2 Maternal age and cause of death in cases of Early Miscarriage  
 
Table 57 Cause and death and maternal age, early miscarriage (excludes 6 cases with no maternal 
age) 
Cause of death  
Maternal age less 
than or equal to 35 
years 
Maternal  
age 36 -40 
years 
Maternal age 
more than or 
equal to 41 years 
Total 
Abruption 3 (2%) 0 (0%) 0 (0%) 
3 (1%) 
Ascending infection 45 (26%) 13 (22%) 0 (0%) 
58 (24%) 
Birth Trauma 0 (0%) 0 (0%) 0 (0%) 
0 (0%) 
Congenital 
abnormalities 6 (4%) 3 (5%) 0 (0%) 
9 (4%) 
Feto-maternal 
Hameorrhage 0 (0%) 0 (0%) 0 (0%) 
0 (0%) 
Infection 0 (0%) 0 (0%) 0 (0%) 
0 (0%) 
Known cord 
accident 1 (1%) 0 (0%) 0 (0%) 
1 (<1%) 
Known IUGR 3(2%) 0 (0%) 1 (10%) 
4 (2%) 
Placenta 1 (1%) 0 (0%) 0 (0%) 
1 (<1%) 
Pre-eclampsia 0 (0%) 0 (0%) 0 (0%) 
0 (0%) 
Pre-term 0 (0%) 0 (0%) 0 (0%) 
0 (0%) 
Twin complications 6 (0%) 2 (3%) 0 (0%) 
8 (3%) 
Unexplained (all) 105 (62%) 42 (70%) 9(90%) 
156 (65%) 
Total:  170 (71%) 60 (25%) 10 (4%) 
 
 
240 
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Figure 28 Cause of death in early miscarriage by maternal age 
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4.6.3 Maternal age and cause of death in cases of Late miscarriage 
Cause of death 
Maternal age less 
than and+ equal to 
35 years 
Maternal age 36 -
40 years 
Maternal Age more 
than or equal to 
41years 
Total 
Abrutpion 5 (4%) 0 (0%) 0 (0%) 
 
 
5 (3%) 
Ascending 
infection 39 (29%) 12 (39%) 7 (54%) 
 
 
58 (3%) 
Birth Trauma 0 (0%) 
    
0 (0%) 
0 (0%) 
 
 
0 (0%) 
Congenital 
abnormalities 4 (3%) 
 
0 (0%) 
1 (8%) 
 
 
5 (3%) 
Feto-maternal 
Hameorrhage 0 (0%) 
     
0 (0%) 
 
0 (0%) 
 
 
0 (0%) 
Infection 1 (1%) 
 
0 (0%) 
 
0 (0%) 
 
 
1 (1%) 
Known cord 
accident 1 (1%) 
 
0 (0%) 
 
0 (0%) 
 
 
1 (1%) 
Known IUGR 5 (4%) 
 
0 (0%) 
 
0 (0%) 
 
 
5 (3%) 
Placenta 4 (3%) 
 
0 (0%) 
 
0 (0%) 
 
4 (2%) 
Pre-eclampsia 0 (0%) 
 
0 (0%) 
 
0 (0%) 
 
0 (0%) 
Pre-term 3 (2%) 
 
0 (0%) 
 
0 (0%) 
 
3 (2%) 
Twin 
complications 3 (2%) 
 
0 (0%) 
1 (8%) 
 
4 (2%) 
Unexplained 
(all) 68 (51%) 19( 61%) 4 (31%) 
 
91 (51%) 
Total:  133 (75%) 31 (18%) 13 (7%) 
 
177 
Table 58 cause of death for maternal age in late miscarriage (excludes 3 cases with no maternal age) 
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Figure 29 Cause of death in late miscarriage by maternal age 
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4.6.4 Maternal age and cause of death in cases of Stillbirth 
Cause of death  
 
 
 
Maternal age less 
than or equal to 35 
years 
 
Maternal age 
36 -40 years 
 
 
Maternal 
age  more 
than or 
equal to 41 
years 
 
          Total: 
Abruption 20 (4%) 7 (7%) 1 (4%) 
 
 
28 (5%) 
Ascending 
infection 46 (9%) 11 (11%) 1 (4%) 
 
 
58 (9%) 
Birth Trauma 6 (1%) 0 (0%) 0 (0%) 
 
 
6 (1%) 
Congenital 
abnormalities 29 (6%) 3 (3%) 3 (12%) 
 
 
35 (6%) 
Feto-maternal 
Haemorrhage 4 (1%) 1(1%) 1 (4%) 
 
 
6 (1%) 
Infection 10 (2%) 1 (1%) 1 (4%) 
 
 
12 (2%) 
Known cord 
accident 2 (<1%) 0 (0%) 0 (0%) 
 
 
2 (<1%) 
Known IUGR 6 (1%) 3 (3%) 0 (0%) 
 
 
9 (1%) 
Placenta 36(7%) 7(7%) 6 (24%) 
 
 
49 (8%) 
Pre-eclampsia 14 (3%) 2 (2%) 0 (0%) 
 
 
16 (3%) 
Pre-term 1 (<1%) 0 (0%) 0 (0%) 
 
 
1 (<1%) 
Twin 
complications 7 (1%) 2 (2%) 0 (0%) 
 
 
9 (1%) 
Unexplained (all) 314 (63%) 65 (64%) 12 (48%) 
 
 
391 (63%) 
Total:  495 (78%) 102 (16%) 25 (4%) 
 
 
622 
Table 59 Cause of death in stillbirth for maternal age (excludes 17 cases with no maternal age) 
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Figure 30 Causes of death in stillbirth by maternal age 
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4.7 Maternal Body Mass Index (BMI) and cause of death  
4.7.1 Maternal BMI and cause of death in all cases 
Cause of death 
BMI 
Underweight 
BMI 
Normal 
BMI 
Overweight 
BMI 
Obese 
Total:  
Abruption 0 (0%) 4 (3%) 4 (2%) 2 (1%) 10 (2%) 
Ascending 
Infection 
0 (0%) 30 (19%) 30 (19%) 25 (16%) 
84 
(18%) 
Birth Trauma 0 (0%) 1 (1%) 3 (2%) 0 (0%) 4 (1%) 
Congenital 
abnormalities 
0 (0%) 9 (6%) 5 (3%) 5 (3%) 19 (4%) 
Feto-maternal 
Haemorrhage 
0 (0%) 0 (0%) 1 (1%) 0 (0%) 1 (<1%) 
Infection 0 (0%) 1 (1%) 2 (1%) 6 (4%) 9 (2%) 
Known cord 
accident 
0 (0%) 0 (0%) 0 (0%) 1 (1%) 1 (<1%) 
Known IUGR 0 (0%) 6 (4%) 2 (1%) 3 (2%) 11 (2%) 
Placenta 0 (0%) 7 (6%) 8 (5%) 5 (3%) 20 (4%) 
Pre-eclampsia 0 (0%) 4 (3%) 2 (1%) 2 (1%) 8 (2%) 
Pre-term 0 (0%) 1 (1%) 0 (0%) 0 (0%) 1 (<1%) 
Twin 
Complication 
0 (0%) 1 (1%) 6 (4%) 4 (3%) 11 (2%) 
Unexplained (all) 4 (100%) 90 (58%) 97 (60%) 96 (65%) 
287 
(61%) 
Total:  4 (1%) 156 (33%) 161 (35%) 
149 
(32%) 
467 
Table 60 Cause of death by maternal BMI (all) 
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Figure 31 Cause of death (all) by maternal BMI 
There was no significant difference in the proportion of unexplained deaths or cases 
of ascending infection in obese mothers in comparison to all other BMIs.  
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4.7.2 Maternal BMI and cause of death in cases of Early miscarriage 
Cause of death 
BMI 
Underweight 
BMI 
Normal 
BMI 
Overweight 
BMI 
Obese 
Total: 
Abruption 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Ascending 
Infection 
0 (0%) 14 (33%) 12 (29%) 6 (14%) 32 (25%) 
Birth Trauma 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Congenital 
abnormalities 
0 (0%) 2 (5%) 1 (2%) 2 (5%) 5 (4%) 
Feto-maternal 
Haemorrhage 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Infection 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Known cord 
accident 
0 (0%) 0 (0%) 0 (0%) 1 (2%) 1 (1%) 
Known IUGR 0 (0%) 1 (2%) 0 (0%) 0 (0%) 1 (1%) 
Placenta 0 (0%) 0 (0%) 1 (2%) 0 (0%) 1 (1%) 
Pre-eclampsia 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Pre-term 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Twin 
Complication 
0 (0%) 0 (0%) 4 (10%) 4 (9%) 8 (6%) 
Unexplained 
(all) 
1 (100%) 25 (60%) 23 (56%) 30 (70%) 79 (62%) 
Total:  1 (1%) 42 (34%) 41 (32%) 43 (34%) 127 
Table 61 Cause of death for early miscarriages maternal BMI 
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Figure 32 Cause of death for early miscarriages with maternal BMI 
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4.7.3 Maternal BMI and cause of death in cases of Late miscarriage 
Cause of 
death 
BMI 
Underweight 
BMI 
Normal 
BMI 
Overweight BMI Obese Total: 
Abruption 0 (0%) 0(0%) 1 (3%) 0(0%) 1 (1%) 
Ascending 
Infection 0 (0%) 7 (28%) 14 (41%) 9 (45%) 29 (37%) 
Birth Trauma 0 (0%) 0(0%) 2 (5%) 0(0%) 2 (3%) 
Congenital 
abnormalities 0 (0%) 0(0%) 0(0%) 0(0%) 0(0%) 
Feto-
maternal 
Haemorrhage 0 (0%) 0(0%) 0(0%) 0(0%) 0(0%) 
Infection 0 (0%) 0(0%) 0(0%) 0(0%) 0(0%) 
Known cord 
accident 0 (0%) 0(0%) 0(0%) 0(0%) 0(0%) 
Known 
IUGR 0 (0%) 1 (4%) 1 (3%) 2 (10%) 4 (5%) 
Placenta 0 (0%) 0(0%) 0(0%) 0(0%) 0(0%) 
Pre-
eclampsia 0 (0%) 0(0%) 0(0%) 0(0%) 0(0%) 
Pre-term 0 (0%) 0(0%) 0(0%) 0(0%) 0(0%) 
Twin 
Complication 0 (0%) 1 (4%) 0(0%) 0(0%) 1 (1%) 
Unexplained 
(all) 0 (0%) 16 (64%) 16 (47%) 9 (45%) 41 (52%) 
Total:  0 (0%) 25 (32%) 34 (43%) 20 (25%) 79 
Table 62 Cause of death in late miscarriage by maternal BMI 
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Figure 33 Cause of death in late miscarriage for maternal BMI 
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4.7.4 Maternal BMI and cause of death in cases of Stillbirth 
Cause of death 
BMI 
Underweight 
BMI 
Normal 
BMI 
Overweight 
BMI 
Obese Total: 
Abruption 0 (0%) 4 (5%) 3 (3%) 2 (2%) 9 (3%) 
Acending 
Infection 0 (0%) 9 (10%) 4 (5%) 
10 
(12%) 23 (9%) 
Birth Trauma 0 (0%) 0 (0%) 2 (2%) 0 (0%) 2 (1%) 
Congenital 
abnormalities 0 (0%) 7 (8%) 4 (5%) 3 (4%) 14 (5%) 
Feto-maternal 
Haemorrhage 0 (0%) 0 (0%) 1 (1%) 0 (0%) 1 (<1%) 
Infection 0 (0%) 1 (1%) 2 (2%) 6 (7%) 9 (3%) 
Known cord 
accident 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Known IUGR 0 (10%) 4 (5%) 1 (2%) 1 (1%) 6 (2%) 
Placenta 0 (0%) 7 (8%) 7 (8%) 5 (6%) 19 (4%) 
Pre-eclampsia 0 (0%) 4 (5%) 2 (2%) 2 (2%) 8 (3%) 
Pre-term 0 (0%) 1 (1%) 0 (0%) 0 (0%) 1 (<1%) 
Twin 
Complication 0 (0%) 0 (0%) 2 (2%) 0 (0%) 2 (1%) 
Unexplained (all) 3 (100%) 49 (57%) 58 (67%) 
57 
(66%) 167(64%) 
Total:  3 (1%) 86 (33%) 86 (33%) 
86 
(33%) 261 
Table 63 Cause of death for stillbirth maternal BMI 
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Figure 34 Cause of death in stillbirth by maternal BMI 
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4.8 Maternal Diabetes Mellitus and Cause of death 
Cause of death 
 
 
 
Early 
Miscarriage 
Any  Diabetes 
Mellitus 
 
 
Late 
miscarriage 
Any Diabetes 
Mellitus 
 
 
Stillbirth Any 
Diabetes 
Mellitus 
 
 
 
Total: 
 
 
 
Abruption 0 (0%) 0 (0%) 0 (0%) 0 (0% 
Acending 
Infection 3 (33%) 1 (14%) 4 (9%) 8 (13%) 
Birth Trauma 0 (0%) 0 (0%) 1 (2%) 1 (2%) 
Congenital 
abnormalities 0 (0%) 0 (0%) 1 (2%) 1 (2%) 
Feto-maternal 
Haemorrhage 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Infection 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Known cord 
accident 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Known IUGR 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Placenta 0 (0%) 0 (0%) 5 (11%) 5 (8%) 
Pre-eclampsia 0 (0%) 0 (0%) 2 (4%) 2 (3%) 
Pre-term 0 (0%) 0 (0%) 0 (%) 0 (0%) 
Twin 
Complication 1 (11%) 1 (14%) 2 (4%) 4 (6%) 
Unexplained 
(all) 5 (56%) 5 (71%) 32 (68%) 43 (68%) 
Total:  9 (14%) 7 (11%) 47 (75%) 63 
 
Table 64 Cause of death in all cases of maternal Diabetes Mellitus 
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Cause of death 
 
Number of cases 
with DM of any 
kind 
No DM 
 
Total: 
 
Abruption 0 (0%) 38 (4%) 38 (4%) 
Acending 
Infection 8 (13%) 168 (17%) 176 (17%) 
Birth Trauma 1 (2%) 6 (1%) 7 (1%) 
Congenital 
abnormalities 1 (2%) 49 (5%) 50 (5%) 
Feto-maternal 
Haemorrhage 0 (0%) 6 (1%) 6 (1%) 
Infection 0 (0%) 13 (1%) 13 (1%) 
Known cord 
accident 0 (0%) 4 (<1%) 4 (<1%) 
Known IUGR 0 (0%) 17 (2%) 17 (2%) 
Placenta 4 (6%) 52 (5%) 56 (5%) 
Pre-eclampsia 2 (3%) 14 (1%) 16 (2%) 
Pre-term 0 (0%) 4 (<1%) 4 (<1%) 
Twin 
Complication 4 (6%) 17 (2%) 21 (2%) 
Unexplained (all) 43 (68%) 613 (61%) 656 (62%) 
Total:  63 1001 1064 
Table 65 Cause of death in all cases with any maternal Diabetes Mellitus and no maternal Diabetes 
Mellitus 
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Figure 35 Cause of death in all cases with any maternal Diabetes Mellitus and no maternal Diabetes 
Mellitus. Significantly greater proportion of twin complications in diabetic mothers compared to non-
diabetic mothers (z=2.574, p= 0.01). 
There was a significantly greater proportion of twin complications in diabetic 
mothers compared to non-diabetic mothers (z=2.574, p= 0.01) of uncertain 
significance.  No other significant differences were observed between diabetic and 
non-diabetic mothers. 
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4.9 Maternal Hypertension and Cause of death 
Cause of 
death 
Early miscarriage 
Hypertension 
Late miscarriage 
hypertension 
Stillbirth 
Hypertension 
Total 
Hypertension 
Abruption 0 (0%) 0 (0%) 6 (9%) 6 (7%) 
Ascending 
Infection 3 (38%) 4 (44%) 1 (1%) 8 (9%) 
Birth Trauma 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Congenital 
abnormalities 0 (0%) 1 (11%) 1 (1%) 2 (2%) 
Feto-maternal 
Haemorrhage 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Infection 0 (0%) 0 (0%) 2 (3%) 2 2%) 
Known cord 
accident 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Known IUGR 0 (0%) 0 (0%) 1 (1%) 1 (1%) 
Placenta 0 (0%) 1 (11%) 10 (14%) 11 (13%) 
Pre-eclampsia 0 (0%) 0 (0%) 14 (20%) 14 (16%) 
Pre-term 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Twin 
Complication 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Unexplained 
(all) 5 (63%) 3 (33%) 34 (49%) 42 (49%) 
Total:  8 (9%) 9 (10%) 69 (80%) 86 
Table 66 Cause of death in those mothers with hypertension 
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Cause of death 
Mothers with 
hypertension 
Mothers with no 
hypertension Total: 
Abruption 6 (7%) 32 (3%) 38 (4%) 
Ascending 
Infection 8 (9%) 168 (17%) 176 (17%) 
Birth Trauma 0 (0%) 7 (1%) 7 (1%) 
Congenital 
abnormalities 2 (2%) 48 (5%) 50 (5%) 
Feto-maternal 
Haemorrhage 0 (0%) 6 (1%) 6 (1%) 
Infection 2 (2%) 11 (1%) 13 (1%) 
Known cord 
accident 0 (0%) 4 (<1%) 4 (<1%) 
Known IUGR 1 (1%) 16 (2%) 17 (2%) 
Placenta 11 (13%) 45 (5%) 56 (5%) 
Pre-eclampsia 14 (16%) 2 (<1%) 16 (2%) 
Pre-term 0 (0%) 4 (<1%) 4 (<1%) 
Twin 
Complication 0 (0%) 21 (2%) 21 (2%) 
Unexplained (all) 42 (49%) 614 (63%) 656 (62%) 
Total:  86 978 1064 
Table 67 Cause of death in those mothers with and without hypertension 
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Figure 36 All causes of death in those with and without maternal hypertension. Significantly greater 
proportion of unexplained deaths in non-hypertensive mothers (z=2.55, p = 0.0108). Significantly 
greater proportion of placental causes of death in hypertensive mothers (z=3.261, p=0.0011) 
 
There was a significantly greater proportion of placental causes of death in 
hypertensive mothers (z=3.261, p=0.0011) and a significantly greater proportion of 
unexplained deaths in non-hypertensive mothers (z=2.55, p=0.0108). No other 
significant differences were observed between the hypertensive and non-
hypertensive mothers.   
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4.10 Fetal maceration and cause of death 
4.10.1 Fetal maceration and cause of death in all cases  
Cause of death None Mild Moderate Severe Total 
Abruption 23 (7%) 2 (2%) 2 (3%) 8 (2%) 35 (4%) 
Ascending Infection 
125 
(39%) 22 (18%) 5 (8%) 16 (4%) 168 (19%) 
Birth Trauma 7 (2%) 0 (0%) 0 (0%) 0 (0%) 7 (1%) 
Congenital 
abnormalities 9 (3%) 2 (2%) 3 (5%) 22 (6%) 36 (4%) 
Feto-maternal 
Haemorrhage 1 (<1%) 0 (0%) 0 (0%) 5 (1%) 6 (1%) 
Infection 3 (1%) 2 (2%) 1 (2%) 4 (1%) 10 (1%) 
Known cord accident 1 (<1%) 3 (3%) 0 (0%) 0 (0%) 4 (<1%) 
Known IUGR 5 (2%) 3 (3%)  1 (2%) 5 (1%) 14 (2%) 
Placenta 3 (1%) 7 (6%) 8 (14%) 28 (7%) 46 (5%) 
Pre-eclampsia 3 (1%) 4 (3%) 1 (2%) 2 (1%) 10 (1%) 
Pre-term 4 (1%) 0 (0%) 0 (0%) 0 (0%) 4 (<1%) 
Twin Complication 12 (4%) 1 (1%) 0 (0%) 5 (1%) 18 (2%) 
Unexplained (all) 
128 
(40%) 73 (61%) 38 (64%) 297 (76%) 536 (60%) 
Total:  
324 
(36%) 119 (13%) 59 (7%) 
392 
(44%) 894 
Table 68 Cause of death and fetal maceration. 
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Figure 37 Cause of death and fetal maceration 
Unexplained deaths were significantly more frequent in macerated cases (z=9.408, 
p<0.0001) and there is a stepwise increase in the proportion of unexplained deaths 
with increasing maceration. 
If cases of ascending infection are excluded from maceration statistical tests, the 
association between unexplained deaths and maceration remains strongly 
significantly (z=3.581, p=0.0003) 
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4.10.2 Fetal maceration and cause of death in cases of Early Miscarriage 
Cause of death None Mild Moderate Severe Total: 
Abruption 2 (2%) 0 (0%) 0 (0%) 1 (1%) 3 (1%) 
Acending Infection 46 (48%) 3 (14%) 1 (33%) 6 (6%) 56 (26%) 
Birth Trauma 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Congenital 
abnormalities 2 (2%) 0 (0%) 0 (0%) 6 (6%) 8 (4%) 
Feto-maternal 
Haemorrhage 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Infection 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Known cord accident 0 (0%) 1 (5%) 0 (0%) 0 (0%) 1 (<1%) 
Known IUGR 0 (0%) 0 (0%) 0 (0%) 4 (4%) 4 (2%) 
Placenta 1 (1%) 0 (0%) 0 (0%) 0 (0%) 1 (<1%) 
Pre-eclampsia 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Pre-term 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Twin Complication 5 (5%) 1 (5%) 0 (0%) 2 (2%) 8 (4%) 
Unexplained (all) 40 (42%) 17 (77%) 2 (67%) 75 (80%) 134 (62%) 
Total:  96 (45%) 22 (10%) 3 (1%) 94 (44%) 215 
Table 69 Cause of death in early miscarriage by fetal maceration (4 cases had no maceration given 
and 27 had “other” as their degree of maceration and were excluded). 
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4.10.3 Fetal maceration and cause of death in cases of Late miscarriage 
Cause of death None Mild Moderate Severe Total: 
Abruption 4 (4%) 0 (0%) 0 (0%) 0 (0%) 4 (3%) 
Acending Infection 48 (53%) 5 (42%) 0 (0%) 4 (10%) 57 (38%) 
Birth Trauma 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Congenital 
abnormalities 0 (0%) 0 (0%) 0 (0%) 2 (5%) 2 (1%) 
Feto-maternal 
Haemorrhage 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Infection 0 (0%) 0 (0%0 0 (0%) 0 (0%) 0 (0%) 
Known cord 
accident 0 (0%) 1 (8%) 0 (0%) 0 (0%) 1 (1%) 
Known IUGR 2 (2%) 2 (17%) 0 (0%) 0 (0%) 4 (3%) 
Placenta 1 (1%) 0 (0%) 1 (17%) 2 (5%) 4 (3%) 
Pre-eclampsia 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Pre-term 3 (3%) 0 (0%) 0 (0%) 0 (0%) 3 (2%) 
Twin Complication 4 (4%) 0 (0%) 0 (0%) 0 (0%) 4 (3%) 
Unexplained (all) 29 (32%) 4 (33%) 5 (83%) 32 (80%) 70 (47%) 
Total: 91 (61%) 12 (8%) 6 (4%) 40 (27%) 149 
Table 70 Cause of death in late miscarriage by fetal maceration (4 cases not given maceration and 27 
had “other” recorded and were excluded). 
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4.10.4 Fetal maceration and cause of death in cases of Stillbirth  
 
Table 71 Cause of death in stillbirth by fetal maceration (14 cases not given maceration status and 95 
had other description and were excluded) 
Cause of death None Mild Moderate Severe Total:  
Abruption 17 (12%) 2 (2%) 2 (4%) 7 (3%) 28 (5%) 
Acending Infection 31 (23%) 14 (16%) 4 (8%) 6 (2%) 55 (10%) 
Birth Trauma 7 (5%) 0 (0%) 0 (0%) 0 (0%) 7 (1%) 
Congenital 
abnormalities 7 (5%) 2 (2%) 3 (6%) 14 (5%) 26 (5%) 
Feto-maternal 
Haemorrhage 1 (1%) 0 (0%) 0 (0%) 5 (2%) 6 (1%) 
Infection 3 (2%) 2 (2%) 1 (2%) 4 (2%) 10 (2%) 
Known cord 
accident 1 (1%) 1 (1%) 0 (0%) 0 (0%) 2 (<1%) 
Known IUGR 3 (2%) 1 (1%) 1 (2%) 1 (<1%) 6 (1%) 
Placenta 1 (1%) 7 (8%) 7 (14%) 28 (11%) 43 (8%) 
Pre-eclampsia 3 (2%) 4 (4%) 1 (2%) 2 (1%) 10 (2%) 
Pre-term 1 (1%) 0 (0%) 0 (0%) 0 (0%) 1 (<1%) 
Twin Complication 3 (2%) 0 (0%) 0 (0%) 3 (1%) 6 (1%) 
Unexplained (all) 59 (43%) 52 (61%) 31 (62%) 188 (73%) 
330(62%
) 
Total:  137 (26%) 85 (16%) 50 (9%) 258 (49%) 530 
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4.10.5 Fetal Maceration in antepartum stillbirth 
Cause of death None Mild Moderate Severe Total: 
Abruption 7 (18%) 2 (3%) 2 (4%) 6 (2%) 17 (4%) 
Acending Infection 8 (20%) 
11 
(15%) 4 (8%) 5 (2%) 28 (7%) 
Birth Trauma 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Congenital abnormalities 1 (3%) 2 (3%) 3 (6%) 14 (6%) 20 (5%) 
Feto-maternal Haemorrhage 0 (0%) 0 (0%) 0 (0%) 5 (5%) 5 (1%) 
Infection 0 (0%) 2 (3%) 1 (2%) 3 (1%) 6 (1%) 
Known cord accident 0 (0%) 
0 
(0%) 0 (0%) 
0 
(0%) 0 (0%) 
Known IUGR 2 (0%) 1 (1%) 1 (2%) 1 (<1%) 5 (1%) 
Placenta 1 (3%) 7 (9%) 7 (14%) 
28 
(11%) 43 (10%) 
Pre-eclampsia 2 (5%) 4 (5%) 1 (2%) 2 (1%) 9 (2%) 
Pre-term 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Twin Complication 0 (0%) 0 (0%) 0 (0%) 2 (1%) 2 (<1%) 
Unexplained (all) 
19 
(48%) 
45 
(61%) 30 (61%) 
182 
(73%) 
276 
(67%) 
 Total: 40 74 49 248 411 
Table 72 Cause of death in antepartum stillbirth by fetal maceration (excluding those with “other 
maceration”) 
The more macerated the fetus in antepartum deaths, the greater the proportion of 
unexplained deaths; 7% of unexplained deaths are non-macerated and 62% of 
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unexplained deaths are severely macerated and the majority of antepartum deaths 
had severe maceration (60%).  
4.10.6 Fetal Maceration in intrapartum stillbirth 
Cause of death None Mild Moderate Severe Total: 
Abruption 10 (10%) 0 (0%) 0 (0%) 1 (8%) 
11 
(9%) 
Ascending Infection 23 (24%) 3 (27%) 0 (0%) 1 (8%) 
27 
(22%) 
Birth Trauma 7 (7%) 0 (0%) 0 (0%) 0 (0%) 7 (6%) 
Congenital abnormalities 6 (6%) 0 (0%) 0 (0%) 0 (0%) 6 (5%) 
Feto-maternal 
Haemorrhage 1 (1%) 0 (0%) 0 (0%) 0 (%) 1 (1%) 
Infection 3 (3%) 0 (0%) 0(0%) 1 (0%) 4 (3%) 
Known cord accident 1 (1%) 1 (0%) 0(0%) 0 (0%) 2 (2%) 
Known IUGR 1 (1%) 0 (0%) 0 (0%) 0 (0%) 1 (1%) 
Placenta 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Pre-eclampsia 1 (1%) 0 (0%) 0 (0%) 0 (0%) 1 (1%) 
Pre-term 1 (1%) 0 (0%) 0 (0%) 0 (0%) 1 (1%) 
Twin Complication 3 (3%) 0 (0%) 0 (0%) 1 (8%) 4 (3%) 
Unexplained (all) 40 (41%) 7 (64%) 1 (100%) 8 (67%) 
56 
(46%) 
Total:  97 11 1 12 121 
Table 73 Cause of death in intrapartum stillbirth by fetal maceration (excluding those with “other 
maceration”) 
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Antepartum stillbirths had a significantly greater proportion of unexplained deaths 
than intrapartum stillbirths (z = 4.166, p<0.0001) and the more macerated the fetus 
in antepartum deaths, the higher the proportion of unexplained deaths. This suggests 
that maceration may have an effect on the ability to give a cause of death in addition 
to the likelihood that intrapartum stillbirths will intrinsically have a more likely 
obvious explanation and be non macerated. 
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4.11 Postmortem interval and cause of death (overall) 
 
Cause of death 
1 - 4 
days 
5 - 8 
days 
9 -12 
days 
13-16 
days 17+ days Total 
Abruption 6 (4%) 17 (4%) 12 (4%) 1 (1%) 1 (2%) 37 (4%) 
Ascending Infection 
24 
(16%) 
68 
(15%) 
46 
(17%) 
19 
(18%) 
11 
(22%) 
168 
(16%) 
Birth Trauma 2 (1%) 3 (1%) 6 (2%) 0 (0%) 0 (0%) 11 (1%) 
Congenital 
abnormalities 7 (5%) 20 (4%) 12 (4%) 4 (4%) 1 (2%) 44 (4%) 
Feto-maternal 
haemorrhage 1 (1%) 3 (1%) 0 (0%) 2 (2%) 0 (0%) 6 (1%) 
Infection 5 (3%) 5 (1%) 3 (1%) 0 (0%) 0 (0%) 13 (1%) 
Known cord 
accident 0 (0%) 2 (<1%) 1 (<1%) 0 (0%) 1 (2%) 4 (<1%) 
Known IUGR 2 (1%) 8 (2%) 4 (1%) 1 (1%) 1 (2%) 16 (2%) 
Placenta 5 (3%) 34 (7%) 9 (3%) 6 (6%) 1 (2%) 53 (5%) 
Pre-eclampsia 1 (1%) 8 (2%) 3 (1%) 1 (1%) 2 (4%) 15 (1%) 
Pre-term 0 (0%) 3 (1%) 0 (0%) 1 (1%) 0 (0%) 4 (<1%) 
Twin complication 1 (1%) 9 (2%) 8 (3%) 2 (2%) 1 (2%) 21 (2%) 
Unexplained (all) 
96 
(64%) 
279 
(61%) 
171 
(62%) 
67 
(64%) 
32 
(63%) 
647 
(62%) 
Total:  
150 
(14%) 
459 
(44%) 
275 
(26%) 
104 
(10%) 51 (5%) 1039 
Table 74 Cause of death by PM interval (25 cases excluded as no PM interval recorded.) 
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Figure 38 Percentage of cases with each cause of death with different PM intervals 
There was no significant effect of PMI on cause of death determination.  
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4.12 ReCoDe classification  
Calculations to determine birthweight centile (Chapter 5), have been used to 
determine the proportion of cases that are small for gestational age (SGA, <10
th
 
centile of the normal liveborn range) within the study population. These cases have 
been coded A7 – Fetal Growth Restriction together with those cases diagnosed with 
antenatal IUGR. (SGA cases could only be calculated for fetuses >23 weeks of 
gestation and therefore the total number of cases that could be classified using the 
ReCoDe system was 529). 
 
 
 
 
 
 
 
 
 
Figure 39 Classification system according to relevant condition at death (ReCoDe)(5) 
 
 
 
Group A: Fetus 
1. Lethal congenital anomaly 
2. Infection 
2.1 Chronic 
2.2 Acute 
3. Non-immune hydrops 
4. Isoimmunisation 
5. Fetomaternal haemorrhage 
6. Twin-twin transfusion 
7. Fetal growth restriction* 
Group B: Umbilical cord 
1. Prolapse 
2. Constricting loop or knot† 
3. Velamentous insertion 
4. Other 
Group C: Placenta 
1. Abruption 
2. Praevia 
3. Vasa praevia 
4. Other “placental insufficiency”‡ 
5. Other 
Group D: Amniotic fluid 
1. Chorioamnionitis 
2. Oligohydramnios† 
3. Polyhydramnios† 
4. Other 
 
Group E: Uterus 
1. Rupture 
2. Uterine anomalies 
3. Other 
Group F: Mother 
1. Diabetes 
2. Thyroid diseases 
3. Essential hypertension 
4. Hypertensive diseases in pregnancy 
5. Lupus or antiphospholipid syndrome 
6. Cholestasis 
7. Drug misuse 
8. Other 
Group G: Intrapartum 
1. Asphyxia 
2. Birth trauma 
Group H: Trauma 
1. External 
2. Iatrogenic 
Group I: Unclassified 
1. No relevant condition identified 
2. No information available 
 
* < 10th customised weight for gestational age 
centile. 
†If severe enough to be considered relevant. 
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ReCoDe Classification  Number of cases 
A1 11 (2%) 
A2 0 (0%) 
A2.1 0 (0%) 
A2.2 0 (0%) 
A3 0 (0%) 
A4 0 (0%) 
A5 3 (1%) 
A6 3 (1%) 
A7 193 (37%) 
B1 2 (<1%) 
B2 0 (0%) 
B3 0 (0%) 
B4 10 (2%) 
B5 0 (0%) 
C1 11 (2%) 
C2 0 (0%) 
C3 0 (0%) 
C4 10 (2%) 
C5 24 (5%) 
D1 36 (7%) 
D2 0 (0%) 
D3 0 (0%) 
D4 0 (0%) 
E1 0 (0%) 
E2 0 (0%) 
E3 2 (<1%) 
F1 16 (3%) 
F2 0 (0%) 
F3 1 (<1%) 
F4 6 (1%) 
F5 0 (0%) 
F6 5 (1%) 
F7 0 (0%) 
F8 9 (2%) 
G1 0 (0%) 
G2 3 (1%) 
H1 0 (0%) 
H2 0 (0%) 
I1 183 (35%) 
I2 0 (0%) 
Total:  528 
Table 75 ReCoDe classification of deaths.  
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Using this classification system, 37% of deaths were SGA and 35% were 
unexplained.  The original ReCoDe paper classified 43% growth restricted and 15% 
as unexplained (5).  
4.13  How often does the autopsy examination identify a specific 
cause of death? 
Further analysis of the cause of death, using the objective criteria, demonstrated that 
19% of the deaths could be classified based on the antenatal history, clinical events, 
antenatal ultrasound scan findings or external / imaging examination.  Placental 
examination alone identified causes for a further 18%. Invasive autopsy examination, 
with associated organ sampling, only provided a specific cause of death in a minority 
(1%) of cases. The remainder of the deaths in the study population were unexplained 
and invasive autopsy provided no additional diagnostic information based on 
currently available ancillary investigations. 
Of the 1% of cases in which a cause of death was determined at invasive autopsy; 
 55% were based on histology findings (the majority being lung histology- see 
histology chapter) 
 9% were based on microbiology findings, 
 27% were based on an internal, macroscopic assessment of organs. 
Autopsy examination Number of cases 
Diagnosis determined by Histology 6 (55%) 
Diagnosis determined by Microbiology 1 (9%) 
Diagnosis determined by internal examination of organs 3 (27%) 
Diagnosis  determined by abnormalities noted within the 
blood 1 (9%) 
Total: 11 
Table 76 Cause of death diagnosed at autopsy using different methods 
 
Autopsy Investigation in Stillbirth 
 
149 
 
Of the 1,064 stillbirth and miscarriage autopsies reviewed, histological analysis of 
tissue provided a specific cause of death in only six (<1%) cases. Histological 
assessment of tissue at autopsy is reviewed in greater detail in Chapter 6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40 proportion of cases that can be allocated a cause of death using either a clinical event, a 
good clinical history or ultrasound scan, those diagnosed after placental examination or autopsy and 
those with no diagnosis after all of the above. 
4.14 Discussion 
Two thirds of the study population had an unexplained cause of death despite 
autopsy examination being performed: 27% of these deaths had no associated 
Clinical event, history or clinical 
USS, external or imaging 
examination 
190 (18%) 
Placental Examination 
191 (18%) 
Autopsy 
Unexplained (including unexplained lesions) 
655 (62%) 
Cause of death found 
11 (1%) 
19% 
37% 
38% 
100% 
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clinical, fetal or placental lesions, being fully unexplained, whereas the remainder 
were unexplained but associated with known risk factors. These proportions are in 
keeping with other studies and highlight that depending on which classification 
system is used, 25-60% of deaths in stillbirth can be classified as unexplained based 
on whether associated conditions are deemed to be sufficient as a cause of death or 
simply a risk factor with the cause remaining unexplained (194). This has important 
consequences since it highlights that the great differences in cause of death assigned 
across studies, centres and classification systems is largely related to the 
interpretation of findings rather than any differences in findings themselves. Until 
objective laboratory criteria are available to determine or confirm mechanisms of 
death, these issues cannot be resolved. It should therefore be recognised that 
currently, a large proportion of the causes of death provided for such deaths are 
speculative, and differences in interpretation of features or findings accounts for 
differences in cause of death rates. This is important for interpretation of research 
data and for counselling parents. 
The second most common cause of death overall was ascending infection, 
representing 17% of the total population, similar to that reported in other studies for 
high income countries (195-197).  A large American study reported that the rate of 
chorioamnionitis, in both pre-term and term fetuses,  has increased in all ethnicities 
over a 15 year period and white mothers continued to have a lower relative risk than 
all other ethnicities until 2009 (198). The present study confirms that Black and 
Asian mothers have significantly more cases of ascending infection than White 
mothers and that ascending infection is a major cause of miscarriage, particularly 
late miscarriage around 20-23 weeks of gestation. 
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White mothers had significantly more unexplained fetal deaths than other ethnicities, 
likely because of their lower rate of ascending infection. Mothers over the age of 40 
had significantly more placental causes of death than mothers less than 40 years of 
age. There are no comparable published studies which examine in detail the specific 
maternal associations and causes of death in stillbirth. 
Importantly, fetuses with more severe maceration changes, indicating a longer 
intrauterine interval between death and delivery (see chapter 5) were associated with 
a greater proportion of unexplained deaths. A stepwise increase in the proportion of 
unexplained deaths with worsening maceration was noted suggesting a likely 
association between the degree of maceration and the ability to identify a specific a 
cause of death at autopsy.  A stepwise decrease in the number of cases of ascending 
infection with worsening maceration was also observed (as expected since ascending 
infection leads to onset of labour), which would account for some, but not all, of this 
difference; the relationship remains even if ascending infection cases are excluded. 
There was no effect on PMI and cause of death, demonstrating that delay between 
delivery and autopsy does not affect the likelihood of determining any specific cause 
of death, providing bodies are suitably refrigerated.   
There were differences in cause of death categories according to gestational age at 
death. Placental abruption, maternal infection, placental abnormalities and 
unexplained lesions were significantly more frequent in later stillbirths than in earlier 
miscarriages whereas ascending infection and unexplained death with a previous 
history of fetal loss were significantly more frequent in miscarriages. 
In order to allow comparison with published data, deaths in this study were also re-
classified using ReCoDe. Using this classification (which includes risk factors as 
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well as causes of death), the proportion of unexplained deaths decreased and the 
highest proportion of deaths became attributed to growth restriction (37%), based 
solely on fetal biometry derived some time after the demise. (There are several major 
flaws with this approach, see Chapter 5 Fetal Growth Restriction Assessment). 
Nevertheless, using ReCoDe, 35% of stillbirths remained unexplained compared to a 
similar 26% in the current series being unexplained, unexplained (in the stillbirth 
sub-category). These findings demonstrate the difficulty in comparability between 
classification systems, even when the same population is being assessed, due to the 
arbitrary and subjective nature of most systems combined with difficulty in 
interpretation of the true significance of factors in any individual case. The original 
ReCoDe study reported a majority of growth restricted fetuses (43%), similar to that 
found in the current study (5). However the present study had more unexplained 
deaths than the ReCoDe study (26% vs 15.2%), largely since we applied strict 
criteria to assigning any findings as a cause of death (5).  
Further analysis of the cause of death, using the study’s objective criteria, found that 
almost 20% of the causes could have been identified from careful review of the 
antenatal history, clinical events, antenatal ultrasound scans or simple external 
examination or imaging of the fetus.  Placental examination provided the cause of 
death for approximately 20% of additional cases. Full invasive autopsy examination 
itself only identified the cause of death in around 1% of cases, most remaining 
unexplained despite autopsy if placental and clinical history were non-contributory. 
Hence, published data, which include all aspects of the postmortem examination 
within the final “autopsy report”, markedly overestimate the role of the invasive 
autopsy component itself in such cases. The findings suggest that: 
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1. The majority of stillbirths could be adequately investigated by detailed 
clinical review, external examination and/or imaging and placental 
examination, without the need for a full autopsy.  
2. Only a minority (around 1%)  of cases require an invasive autopsy to give a 
likely cause of death  
3. Two thirds of stillbirth deaths cannot be given a definitive cause of death 
despite current antenatal, clinical and autopsy practise, and there is great 
variation in interpretation of many findings. 
4. The major challenge remaining is therefore to develop novel methods of 
investigation to determine mechanisms of intrauterine death to reduce the 
proportion of “unexplained” cases. 
It has been suggested that antenatally undiagnosed growth restriction is one of the 
main causes of death in stillbirth; Chapter 5 discusses this in detail (5). The present 
data estimate that only 10-20% of stillbirths are likely to be genuinely growth 
restricted and improving antenatal care to detect IUGR may reduce some otherwise 
unexplained deaths, but will not change the fact that the underlying mechanism of 
stillbirth remains unknown in most cases and only a minority are given a definite and 
accurate cause of death after autopsy.  It is clear from these results that autopsy 
practise must evolve. There must be acceptance that areas of uncertainty exist and 
the usefulness of current autopsy techniques, with an aim to develop new methods of 
investigation with improved objectivity and efficacy.  
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5.0 Background  
Depending on which classification system is used, 15-60% of stillbirths remain 
unexplained, despite autopsy examinations being undertaken by trained professionals 
(4, 5). Much of this variation is related to the variable attribution of growth 
restriction to the cause of death. 
Fetal growth restriction (FGR) implies a pathological restriction of the genetic 
growth potential  whereas small for gestational age (SGA) simply describes a fetus 
whose biometry falls below an arbitrary centile, usually the 10
th
, of the expected 
normal range for gestational age (199, 200). Not all FGR fetuses are SGA and not all 
SGA fetuses are FGR. Fetal birthweight is not only affected by pathological 
abnormalities but also physiological differences such as parental ethnicity and height 
as well as maternal parity (199). Indeed, 50-70% of SGA fetuses (based on standard 
charts) are likely to be constitutionally small, with fetal growth appropriate for 
maternal size and ethnicity (200). Customised growth charts have therefore been 
developed to reduce such effects and are recommended by the Royal College of 
Obstetricians and Gynaecologists in their 2014 Green Top Guideline (199, 201). 
Despite this, distinguishing incidental SGA from pathological FGR remains a 
challenge both antenatally and in particular postmortem.   
FGR has been suggested as the single largest population attributable risk for stillbirth 
which could be significantly ameliorated by antenatal recognition (61).  Studies from 
the 1990’s report antenatal detection rates for fetuses delivered SGA of only 15-24% 
(84, 202). Using customised growth charts detection rates appear improved, to 
around 30%, suggesting that increased surveillance for SGA increases its detection 
(52, 61).  
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The Confidential Enquiry into Stillbirths with Fetal Growth Restriction reported an 
association between stillbirths with FGR  and substandard care  with such deaths 
considered potentially avoidable (203).  The rate of stillbirth (per 1000 births) can 
vary from an average of 4.2, down to 2.4 without FGR; 9.7 when FGR is detected 
antenatally; and up to 19.8 when FGR is present but not detected during the antenatal 
period (52).   
5.1 Chapter aims 
This chapter aims to investigate the frequency of SGA and FGR in a large series of 
stillborn fetuses, highlighting maternal associations, specific causes of fetal death 
and the role that secondary changes such as fetal maceration, intrauterine interval 
and postmortem interval may have in the accuracy of diagnosing SGA and FGR at 
autopsy. Specifically, the chapter will cover: 
1. The proportion of stillborn fetuses found to be SGA at autopsy. 
2. The causes of death in cases of SGA and FGR stillborn fetuses. 
3. Maternal demographic associations of SGA stillborn fetuses  
4. The effects of fetal maceration and intrauterine/postmortem interval on fetal 
weight and SGA estimation postmortem.  
 
5.2 Method 
The Microsoft Access Autopsy Database was used to collate postmortem and 
antenatal details available for all stillbirths, early and late miscarriages from 2005 – 
2013 from Great Ormond Street Hospital and St George’s Hospital, London.  Data 
was analysed through queries and statistical tests run using Microsoft Access, Excel, 
Graph Pad Prism and Stats Direct. Statistical test results can be viewed in detail in 
Appendix 3.  
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5.2.1 Proportion of SGA  
Neonatal growth charts published by the World Health Organisation (WHO) were 
used to determine normal expected weight centiles for fetuses born after 23 weeks’ 
gestation. (Males and females were evaluated separately since infant sex has a 
marked effect on birthweight (204)). Individualised growth charts could not be used 
for this study due to its retrospective nature and the lack of detailed maternal 
demographic information required from archival postmortem reports. Nevertheless, 
since all comparisons are between groups, the findings and intergroup differences 
remain valid. These data were used to calculate the gestational age corrected 
expected birthweights and delta values for each case (the number of standard 
deviations (SDs) by which the observed birthweight differed from the expected 50
th
 
centile weight from the normal range.)  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 40 WHO neonatal growth charts used as controls (Permission to reproduce this figure has 
been granted by RCPCH)  (205) 
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Figure 41 Normal distribution curve (206) 
 
 
To calculate which fetuses were below the 10
th
 centile in the study population the 
following calculation was used:  
 
(Observed weight (study birth weight) – Expected weight (WHO 50th centile for same gestation)) 
SD in grams for gestation (calculated from WHO charts) 
 
The resulting delta value corrects for gestational age and fetal sex effects and 
therefore allows valid comparison between groups regardless of the gestational age 
distributions. Cases with a delta value below -1.375 (approximating the 10
th
 centile 
of the normal range) were denoted as SGA (see appendix 5). 
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5.3 Results  
5.3.1 Frequency of antenatally diagnosed FGR from the clinical history 
Of the total population, 43 (4%) cases had an antenatal diagnosis of Intrauterine 
Growth Restriction (IUGR) (Table 77), including 35 cases >23 weeks (35 of 674; 
5%). 30 had delta birthweights available; 26 (87%) were SGA as well as being 
diagnosed with antenatal IUGR 
25 of the total 43 cases (58%) had additional or other specific classification 
identified as the cause of death (Table 78.). The most common finding in this 
category was abnormality of the placenta such as infarction, followed by clinically 
diagnosed pre-eclampsia.  
Table 77 Cause of death in known cases of IUGR.  35 cases out of 42 were >23 weeks gestation 
 
 
 
 
 
 
 
 
 
 
 
Specific 
classification of 
death following 
autopsy 
No other cause of 
death found at 
autopsy 
Total: 
 
Total 
study 
population 
Known 
IUGR from 
antenatal 
History: 
25 (58%) 
 
 
18 (42%) 
 
 
43 (4%) 
 
 
1064 
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Specific classification of death following 
autopsy in cases of antenatally detected 
IUGR 
Number of cases 
 
Placental abruption 3 (7%) 
Ascending genital tract infection 1 (2%) 
Congenital abnormalities 4 (9%) 
Feto-maternal haemorrhage 1 (2%) 
Placental malperfusion lesions 9 (21%) 
Pre-eclampsia 7 (16%) 
No specific additional found (therefore 
known IUGR given as COD in study) 18 (42%) 
Total:  43 
Table 78 Cause of death in cases of known  antenatal IUGR 
 
In the 58% of cases that had a specific identifiable cause of death at autopsy, this 
was used as the final cause of death. Where no other specific cause of death was 
identified, the case was classified as Known IUGR. 
5.3.2 Autopsy findings 
There were 533 stillbirths with a recorded birthweight delivered at greater than 23 
weeks gestation. Of these, 192 (36%) had birthweights below the 10
th
 centile and 
were thus SGA based on WHO charts for normal livebirths (Table 79). 
Male Female 
 
107 (56%) cases SGA(38% of all males) 
 
 
 
85 (44%) cases SGA(34% of all females) 
Table 79 Proportion of male and female stillbirths>23 weeks gestation that were SGA 
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Cause of death at autopsy in SGA cases 
Cause of death Number of cases 
Abruption 11 (6%) 
Ascending Infection 12 (6%) 
Congenital abnormalities 17 (9%) 
Feto-maternal Haemorrhage 2 (1%) 
Infection 2 (1%) 
Known IUGR 11 (6%) 
Placenta 36 (19%) 
Pre-term 0 (0%) 
Pre-eclampsia 7 (4%) 
Twin complications 4 (2%) 
Unexplained 90 (47%) 
Total:  192 
Table 80 Causes of death in cases of SGA 
Nearly half of cases of SGA (47%) had no specific identifiable cause of death (Table 
80), whilst the most common specific category in this group was placental 
abnormalities (19%), typical of pathological FGR and uteroplacental malperfusion. 
These findings are similar to those observed in cases with antenatally detected 
IUGR. When comparing causes of death in non SGA and SGA fetuses, congenital 
abnormalities and  placental causes of death were more frequently observed in SGA 
fetuses ( z= 2.796 p=0.0052 and  z=5.897, p<0.0001), however, unexplained deaths 
were more frequently observed in non SGA fetuses (z= 5.582, p<0.0001). 
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Cause of death Non SGA SGA 
Abruption 12 (4%) 11(6%) 
Ascending Infection 38 (11%) 12 (6%) 
Birth Trauma 3 (1%) 0 (0%) 
Congenital Abnormalities 11 (3%) 17 (9%) 
Fetomaternal Haemorrhage 3 (1%) 2 (1%) 
Infection 6 (2%) 2 (1%) 
Known IUGR 0 (0%) 11 (6%) 
Known cord accident 2 (1%) 0 (0%) 
Placenta 12 (4%) 36 (19%) 
Pre-eclampsia 6 (2%) 7 (4%) 
Pre-term 2 (1%) 0 (0%) 
Twin complication 3 (1%) 4 (2%) 
Unexplained 243 (71%) 90 (47%) 
Total: 341 192 
Table 81 Causes of death in cases of Non SGA and SGA: congenital abnormalities and placental 
causes of death more frequent in SGA ( z= 2.796 p=0.0052 and  z=5.897, p<0.0001); unexplained 
deaths more frequent in non SGA (z= 5.582, p<0.0001). 
 
Figure 42 Causes of death in cases of Non SGA and SGA: congenital abnormalities and placental 
causes of death more frequent in SGA (z=2.79,  p=0.052 and  z=5.897, p<0.0001); unexplained 
deaths more frequent in non SGA (z= 5.582, p<0.0001). 
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Proportion of unexplained deaths with SGA 
In the total study population there were 611 cases with an unexplained (all) cause of 
death, of whom 411 (67%) were stillbirths >23 weeks. 335 cases had a birthweight 
provided and therefore could be used in the SGA calculations. Of these unexplained 
deaths, 90 cases (27%) were SGA based on birthweight. 
5.3.3 Maternal obesity and SGA  
84 cases in the SGA population had a recorded maternal Body Mass Index (BMI). 
The majority of mothers had a normal BMI (significantly overrepresented in the 
SGA group z = 2.029,  p=0.0425), and there was a significant overrepresentation of 
underweight mothers in the SGA group (Table 82) (p=0.02).  
Maternal BMI Non SGA SGA 
Underweight 0 (0%) 3 (4%) 
Normal 43 (35%) 36 (42%) 
Overweight 53 (34%) 22 (26%) 
Obese 51(31%) 24 (28%) 
Total 147 85 
Table 82 Maternal BMI in cases of SGA and the remainder of the study population. There were 
significantly more underweight mothers in the SGA population (z= 2.293, p= 0.02)  
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Figure 43 Maternal BMI in cases of SGA and Non SGA. Normal weight and underweight mothers 
were significantly overrepresented in the SGA group (z = 2.029, p = 0.0425 and z=2.293, p= 0.02)  
5.3.4 Maternal ethnicity and SGA  
154 SGA cases had a recorded maternal ethnicity. There were no significant 
differences between the two groups.    
Maternal Ethnicity Non SGA SGA 
White 174 (67%) 105 (68%) 
Mixed 9 (3%) 2 (1%) 
Asian 18 (7%) 15 (10%) 
Black 57 (22%) 32 (21%) 
Total 258 154 
Table 83 Maternal ethnicity in cases of non SGA and SGA.  
 
 
Figure 44 Maternal ethnicity in non SGA and SGA cases.  
 
5.3.5 Maternal DM and SGA  
11 cases in the SGA population had mothers with some form of diabetes mellitus. 
There was no significant difference in the proportion of mothers with gestational 
diabetes versus other forms of diabetes mellitus in the SGA group when compared to 
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the non SGA group (Table 85). There was also no significant difference in the 
number of mothers with any form of diabetes mellitus in the SGA population 
compared to the remainder of the study population. 
Maternal Diabetes Number of cases 
Diabetes Mellitus 5 (45%) 
On Insulin 2 
No Insulin 1 
No further information 2 
  
 Gestational DM 6 (55%) 
Total:  11 
Table 84 Maternal Diabetes Mellitus in cases of SGA 
 
 Maternal Diabetes Mellitus Non SGA SGA  
Diabetes Mellitus 11 (38%) 5 (45%) 
Gestational Diabetes 18 (62%) 6 (54%) 
Total:  29 11 
Table 85 Maternal Diabetes mellitus in cases of SGA and the remainder of the study population. No 
significant differences were found.  
 
5.3.6 Maternal hypertension and SGA  
24 (13%) SGA fetuses had mothers with some form of hypertension, the majority of 
which (42%) was pre-eclampsia (Table 86). There were no statistically significant 
differences between the two groups in the total number of cases with or without any 
form of hypertension, or between those with different types of hypertension.  
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Figure 45 Maternal hypertension in cases of SGA 
 
 
Maternal Hypertension Non SGA SGA  
Pre-eclampsia 11 (32%) 10 (59%) 
Pregnancy induced 12 (35%) 2 (12%) 
Chronic 11 (32%) 5 (29%) 
Total 34 17 
Table 86 Maternal hypertension in cases of SGA and the remainder of the study population.. 
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Figure 46 Maternal hypertension in cases of SGA and the remainder of the study population.  
 
5.3.7 Maternal age and SGA 
190 cases of SGA fetuses had a recorded maternal age (Table 87 and Figure 47). 
There was no significant difference between the two groups in mothers less than 35 
years and greater than or equal to 35 years.  
 
Maternal Age 
(years) 
Non SGA Cases 
 
SGA Cases 
 
<19  20 (6%) 6 (3%) 
20-24  39 (12%) 31 (16%) 
25-29  80 (24%) 50 (26%) 
30-34  114 (34%) 55 (29%) 
35-39  62 (18%) 34 (18%) 
40-44  23 (7%) 12 (6%) 
>45 0 (0%) 2 (1%) 
Total 338 190 
Table 87 Maternal age distribution in cases of SGA and the remainder of the study population. 
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Figure 47 Comparison of maternal age in the SGA population and the remainder of the study 
population.  
 
5.3.8 Effects of fetal maceration  
86% of stillborn SGA fetuses had some degree of maceration noted at autopsy 
(Table 88), compared to 73% of non-SGA stillborn fetuses. Out of 415 cases with 
maceration, 28 (7%) were SGA with mild maceration and 100 (24%) were SGA with 
moderate or severe maceration. 
Fetal Maceration Number of cases 
None 27 (14%) 
Mild 28 (15%) 
Moderate                             12 (6%) 
Severe 88 (46%) 
Other description 35 (18%) 
Total: 190 
Not given 2 
Table 88 Fetal maceration in cases of SGA 
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Figure 48 Fetal maceration in cases of SGA 
A significantly greater proportion of SGA fetuses were macerated compared to the 
non SGA population (z=2.571 p=0.0102). 
 
Degree of maceration Non SGA SGA 
None 79 (24%) 27 (14%) 
Mild 47 (14%) 28 (15%) 
Moderate 31 (9%) 12 (6%) 
Severe 128 (38%) 88 (46%) 
Other 50 (15%) 35 (18%) 
Total: 335 190 
Table 89 Fetal maceration in cases of non SGA and SGA. Excludes 8 cases with no description of 
maceration. Significantly more macerated fetuses in the SGA population (z=2.571 p=0.0102) 
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Figure 49 Fetal maceration in cases of non SGA and SGA. Significantly greater proportion of 
macerated fetuses in the SGA population (z=2.578 p=0.0099) 
 
Excluding cases of Ascending Infection  
Fetal Maceration Non SGA SGA Total: 
None 56 (19%) 21 (12%) 77 (16%) 
Mild 39 (13%) 24 (13%) 63 (13%) 
Moderate 29 (10%) 12 (7%) 41 (9%) 
Severe 123 (41%) 88 (49%) 211 (44%) 
Other description 50 (17%) 33 (19%) 83 (17%) 
Total: 297 178 475 
Not given 6 2 
 Table 90 Fetal maceration in cases of non SGA and SGA. Excluding all cases of ascending infection.  
 
When cases of ascending infection were excluded, there continued to be a 
significantly greater proportion of macerated cases in the SGA population than in the 
non-SGA population (z=2.020 p=0.0434), indicating that maceration itself is 
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associated with reduced body weight for gestational age rather than SGA fetuses 
dying in utero and hence being macerated (See Chapter 6 on organ weights for 
further details).  
  
 
Figure 50 Fetal maceration in cases of non SGA and SGA. Excluding all cases of ascending 
infection. There was a significantly greater proportion of macerated cases in the SGA population than 
in the non-SGA population (z=2.020 p=0.0434). 
5.3.9 Effect of intrauterine and postmortem intervals on fetal weight and 
implications for SGA diagnosis at autopsy 
Intrauterine interval (IUI) was calculated as a minimum value according to the 
antenatal notes i.e.  the fetus had been dead in utero for at least X number of days 
according to either the last fetal ultrasound scan results or fetal movements felt by 
the mother.  Fresh intrapartum deaths were recorded as having 0 days intrauterine 
interval.    
431 of 1,064 cases had a recorded birthweight, body weight and well documented 
intrauterine interval, of which 308 were >23 weeks of gestation. Seven cases were 
excluded for not having a status of maceration recorded. 103 cases were SGA. There 
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was a relationship, between increasing intrauterine interval and more severe 
maceration. (Figure 51) (z=15.45, p<0.0001). However, maceration severity was not 
closely related to IUI; whilst all cases with prolonged (>4 days) documented IUI 
demonstrated moderate or severe maceration, so did some cases with an IUI of only 
two days. Presence of significant maceration appears to be a reliable indicator of 
intrauterine death prior to delivery, with retention of at least 24-48 hours, but cannot 
be used to determine the exact period since death and delivery. 
 
Figure 51 Percentage of cases with different degrees of maceration according to intrauterine 
interval. With increasing IUI, maceration becomes more severe (z=15.45, p<0.0001). 
In addition, there was a significant relationship between intrauterine interval and 
delta birth weight (Figure 52) (p<0.0001). As the intrauterine interval increased, the 
delta birth weight value decreased (became more negative) indicating that with 
intrauterine retention the fetus loses weight in utero. A. prolonged intrauterine 
interval therefore affects fetal birthweight and hence the proportion of SGA. 
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Figure 52 The significant linear relationship between intrauterine interval and delta birthweight (p< 
0.0001) 
 
The proportion of SGA cases in stillbirths > 23 weeks was 21% in those with 0 days 
IUI, 30% in those with 1-2 days IUI and 44% in those > 2 days IUI. There were 
significantly more fetuses with an IUI of >2 days in the SGA group (z=3.324, p = 
0.0009) compared to the non-SGA population (Table 91). 
 
Intrauterine Interval 
 
Non SGA  
 
SGA 
 
Total 
0 days 60 (29%) 16 (16%) 
 
76 (25%) 
1- 2 days 80 (39%) 35 (34%) 
 
115 (37%) 
> 2 days  65 (32%) 52 (51%) 
 
117 (38%) 
Total:  205 103 
 
308 
Table 91 Intrauterine interval in non SGA and SGA cases. Significantly more fetuses with a 
prolonged IUI (> 2 days) in the SGA group (z=3.324 p=0.0009) 
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Figure 53 Intrauterine interval in non SGA and SGA cases. Significantly more fetuses with a 
prolonged IUI (> 2 days) in the SGA group (z=3.324 p=0.0009). 
 
5.3.10 Postmortem interval and birth weight/ body weight differences 
615 cases had both reliably recorded birthweight and body-weight at autopsy to 
allow for the calculation of fetal weight change over the time period between birth 
and autopsy (.i.e. the postmortem interval (PMI) (Figure 54). 
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Figure 54 Postmortem interval and recorded percentage fetal weight loss in all cases (excludes 369 
cases with no birth weight, 57 typed errors and 11 cases which lost apparently> 92% of their birth 
weight and 1 case with a PMI of 79 days)) 
There was an average 12% loss of fetal birthweight whilst the fetus was refrigerated 
pending autopsy and an average PMI of 8 days. As PMI increased the average 
percentage fetal weight loss significantly increased (p = 0.0001) (Table 92 and 
Figure 55) 
PM Interval Average % weight loss 
1 Day -1.76 
2 Days -8.21 
3 days -7.27 
4 days -8.32 
5 days -8.53 
6 days -12.78 
7 days -9.11 
8 days -11.36 
9 days -13.99 
10 days -15.19 
>10 days -15.19 
Table 92 Average percentage weight loss(all cases). As PMI increases percentage weight loss 
increases (p = 0.0001) 
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Figure 55 Average percentage weight loss in all cases. AS PM interval increases percentage weight 
loss increases (p= 0.0001) 
Furthermore, calculating delta body weight (using the same method as used to 
calculate delta birthweight), 255 cases were classified as SGA; a 12% rise compared 
to using delta birth weight for the calculation.   
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5.4 Discussion 
The findings of this chapter have demonstrated that, based on birthweight against 
standard fetal size charts, 36% of stillbirths >23 weeks of gestation initially appear to 
be SGA (38% male and 34% female); significantly greater than the expected 10%. 
Similar percentages were reported in a smaller UK study in which 44% were SGA, 
after a detailed review of the notes and the use of customized growth charts. Another 
study, using the ReCoDe classification, found 43% of stillbirths to be SGA (5, 207). 
A French study reported 49% of cases as SGA (208). However, within the same 
study, when the hierarchy of SGA was reduced such that low birthweight for 
gestational age was retained only in the absence of other conditions, the proportion 
of stillbirths assigned to the FGR category decreased from 38.2 to 14% (208).  
The majority of SGA fetuses in the present study (48% male and 46% of females) 
had no specific identifiable cause of death at autopsy and were hence classified as 
Unexplained. However, of the total number of unexplained deaths in the study, only 
around 27% were SGA.  
The most common specific findings in cases with known IUGR or SGA were 
abnormalities of the placenta, mainly changes suggestive of uteroplacental 
malperfusion with other specific causes including abruption and infection. These 
figures are similar to the French stillbirth study outlined above, in which 25.5% of 
the SGA cases had a placental cause of death (208). The literature review reveals 
very few studies which report, in detail, the causes of death within the subcategory of 
stillborn fetuses born SGA. This may be because one of the most frequently used 
classification systems (ReCoDe) uses a separate category for FGR (in reality SGA) 
and thus the mechanism of death in such cases is assumed to be growth restriction 
and not reviewed further (5). The present study highlights that although the fetus 
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may be SGA, or even FGR, this alone may not be the cause of death. Indeed, 60% of 
the cases identified antenatally with FGR had a specific or alternative cause of death 
at autopsy including, placental abruption, ascending infection, congenital 
abnormalities, other abnormalities within the placenta or feto-maternal haemorrhage.  
5.4.1 Estimation of fetal size is affected by changes occurring after death 
Maceration, the process of fetal decomposition after intrauterine death, is rarely 
investigated or analysed in current practise (167). Within this study, 89% of SGA 
fetuses showed some degree of maceration: a significantly higher proportion than 
non SGA fetuses. In addition, as the intrauterine interval increased, the more 
macerated the fetus appeared at autopsy. Furthermore, as the intrauterine interval 
increased, fetal delta birthweight decreased, indicating that fetuses progressively lose 
weight following death in utero. Therefore if birthweight is considered without 
adjustment for effects of intrauterine interval and fetal maceration, the proportion of 
SGA cases will inevitably be erroneously overestimated. Finally, fetal weight also 
further decreased during the postmortem interval with an average 12% loss of 
birthweight between delivery and autopsy. If delta body weight at autopsy is used 
instead of delta birth weight to assess for SGA, there will be a further > 10% rise in 
the number of fetuses diagnosed with SGA, all erroneously, highlighting that 
pathologists need to carefully consider which weight they use to assess for SGA and 
account for post-death changes. (See also chapter regarding organ weights and 
weight ratios for diagnosis of IUGR and effects of postmortem changes). 
These data suggest that, overall, around 30-40% of stillbirths initially appear to be 
SGA, but many of these are erroneously classified due to the effects of postmortem 
and post-delivery changes. Since around half of all SGA fetuses probably represent 
physiological small size, and the current data indicate that around 20% of apparent 
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SGA fetuses are erroneously classified as such due to postdeath changes, it is 
estimated that around 10-20% of clinically unexplained stillbirths may be related to 
pathological growth restriction (209). This has implications for the maximum likely 
effects of major National programmes to increase detection of growth restriction to 
reduce stillbirth rates.  
In conclusion, this chapter has demonstrated that: 
 Based purely on unadjusted birthweight centiles, around 35% of stillbirths 
are SGA. 
 There is a significant association between increasing maceration and 
increasing rate of SGA. 
 The longer the intrauterine interval, the greater the degree of fetal maceration 
and the more delta birthweight decreases. 
 Fetuses lose on average 12% of their birthweight in the interval between 
delivery and autopsy. 
 Without adjusting for such factors, using birthweight or bodyweight alone 
will erroneously significantly overestimate the role of SGA as an underlying 
factor in stillbirth causation. 
To further assess the relationship between stillbirth and FGR/ SGA, further research 
is required into the biological and pathological mechanisms of death in FGR/SGA, 
accounting for the relationship between the intrauterine interval, postmortem 
interval, maceration and fetal birthweight.  
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6.0 Background 
The Royal College of Pathologists recommends the weighing of all major organs at 
autopsy in cases of stillbirth/ miscarriage; these guidelines based primarily on expert 
opinion rather than published data (159). Only one published study reviews the 
effects of a maternal factor - maternal diabetes mellitus-  on fetal organ weights; a 
surprising find when it is known that other maternal factors such as body mass index 
and ethnicity are associated with stillbirth  (52, 94, 95, 210).  
There are also no published studies which review the effects on organ weights of 
different causes of death in stillbirth, (other than brain:liver weight ratio in IUGR see 
below), and hence the potential usefulness of organ weight metrics for determining 
cause or mode of death.  Furthermore, the postmortem brain:liver weight ratio is 
commonly used as a marker of nutrition and growth in fetuses but this is based on 
limited data. Finally, few published studies have examined the effects of intrauterine 
retention, fetal maceration and postmortem interval on organ weights at autopsy and 
therefore - possible effects on brain:liver weight ratio (169, 170, 211).  From results 
demonstrated previously within this thesis (Chapter 5) it has been established that 
without adjustment for effects of intrauterine interval and fetal maceration, the 
proportion of Small for Gestational Age (SGA) cases will be erroneously 
overestimated, based on either both fetal birthweight and especially bodyweight 
recorded at autopsy. If maceration changes also affect organ weights, especially if 
this effect is variable by organ, organ weights and ratios such as the brain: liver 
weight ratio, such weights and ratios will not be an accurate way to diagnose fetal 
malnourishment or IUGR in this setting. 
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6.1 Chapter Aims 
The aims of this Chapter are therefore to examine whether there are any significant 
differences or relationships between gestational age and sex adjusted fetal organ 
weights (see methods) and: 
1. Maternal body mass Index 
2. Maternal Hypertension 
3. Maternal Diabetes Mellitus 
4. Small for gestation age fetuses 
5. The cause of death allocated at autopsy 
6. Intratuterine retention and fetal maceration 
In cases where a significant relationship exists, body:organ weight ratios will be 
calculated to assess whether organs are disproportionately lighter compared to body 
weight or changes in organ weights are simply proportional to overall changes in 
fetal body weight. Brain:liver weight ratio will also be examined in detail including 
its relationship to fetal maceration, intrauterine growth restriction/ SGA and cause of 
fetal death.  
6.2 Methods 
The Microsoft Access Autopsy Database was used to collate postmortem and 
antenatal details available for all stillbirths and early and late miscarriages from 2005 
– 2013 from Great Ormond Street Hospital and St George’s Hospital, London.  Data 
was analysed through queries and statistical tests run using Microsoft Access, Excel, 
Graph Pad Prism and Stats Direct. Statistical tests can be viewed in detail in 
appendix 3. 
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6.2.1Calculating Delta Organ weights 
1. Female and male fetal organ weights were plotted separately against the fetal 
gestation for each case  
2. Polynomial regression calculations assessed the trend and were used to 
calculate organ weights on the 50
th
 centile 
3. Using Stats Direct the polynomial regression equation was interpolated X to 
Y to determine the 2.5
th
 centile for each gestation 
4. The standard deviation in grams for each gestation was calculated by: 
(50
th 
centile value– 2.5th centile value) 
1.96 
 
5. The delta value for each organ was then calculated by: 
Observed organ weight (g) –Expected organ weight (g) (50th centile) 
Standard deviation (g) 
 
Calculating a delta organ weights allows for the comparison of organ weights 
between different clinical groups, without the confounding factors of gestational age 
or fetal sex. 
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6.3 Organs analysed 
Within the study: 
 911 brains weighed and 52 excluded from analysis (33 no gestation and 19 typed 
errors/ outliers) 
 957 livers weighed and 41 excluded from analysis (34 no gestation and 7 typed 
errors/outliers) 
 930 thymus’ weighed and 36 excluded from analysis ( 33 no gestation and 3 typed 
errors/outliers) 
 967 hearts weighed and 36 excluded from analysis (34 no gestation and 2 typed 
errors/outliers) 
 313 combined lungs weighed and 38 excluded from analysis (37 no gestation 
and 1 typed error/outlier) 
 406 combined kidneys weighed and 43 excluded from analysis ( 37 no gestation 
and 6 typed errors/outliers) 
 913 spleens weighed and 42 cases were excluded from analysis (36 no gestation 
and 6 typed errors/outliers) 
 952 combined adrenals weighed and 38 excluded from analysis (Excludes: 33 
no gestation and 5 typed errors/outliers) 
 745 pancreas’ weighed and 39 excluded from analysis (36 no gestation and 3 
typed errors/outliers) 
 154 thyroids weighed and 34 excluded from analysis (33 no gestation and 1 typed 
error/outlier) 
(NB: For the purposes of this study, typed error/ outliers were those in which the recorded organ 
weight was non-physiological, usually an order of magnitude larger or smaller than expected 
suggesting a transcription error or a missing or additional decimal place) 
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Figure 56, Figure 57, Figure 58, Figure 59, Figure 60, Figure 61, Figure 62, Figure 63, Figure 
64, Figure 65 Polynomial regression of fetal gestation and organ weights for males and females 
(Brain, Liver, Thymus, Heart, Combined kidneys, Combined Lungs, Spleen, Pancreas and Thyroid).  
 
6.4 Results 
Each organ was statistically analysed over six different categories and assessed 
separately for male and female fetuses: 
1. Body Mass Index: The comparison of delta organ weights in mothers with 
Normal (N) BMI versus Obese and Overweight (OW) BMI and underweight 
(UW) BMI versus Obese 
 
2. Hypertension: The comparison of organ delta weights for those mothers with 
versus those mothers without hypertension. 
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3. Diabetes Mellitus: The comparison of delta organ weights in mothers with 
versus those without any form of Diabetes Mellitus. 
 
4. Small for gestational age (SGA): The comparison of organ delta weights in 
those fetuses with delta birthweights less than the 10
th
 centile (<-1.375) 
versus those with birthweight delta values greater than the 10
th
 centile (> -
1.375). 
 
 
5. Cause of death: The comparison of organ delta weights in cases of ascending 
infection versus unexplained cases and in placental causes of death versus 
unexplained causes of death (since these categories were the most frequent 
causes of death in Chapter 4). 
 
6. Maceration: The comparison of organ delta weights in those cases with 
maceration versus those with no maceration. 
6.4.1 Significant results  
 Diabetes Mellitus: Fetuses of diabetic mothers had heavier adrenal glands than 
non-diabetic mothers (males p=0.0279,  females p=0.038) 
 
 Small for gestational age (SGA): Most organs (brain, liver, heart, thymus, lungs, 
kidneys and thyroid) were significantly lighter in SGA fetuses than non SGA 
fetuses (Males and females p<0.0001, p<0.0001, p<0.0001, p<0.0001, p<0.0001, 
p<0.0001, male thyroid p= 0.0299, female thyroid p=0.0027 respectively).  
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 Cause of death:  
 
 The liver was lighter in cases of placental causes of death than in 
unexplained death (p<0.0001) and heavier in cases of ascending infection 
than unexplained death (males: p= 0.0032, females: p<0.0001).  
 The adrenal glands were heavier in placental causes of death than in 
unexplained causes of death and heavier in cases of ascending infection 
than in unexplained death (males p=0.0003 and p= 0.0214 and females 
p<0.0001 respectively). 
 The thymus gland was lighter in placental causes of death compared to 
unexplained deaths (males p=0.0001 and females p=0.0069).  
 
 Maceration: Most organs (brain, liver, thymus, heart, lungs, adrenals, and 
thyroid) were lighter in macerated fetuses compared to non-macerated (males 
p=0.0008, p<0.0001, p<0.0001, p=0.0003, p=0.0081, p=0.0066, p= 0.0065 and 
females p< 0.0001 for all except thyroid where p=0.0069).  
Some changes were noted only for male or female fetuses and are therefore of 
uncertain significance. 
 Body mass index: In female fetuses only overweight mothers delivered fetuses 
with heavier hearts than mothers with a normal BMI (p=0.0427) 
 
 Hypertension: In female fetuses only, mothers with hypertension delivered 
fetuses with lighter spleens compared to non-hypertensive mothers (p=0.0091) 
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 Cause of death: In female fetuses only the brain, heart lungs, kidneys and spleen 
were heavier in cases if ascending infection than in unexplained death (p=0.0249, 
p<0.0001, p<0.0001, p<0.0001 and p=0.0023 respectively) and the spleen was 
lighter in placental causes of death than in unexplained death (p=0.0023); but the 
pancreas was heavier in cases of placental causes of death than in unexplained 
death (p=0.0002). In males only the brain, heart lungs and kidneys were lighter 
in placental causes of death than in unexplained death (p<0.0001, p=0.0005, 
p=0.0006, p<0.0001 respectively) 
 
 Maceration: In female fetuses the kidney, spleen and pancreas were also 
significantly lighter in macerated fetuses compared to non-macerated (p< 0.0001 
for kidney and spleen and p=0.0001 for pancreas). 
All other comparisons showed no significant differences. 
6.4.2 Ratio calculations 
Body:organ weight ratios were calculated - for those organs with significant results 
detailed above- in relation to maceration, cause of death and SGA categories, for 
male and female fetuses. The aim of assessing these ratios was to establish; 
1. In cases of maceration, were organ weights lighter because the organs 
themselves were selectively degenerate (disproportionally lighter) or were 
the organs proportionally lighter simply because macerated fetuses had 
lower overall body weight.  
 
2. In different causes of death, were the organs lighter because of effects of the 
cause of death on individual organs or was the whole fetus symmetrically 
smaller as an effect of the cause of death  
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3. In cases of SGA, were organs weights lighter because the organs themselves 
were pathologically small (disproportionally lighter) or were the organs 
proportionally lighter simply because SGA fetuses had lower body weight. 
 
Polynomial and linear regression analysis found that none of these ratios were 
significantly associated with gestational age over the range assessed and thus 
original (observed weight in grams) ratios were used. 
 
6.4.3 Significant Results 
SGA 
1. Body:organ weight ratios for the thymus, liver and spleen were significantly 
greater in cases of SGA compared to non SGA ( males: p<0.0001, p<0.0001, 
p=0.0002 , females: p<0.0001, p<0.0001, p=0.0063 ) 
a. Finding: SGA fetuses have disproportionally lighter thymuses, livers 
and spleens  
b. Implication: The thymus, liver and spleen preferentially lose weight 
more than the body in cases of SGA 
 
2. In males and females Brain:Thymus weight ratio was significantly greater in 
SGA fetuses compared to non SGA fetuses (p<0.0001 in both sexes) 
a. Finding: SGA fetuses have disproportionally lighter thymuses 
compared to brains.  
b. Implication: The thymus preferentially loses weight more than the 
brain in cases of SGA 
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All other male and female organs had non-significant p values comparing organ 
weight ratios in SGA and Non SGA fetuses or changes only present in one sex and 
were thus excluded.   
Cause of death 
1. The Body:Brain  and Body:Liver weight ratios are significantly greater in 
cases of unexplained causes of death compared to cases of ascending 
infection (Males: p=0.0017 and p<0.0001 respectively females: p= 0.0008 
and p<0.0001 respectively) 
a. Fetuses with unexplained death have disproportionally lighter brains 
and livers, or cases of ascending infection have disproportionally 
heavier brains and livers.  
However, to address this, when comparing only non-macerated unexplained deaths, 
with cases of non-macerated ascending infection, these organs weight ratios are no 
longer significantly different. The lungs, however are still significantly heavier in the 
cases of ascending infection likely due to pneumonia and infiltration of the lungs of 
neutrophils and congestion. These findings suggest that in general it is maceration 
that is causing the difference in results, not the mechanism of death.  
2. The Body:Liver and Body:Thymus weight ratios are significantly greater 
with placental causes of death compared to unexplained death (Males: 
p<0.0001 and p=0.0008 respectively Females: p<0.0001 and p=0.0166 
respectively) 
a. Fetuses with a placental mechanism of death have disproportionally 
lighter livers and lighter thymuses. 
 
Autopsy Investigation in Stillbirth 
 
193 
 
Maceration 
Male and female Body:Organ weight ratios for most organs (liver, thymus, lung, 
pancreas, adrenal gland, kidney, heart), were significantly higher in macerated 
fetuses compared to non-macerated fetuses (males: p<0.0001, p=0.0045, p=0.0086, 
p=0.0033, p<0.0001, p=0.0032, , p=0.0096 respectively females: p<0.0001, 
p=0.0049, p<0.0001, p=0.0187, p<0.0001, p<0.000, p<0.0001 respectively). Note 
that overall, the brain weight ratio was not significantly affected. 
a. Finding: Macerated fetuses have disproportionally lighter organs 
b. Implication: Organs preferentially lose weight more than the 
musculoskeletal elements of the body with maceration 
(Males body:thyroid and female body:brain weight ratios were also significantly 
higher in macerated fetuses compared to non-macerated fetuses (p= 0.0014 and 
p=0.0017 respectively) but are unlikely to represent true findings as they were not 
present in both sexes).  
The female spleen and thyroid gland showed no significant difference between ratios 
in macerated and non-macerated fetuses. 
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(212)  
Further points 
There was no significant difference in body:liver, body:heart or body:adrenal weight 
ratios according to maternal body mass index.  
Thymus 
Heart 
Lung 
Liver 
Pancreas 
Kidney and 
adrenal 
gland 
 
 
Figure 66 In the non-macerated fetus organs 
are of usual proportions. 
 
Figure 67 With maceration the fetus is lighter but 
internal thoracoabdominal organs such as the liver, 
thymus, lungs, pancreas, adrenal glands, kidneys 
and heart are all disproportionally reduced in 
weight in relation to the body. 
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6.4.4 Brain:Liver weight ratio 
 
Figure 68 Proportion of cases with specific Brain:Liver weight ratios (males and females) in cases of 
SGA; non SGA; macerated and non-macerated; SGA cases with a placental cause of death and SGA 
without a placental cause of death. (Excludes 27 cases with a brain:liver weight ratio > 10). 
There were significant associations between Brain:Liver weight ratio (for males and 
females) and  fetal maceration and specific causes of death specifically: 
1. Brain:Liver weight ratio distribution is significantly greater in macerated 
fetuses compared to non-macerated fetuses (p<0.0001 in both sexes). Median 
3.94 (range 0.09-9.97) versus median 2.78 (range 1.17-9.95), median 
difference 1.08 (95% CI 0.90 to 1.27).  
c. Finding: Macerated fetuses have disproportionally lighter livers in 
relation to their brains than non-macerated fetuses  
d. Implication: The liver preferentially loses weight more than the brain 
in cases of maceration and the Brain:Liver weight ratio is therefore 
artefactually increased due to the secondary effects of maceration 
rather than IUGR. 
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Brain:Liver weight ratio remains significantly greater for macerated unexplained 
deaths compared to non-macerated unexplained deaths (p<0.0001). Median 3.84 
(range 0.09-9.88) versus median 3.05 (range 1.47-9.95), median difference 0.77 
(95% CI 0.52 – 1.04). In macerated stillbirths the Brain:Liver weight ratio should 
therefore be adjusted by 0.8 to take into account the effects of maceration.  
2. Brain:Liver weight ratio is significantly greater in non-macerated 
unexplained  deaths  compared to non-macerated ascending infection deaths 
(p= 0.003). Median 3.05 (range 1.47-9.95) versus median 2.65 (range 1.32 -
4.38), median difference 0.40 (95% CI 0.19 -0.62). 
a. Finding: Unexplained deaths have lighter livers than cases of 
ascending infection. 
b. Implication: Unexplained deaths probably contain a proportion of 
unidentified IUGR cases with smaller livers than cases of ascending 
infection or ascending infection is associated with brain swelling. (NB: 
Delta Brain weight and delta liver weight are both significantly lighter in 
unexplained deaths compared to cases of ascending infection suggesting both 
factors contribute to the ratio difference) 
 
3. Brain:Liver weight ratio is significantly greater in SGA fetuses compared to 
non SGA fetuses (p<0.0001 in both sexes). Median 4.84 (range 0.51-9.88) 
versus median 3.42 (range 1.32- 8.92), median difference 1.38 (95% CI 1.03-
1.72). 
a. Finding: SGA fetuses have a disproportionally lighter liver in 
relation to their brain weight.  
Autopsy Investigation in Stillbirth 
 
197 
 
b. Implication: The liver preferentially gains weight less than the brain 
in cases of SGA 
 
4. If cases of SGA are divided into “true” IUGR i.e. those with a placental cause 
of death such as abruption, known IUGR, Placental pathology, Pre-eclampsia 
and those without a placental cause of death (i.e. all other causes such as 
ascending infection, feto-maternal haemorrhage, congenital abnormalities, 
infection and unexplained deaths) there is a significant difference in the 
brain: liver weight ratio between groups (p<0.0001). Median 6.03 (range 
0.51-10.00) versus median 4.27 (range 1.17- 9.88), median difference 1.55 
(95% CI 0.86-2.21). 
a. Finding: SGA with placental causes of death have disproportionally 
lighter livers in relation to brain weight than those with birthweight 
<10
th
 centile but no features of IUGR. 
b. Implication: Brain:Liver weight ratio is significantly more affected in 
cases of SGA with placental abnormalities, likely representing true 
IUGR compared to any other SGA case, which may be 
“physiological”. 
A Brain:Liver weight ratio of 6 differentiates  “true” placental IUGR SGA cases 
from SGA cases without  significant placental pathology with 53% sensitivity and 
80% specificity (Figure 69).  
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Figure 69 ROC curve of Brain:Liver weight ratio for cases or “true” IUGR against all other SGA 
cases based on a brain:liver weight ratio of 6. 
Furthermore there are significant differences in the Brain:Liver weight ratios 
between cases of non-SGA with an unexplained cause of death, SGA with a 
placental causes of death (true IUGR) and SGA cases with a non-placental cause of 
death (p<0.0001 for all (Figure 70). 
Figure 70 Brain:Liver weight ratio in Non SGA cases with an unexplained cause of death, SGA cases 
with placental causes of death (true IUGR) and SGA cases with a non-placental cause of death. Each 
group have significantly different brain:liver weight ratios in comparison to the other (p<0.0001 for 
all).  
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5. Brain:Liver weight ratio is significantly greater in cases of SGA with a 
placental cause of death compared to any other cause of death regardless of 
bodyweight centile (SGA and non SGA fetuses) (p<0.0001). Median 6.10 
(range 0.51-10.00) versus median 3.59 (range 1.17- 9.88), median difference 
2.38 (95% CI 1.83 – 2.94). 
a. Finding: SGA cases with a placental cause of death have 
disproportionally lighter livers to brains than cases with any other 
cause of death  
b. Implication: A greater Brain:Liver weight ratio is likely a marker of 
true pathological IUGR with placental abnormalities. 
A Brain:Liver weight ratio of 5 would identify  IUGR ( “true” placental IUGR in 
comparison to all other causes of death) with a sensitivity of 73% and a specificity of 
85%. Using a ratio of 6 would provide a specificity of 92% but would reduce the 
sensitivity to 55% (Figure 71). Note there is no Brain:Liver weight ratio that 
absolutely distinguishes the pathology groups; some placental IUGR cases have 
Brain:Liver ratio of 2 and some cases with no evidence of placental disease or other 
pathology have Brain:Liver ratio of 9. However, cases with birthweight> 10
th
 centile 
with unexplained cause of death and no placental pathological lesions only very 
rarely have a Brain:Liver ratio above six.  
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Cutoff 
Sensitivity 
% 95% CI 
Specificity 
% 95% CI 
Likelihood 
ratio 
> 3 91.84 
80.40% to 
97.73% 32.39 
27.76% to 
37.29% 1 
> 4 83.67 
70.34% to 
92.68% 60.93 
55.88% to 
65.80% 2 
> 5 73.47 
58.92% to 
85.05% 84.83 
80.88% to 
88.25% 5 
> 6 55.1 
40.23% to 
69.33% 91.77 
88.59% to 
94.31% 7 
> 7 30.61 
18.25% to 
45.42% 95.89 
93.41% to 
97.63% 7 
> 8 24.49 
13.34% to 
38.87% 97.17 
95.00% to 
98.58% 9 
> 9 6.122 
1.281% to 
16.87% 98.97 
97.39% to 
99.72% 6 
Table 93 Sensitivity and specificity used to define True IUGR cases (<10
th
 centile with evidence of 
placental disease) in comparison to other causes of death for Brain:Liver ratio cut offs 3-9. 
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Figure 71 ROC curve of Brain:Liver weight ratio for cases or “true” IUGR against other causes of 
death (SGA and non SGA) based on a Brain:Liver weight ratio of 6. 
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6.4.5 Body:Thymus weight ratio 
Figure 72 Proportion of cases with specific Body:Thymus weight ratios (males and females) in cases 
of SGA; non SGA; macerated and non-macerated; SGA cases with a placental cause of death and 
SGA without a placental cause of death.  
Using Brain:Liver weight ratio to establish if a fetus is growth restricted  requires an 
invasive autopsy. If Body:Thymus weight ratio could be used instead, a more limited 
autopsy is all that would be required. 
There are significant associations between Body:Thymus weight ratio (for males and 
females) and  fetal maceration, specific causes of death and SGA specifically: 
1. Body:Thymus weight ratio is significantly greater in macerated fetuses 
compared to non-macerated fetuses (p<0.0001). Median 532.69 (range 0.005-
14890) versus median 405.75 (range 4.39-13250), median difference 95.06 
(95% CI 140.25 to 52.08).  
a. Finding: Macerated fetuses have disproportionally lighter thymus’ in 
proportion to their body weight than non-macerated fetuses  
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b. Implication: The thymus disproportionately loses more weight than 
the body in cases of maceration. 
2. Body:Thymus weight ratio is significantly greater in SGA fetuses compared 
to non SGA fetuses (p<0.0001). Median 638.89 (range 5.82-14890) versus 
median 355.14 (range 29.39 - 2618), median difference 242.88 (95% CI 
184.82 to 313.85). 
a. Finding: SGA fetuses have a disproportionally lighter thymus’ in 
relation to their body weight.  
b. Implication: The thymus disproportionately loses more weight than 
the body in cases of SGA 
 
3. If cases of SGA are divided into “true” IUGR - those with a placental cause 
of death  (i.e. abruption, known IUGR, Placenta, Pre-eclampsia) and those 
without a placental cause of death (i.e. ascending infection, feto-maternal 
haemorrhage, congenital abnormalities, infection and  unexplained deaths) 
there is a significant difference in the body:thymus weight ratio between 
groups (p=0.0054). Median 830.56 (range 154.38- 6016.67) versus median 
551.43 (range 5.82- 14890), median difference 208.66 (95% CI 70.10 to 
386.95). 
a. Finding: SGA with placental causes of death have disproportionally 
lighter thymus’ in relation to body weight. 
b. Implication: Body:Thymus weight ratio is significantly more 
affected in cases of SGA with placental abnormalities than in any 
other SGA case, which may be “physiological”. 
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A Body:Thymus weight ratio of 855.5 would identify  “true” IUGR from other SGA 
cases without  significant placental pathology with 50% sensitivity and 75% 
specificity (Figure 73).  
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Figure 73 ROC curve of Body:Thymus weight ratio for cases or “true” IUGR against all other SGA 
cases based on a Body:Thymus weight ratio of 855.5. 
 
4. Body:Thymus weight ratio is significantly greater in cases of SGA with a 
placental cause of death compared to any other causes of death regardless of 
bodyweight centile (SGA and non SGA fetuses) (p<0.0001). Median 830.56 
(range 154.38- 6016.67) versus median 394.71 (range 5.82 - 14890), median 
difference 369.47 (95% CI 247.48 to 530.81). 
c. Finding: SGA cases with a placental cause of death have 
disproportionally lighter thymus’ to body weight than cases with any 
other cause of death  
d. Implication: Body:Thymus weight ratio is related to true SGA with 
placental abnormalities. 
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A Body:Thymus weight ratio of 671.7 would identify “true” IUGR compared to all 
other causes of death with a sensitivity of 61% and a specificity of 79%. Using a 
ratio of 863.9 would provide an even higher specificity of 88% but would reduce the 
sensitivity to 50% (Figure 74). 
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Figure 74 ROC curve of Body:Thymus weight ratio for cases or “true” IUGR against all other 
causes of death (SGA and non SGA) for a Body:Thymus weight ratio of 863.9. 
Whilst abnormal, the Body:Thymus weight ratio does not identify pathological 
IUGR as well as the Brain:Liver weight ratio. 
6.5 Discussion 
The findings of this chapter have demonstrated that organ weights are significantly 
affected by maternal factors as well as the process of fetal maceration, the cause of 
death and the underlying mechanism for demise. 
Firstly, diabetic mothers delivered fetuses with heavier adrenal glands than non-
diabetic mothers. One other study was found reviewing autopsy data between 
mothers with and without Diabetes Mellitus and reported no significant difference in 
fetal adrenal gland weight between diabetic and non-diabetic mothers, however, the 
study population was much smaller than the present study(only 55 cases) (210).  
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The brain, liver, heart, thymus, lungs, kidneys and thyroid are all significantly lighter 
in SGA fetuses compared to non SGA and when taking into account body weight, 
the liver, spleen and thymus are significantly disproportionately lighter in cases of 
SGA. 
The brain, liver, thymus, heart, lungs, adrenals, and thyroid are also lighter in 
macerated fetuses compared to non-macerated and this persists when taking into 
account fetal body weight, indicating preferential visceral organ weight loss with 
maceration.  
Only the liver and thymus are significantly lighter in cases with demonstrated 
placental causes of death compared to other deaths and these relationships persist 
when taking into account fetal body weight.   
As highlighted above, the overall birth weights (delta values) for fetuses with 
maceration were lower with a disproportionate loss of weight from almost all 
visceral organs. Furthermore, the liver lost more weight than the brain in macerated 
cases indicating that the Brain:Liver weight ratio is erroneously increased simply due 
to the effects of maceration rather than underlying pathology such as IUGR, and this 
should be accounted for when interpreting Brain:Liver weight ratios in clinical 
practice; on average the Brain;Liver weight ratio should be reduced by 1 unit to 
account for the artefactual effects of maceration. A previous, study reported similar 
results in which weights of the liver, thymus and spleen were markedly lighter with 
increasing maceration; the lungs, kidneys and adrenals moderately lighter and the 
heart and brain weights only slightly lighter as maceration status increased (168).  
Brain:Liver weight ratio has long been used as an autopsy method of assessing fetal 
undernutrition and growth. However this is based on remarkably limited data. In 
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1972 a study of 95 stillbirths and neonatal deaths examined the association of brain 
to liver weight ratio, fetal gestation and fetal birthweight (169).  The average 
Brain:Liver weight ratio in those with a mean birthweight or one standard deviation 
above the mean was 3 in gestations greater than 27 weeks. In those with a 
birthweight below the 10
th
 centile the Brain:Liver weight ratio varied at different 
gestations: at 25-30 weeks the ratio fell in the range of 1.7-4.1 but at 31-42 weeks 11 
of 15 cases had a ratio of 4.5 or greater (169). In all of these cases the placenta was 
reported to show chronic insufficiency and in seven cases there was a history of pre-
eclampsia, hypertension, twin birth or low urinary oestriol excretion (169).  
In 2001, Brain:Liver weight ratio was analysed in 182 stillbirths with the aim of 
exploring the relationships between low fetal body weight and maternal history 
(170). Cases were split into three groups; those symmetrically small; those with 
asymmetrical growth restriction and those with no evidence of growth restriction 
(170). Growth restriction was actually SGA based on bodyweight below the 10
th
 
centile. A Brain:Liver weight ratio greater than 3 was classed as abnormal and it was 
reported that the asymmetrically growth restricted fetuses had significantly higher 
Brain to Liver weight ratios (p<0.0001) (170). A cut off point for the Brain:Liver 
weight ratio of 3 had sensitivity of 55% and specificity of 63% for detecting SGA;  a 
cut off of 6 had sensitivity of 11% but a specificity of 97% (170). If only cases 
greater than 20 weeks gestation were used and SGA was described as being below 
the 5
th
 centile rather than the 10
th
, the sensitivity of a Brain:Liver weight ratio of 3 
was 83% and the specificity 66% in detecting SGA fetuses (170).  
The present results provide definitive data regarding use of Brain:Liver weight ratio 
in the perinatal autopsy setting. First the study is far larger than all previous studies 
combined, secondly, the findings are presented in relation to pathological findings in 
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addition to simple birthweight centiles, and finally, data is presented on the impact of 
changes such as maceration, which were not evaluated in any previous study. The 
present study data confirms that the Brain:Liver weight ratio is significantly greater 
in cases of SGA with a placental cause of death compared to cases with birthweight 
< 10
th
 centile but with no pathological placental findings or with another cause of 
death. A Brain:Liver weight ratio of 5 can identify “pathological” placental IUGR 
compared to other causes of death with a sensitivity of 73% and a specificity of 85%. 
A ratio of 6 improves specificity to 92% but reduces sensitivity to 55%. 
Furthermore, it is possible to differentiate “pathological” IUGR (i.e. cases of SGA 
with concurrent placental abnormalities and a placental cause of death) from cases 
that have biometry below the 10
th
 centile but with no placental abnormalities using a 
Brain:Liver weight ratio of 6 for a sensitivity of 53% and a specificity of 80%. In 
addition, since for all causes of death cases with maceration have artefactually 
relatively lighter livers secondary to the process occurring after death, on average, it 
is necessary to adjust Brain:Liver weight ratio by around 1 unit in macerated fetuses 
to avoid erroneously assigning IUGR where non exists.  
Only one study to date has evaluated the accuracy of postmortem magnetic 
resonance imaging (MRI) in the measurement of fetal organ volumes compared to 
the standard autopsy measurements of organ weights (213). This MRI study was 
small; 25 perinatal deaths from 16-40 weeks gestation were examined (213). MRI 
was performed prior to autopsy and it was found that there was a linear relationship 
between MRI organ volume estimates and the autopsy organ weights recorded (214). 
ROC curve statistical analysis demonstrated an area of 0.61 for postmortem MRI 
detection of a Brain:Liver weight ratio greater than or equal to 4 (214). This suggests 
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that postmortem MRI may have the potential to replace invasive autopsy 
measurements of Brain:Liver weight ratio but further larger studies are needed. 
The present study also evaluated whether a more limited autopsy approach that does 
not involve removal of the brain, could provide accurate assessment of fetal growth 
restriction by examining the relationship between the Body:Thymus weight ratio and 
fetal maceration, fetal SGA and cause of death. Results showed significant 
differences between macerated and non-macerated groups; SGA and non SGA 
groups; and SGA cases with and without placental causes of death. However, 
although useful, the sensitivity and specificity of Body:Thymus weight ratios are not 
as effective as brain to liver weight ratio for detecting “true” IUGR. 
This study is the first large scale, detailed evaluation of fetal organ weights in 
stillbirths and has determined that fetal maceration and cause of death affect specific 
organ weights. More importantly the study has evaluated, in detail, the role of the 
Brain:Liver weight ratio in the pathological detection of IUGR/ SGA. In conclusion, 
the Brain:Liver weight ratio, when calculated in the correct context and taking into 
account fetal maceration, may  be used to help evaluate and separate cases of “true” 
fetal IUGR and SGA from more physiological cause of SGA in stillbirth autopsy.  
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7. The Placenta 
Autopsy Investigation in Stillbirth 
 
210 
 
7.0 Background 
The placenta and the umbilical cord are the life support system for a human fetus. 
Abnormalities and infections within the arteries, veins, villi or umbilical cord can 
fatally disrupt blood and nutrient flow to the developing fetus. (117) 
Abnormalities that can occur include: 
1. Ascending Genital Tract infections which can cause preterm delivery, 
hypoxia and death (142). 
2. Haematogenous Infections such as Toxoplasmosis and cytomegalovirus 
(144) 
3. Hypertension and Pre-eclampsia/Eclampsia of which the former affects 
around 5-8% of pregnancies (145). Pre-eclampsia can be defined as maternal 
endothelial dysfunction with clinical hypertension, oedema and proteinuria 
(117).  
4. Placental Abruption, defined as the complete or partial separation of a 
normally implanted placenta before delivery (148). Complications may 
include fetal death, severe haemorrhage, need for blood transfusions, 
emergency hysterectomy, disseminated intravascular coagulopathy and renal 
failure (148).  
5. Specific pathologies only diagnosable on histological examination associated 
with growth restriction and fetal death such as massive perivillous fibrin 
deposition (149) 
6. The spectrum of changes associated with maternal vascular malperfusion 
including those previously known as uteroplacental vascular disease (150). 
Placental abnormalities are a common cause of death in stillbirth, ranking second 
only to unexplained deaths (151).  A review of over 40 papers of placental pathology 
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in association with stillbirth reported that the placenta was the likely cause of 
stillbirth in 11 - 65% of cases, with placental abruption the most frequent specific 
cause (152). However, at present there are no clinically useful first or second-
trimester tests of placental function to predict stillbirth, although uterine artery 
Doppler indices and maternal serum PAPP-A levels appear to be promising 
candidates for early detection of placental dysfunction (153). 
The aim of this chapter is to analyse all placentas submitted for examination in 
stillbirth and miscarriage autopsies in relation to:  
1. Placental cord insertion 
2. Placental histological findings and their relationship to cause of death  
3. Detailed analysis of placentas with ascending infection or maternal vascular 
malperfusion with regard to gestational age, type of death, maceration and 
maternal demographic factors. 
4. Detailed review of cases with other specific significant placental pathologies. 
5. Review of cases with unexplained cause of death and placental lesions of 
uncertain significance.  
 
7.1 Methods 
The Microsoft Access Autopsy Database was used to collate postmortem and 
antenatal details available for all stillbirths, early and late miscarriage from 2005 – 
2013 from Great Ormond Street Hospital and St George’s Hospital, London.  Data 
was analysed through queries and statistical tests run using Microsoft Access, Excel, 
Graph Pad Prism and Stats Direct. Statistical tests can be viewed in detail in 
Appendix 3.   
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7.2 Results 
946 of 1,064 (89%) total cases had placentas submitted for examination as part of the 
autopsy (Table  94) 
 Early 
miscarriage 
Late 
miscarriage 
Stillbirth Total 
Number of 
cases with a 
placenta 
submitted 
 
203 (83%) 
 
168 (94%) 
 
575 (90%) 
 
946 (89%) 
Number of 
cases with no 
placenta 
submitted  
 
43 (17%) 
 
11 (6%) 
 
64 (10%) 
 
118 (11%) 
 
Total: 
 
246 
 
179 
 
639 
 
1064 
Table 94 Placenta submitted for examination within each death category  
7.2.1 Maternal Ethnicity and the Placenta 
 
Figure 75 Placental disc weight and maternal ethnicity 
There was a recorded maternal ethnicity in 403 of the 946 placentas submitted for 
examination including: 
 337 white mothers 
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 107 black mothers 
 44 Asian mothers 
 12 mixed or oriental mothers 
There was a significant difference in the placental weight between black and white 
mothers: white mothers had significantly heavier placentas than black mothers (p= 
0.014). However the placental weight was not adjusted for gestational age and it is 
known that black mothers had more frequent miscarriages than white mothers 
(Chapter 3) and this is therefore the likely cause for this difference.  
 
7.2.2  Cord Insertion 
Overall, the cord was most frequently eccentrically inserted into the placenta and 
there were no significant differences in cord insertion site between categories 
(insertion site based on description of reporting pathologist at the time of autopsy).   
Cord insertion 
Early 
miscarriage 
Late 
miscarriage Stillbirth 
Total 
Not given 119 (48%) 54 (30%) 141 (22%) 
 
314 (29%) 
Central 46 (19%) 32 (18%) 174 (27%) 
 
252 (24%) 
Eccentric 69 (28%) 74 (41%) 255 (40%) 
 
398 (37%) 
Marginal 8 (3%) 13 (7%) 42 (7%) 
 
63 (6%) 
Vellamentous 4 (2%) 5 (3%) 24 (4%) 
 
33(3%) 
Furcate 0 (0%) 0 (0%) 2 (<1%) 
 
2 (<1%) 
Other 0 (0%) 1 (1%) 1 (<1%) 
 
2 (<1%) 
Total: 246 179 639 
 
1064 
Table 95 Cord insertions in each death category 
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Figure 76 Cord insertions for each death category (excluding not givens) 
 
A large UK study recorded the cord insertion in 861 singleton pregnancies live born 
at 37-42 weeks gestation. The study reported a cord centrality index (CI) – a 
measurement used to assess the point of umbilical cord insertion from the centre of 
the placenta. The CI ranged from 0.02 – 1.0 with a mean of 0.36 and was not 
significantly different between affected (i.e. cases with pre-eclampsia, pregnancy 
induced hypertension, Diabetes or SGA) and non-affected cases. When comparing 
results to the present study, it was found that the stillbirth population in the present 
study had significantly more central and vellementous cord insertions and live born 
fetuses had significantly more eccentric cord insertions (p= 0.0116, p<0.0001 and 
p<0.0001 respectively) (Table 96) but these are very subjective categories. 
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Cord insertion Study Population 
Reference Live born 
population 
Central 252 (34%) 239 (28%) 
Eccentric 398 (53%) 551 (64%) 
Furcate 2 (<1%) 0 (0%) 
Marginal 63 (8%) 69 (8%) 
Vellementous 34 (5%) 2 (<1%) 
Other 2 (<1%) 0 (0%) 
Total: 751 861 
Table 96 Cord insertions in present study and reference study population. The stillbirth population in 
the present study had significantly more central and vellementous cord insertions and live born 
fetuses had significantly more eccentric cord insertions (p= 0.0116, p<0.0001 and p<0.0001 
respectively) 
 
 
Figure 77 Cord insertions in present study and reference study population. The stillbirth population 
in the present study had significantly more central and vellementous cord insertions and live born 
fetuses had significantly more eccentric cord insertions (p= 0.0116, p<0.0001 and p<0.0001 
respectively) 
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7.2.3 Histology of the cord, membranes and placenta and cause of death 
Histology Early Miscarriage Late miscarriage Stillbirth 
 
Total 
Cord, membranes 
and placenta normal 94 (38%) 70 (39%) 172 (27%) 
 
336 
(32%) 
Cord and placenta 
normal, membranes 
abnormal 9 (4%) 9 (5%) 28 (4%) 
 
46 
(4%) 
Cord normal, 
membranes and 
placental abnormal 32 (13%) 17 (9%) 68 (11%) 
 
117 
(11%) 
Cord and membranes 
normal, placenta 
abnormal 38 (15%) 31 (17%) 196 (31%) 
 
265 
(25%) 
Cord abnormal, 
membranes and 
placental normal 1 (1%) 2 (1%) 17 (3%) 
 
20 
(2%) 
Cord  and 
membranes 
abnormal, placental 
normal   1 (1%) 10 (6%) 5 (1%) 
 
16 
(2%) 
Cord, membranes 
and placenta 
abnormal 19 (8%) 22 (12%) 49 (8%) 
 
90 
(8%) 
Cord and placenta 
abnormal, 
membranes normal  4 (2%) 4 (2%) 33 (5%) 
 
41 
(4%) 
Not information 
given 38 (15%) 13 (7%) 57 (9%) 
 
108 
(10%) 
Too Autolysed 1 (<1%) 0 (0%) 0 (0%) 
 
1 
(<1%) 
Cord Normal, no 
other histology 4 (2%) 0 (0%) 10 (2%) 
 
14 
(1%) 
Cord Abnormal, no 
other histology 2 (1%) 0 (0%) 2 (<1%) 
 
4 
(<1%) 
No cord, placenta 
normal 0 (0%) 1(1%) 1 (<1%) 
 
31 
(3%) 
No cord, membranes 
and placenta 
abnormal 3 (1%) 0 (0%) 1 (<1%) 
 
4 
(<1%) 
Total: 246 179 639 
 
1064 
Table 97 Histological findings of the cord, membranes and placenta in each death category. 
One third of all deaths had completely normal histology of the cord, membranes and 
placenta. However, nearly one third of all stillbirths had at least some abnormality 
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identified on histological examination of the placenta (with normal membranes and 
cord); a significantly greater proportion than in cases of miscarriage (z=5.689, 
p<0.0001).  347 stillbirths had at least some degree of abnormal placental histology 
(not including any abnormalities of the cord or membranes) of which 208 had 
significant abnormalities that either were a direct cause of death (labelled as placenta 
or abruption- as per definitions in Chapter 4) or may have been indirectly linked to 
the cause of death (for example ascending infection,  twin complications or maternal 
infection) (Table 98). 
Specific cause of death  
Number of cases with a 
placental abnormality linked to 
cause of death 
Abruption 26 (13%) 
Ascending Infection 49 (24%) 
Placenta 48 (23%) 
Unexplained placenta 50 (24%) 
Pre-eclampsia 14 (7%) 
Twin complications 8 (4%) 
Known IUGR 4 (2%) 
Fetomaternal haemorrhage 5 (2%) 
Maternal infection 4 (2%) 
Total:  208 
Table 98 Specific causes of death diagnosed by abnormalities in the histological examination of the 
placenta (definitions for causes can be found in Chapter 4) 
 
Overall (including stillbirths and miscarriages), there were 304 cases in which 
abnormalities of the placenta (found histologically or through a good clinical history) 
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provided a specific cause of death; 58% were cases of ascending infection, mainly 
associated with miscarriage (66%) (Table 99, Figure 78). 
Causes of death provided by 
histological abnormalities of the 
placenta  
Miscarriages Stillbirths Total 
Abruption 8 (21%) 30 (79%) 38 (13%) 
Ascending Infection 117 (66%) 59 (34%) 176 (58%) 
Known IUGR 9 (50%) 9 (50%) 18 (6%) 
Placenta *  5 (9%) 
 
51 (91%) 
 
56 (18%) 
Pre-eclampsia 0 (0%) 16 (100%) 16 (5%) 
Total 139 (46%) 165 (54%) 304 
Table 99 Specific causes of death provided by histological abnormalities of the placenta  
 
Figure 78 Specific causes of death provided by histological abnormalities of the placenta  
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18% of all causes of death* (Table 99) were from specific placental abnormalities 
labelled “placenta” (Table 100) 
*Placental Pathology in 
“Placenta” cause of death:  
Miscarriages Stillbirths Total: 
Fetal Vascular Occlusion 0 (0%) 5 (100%) 5 (9%) 
Chronic Histiocytic intervillositis 1 (33%) 2 (67%) 3 (5%) 
Massive perivillous fibrin 
deposition 
1 (17%) 5 (83%) 6 (11%) 
Maternal vascular malperfusion 3 (7%) 39 (93%) 42 (75%) 
Total:  5 (9%) 51 (91%) 56 
 Table 100 Significant placental pathology in cases with “placenta” as their cause of death 
The majority of cases (91%) with specific placental abnormalities were in stillbirths 
and overall the most common pathological abnormality was maternal vascular 
malperfusion, accounting for 75% of cases. 
 
Figure 79 Significant placental pathology in cases with “placenta” as their cause of death 
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7.2.4 Ascending infection   
176 autopsies were given the diagnosis of ascending infection as a cause of death 
with histological evidence of chorioamnionitis within the placenta, membranes or 
cord and/ or fetal pneumonia. 165 of these cases had placentas submitted for 
histological examination. Cases of ascending infection peaked in fetuses miscarried / 
stillborn at 22 weeks gestation (Figure 80). There was a further peak at term/post-
term. In such cases determining whether the ascending infection was a cause or 
contributor to death with certainty is impossible.  
Gestation (weeks) Number of cases 
13 1 (1%) 
14 1 (1%) 
15 2 (1%) 
16 2 (1%) 
17 14 (8%) 
18 17 (10%) 
19 13 (8%) 
20 12 (7%) 
21 12 (7%) 
22 24 (14%) 
23 18 (11%) 
24 8 (5%) 
25 9 (5%) 
26 0 (0%) 
27 2 (1%) 
28 3 (2%) 
29 1 (1%) 
30 1 (1%) 
31 0 (0%) 
32 3 (2%) 
33 3 (2%) 
34 0 (0%) 
35 1 (1%) 
36 4 (2%) 
37 0 (0%) 
38 0 (0%) 
39 1 (1%) 
40 4 (2%) 
>40 12 (7%) 
Total: 169 
Table 101 Number and percentage of ascending infection cases with different fetal gestations 
(excludes 7 cases with unknown gestation) 
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Figure 80 Fetal gestation in cases of ascending infection (excludes 4 cases with no gestation)  
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Type of death 
Type of death Number of cases 
Intrauterine death < 24 hours retention 31 (18%) 
Intrauterine death > 24 hours retention 27 (15%) 
Intrapartum death - known 9 (5%) 
Intrapartum death - fresh 109 (62%) 
Total: 176 
Table 102 Number and percentage of cases of each death type in those foetuses with ascending 
infection as their cause of death  
 
Figure 81 Percentage of cases with ascending infection in each death type 
The majority of fetuses with ascending infection (62%) were fresh intrapartum 
deaths, followed by intrauterine death with an intrauterine retention time of less than 
24hours (18%).  
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Of those cases with ascending infection and intrauterine retention of more than 24 
hours (27 cases), the majority (46%) were delivered within 2 days of intrauterine 
death (Table 103) and five cases had a record of premature rupture of membranes in 
the antenatal history provided. The cases with longer intrauterine intervals are likely 
to represent secondary ascending infection rather than infection as the underlying 
cause of death. 
Intrauterine Interval (days) Number of cases 
2 6 (46%) 
3 2 (15%) 
4 0 (0%) 
5 2 (15%) 
6 0 (0%) 
7 1 (7%) 
>10 1 (7%) 
>20 1 (7%) 
Total: 13 
Table 103 Intrauterine interval in those cases with intrauterine retention>24 hours (14 cases had no 
recordable intrauterine interval) 
Fetal Maceration 
Fetal Maceration Number of cases 
None 125 (72%) 
Mild 22 (13%) 
Moderate 5 (3%) 
Severe 16 (9%) 
Other 6 (3%) 
Total 174 
Table 104 Degree of maceration in cases of ascending infection (2 cases excluded as no details of 
maceration given)  
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Figure 82 Degree of maceration in cases of ascending infection 
The majority of cases had no or mild fetal maceration in keeping with the fact most 
cases were fresh intrapartum deaths as a consequence of the ascending infection.  Of 
those with moderate maceration; 
 Four cases were intrauterine deaths of >24 hours 
 One case was an intrauterine death of < 24 hours.  
In the 16 cases with severe maceration, the majority (14 cases) were retained in utero 
for > 24 hours. 
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Maternal ethnicity 
Maternal ethnicity 
Number of 
cases with 
Ascending 
Infection 
Number of 
cases with 
different 
cause of 
death  
Total 
White 48 (36%) 
 
421 (68%)  
 
469 
Mixed or Chinese 3 (2%) 
 
15 (2%) 
 
18 
Asian 12 (9%) 
 
46 (7%) 
 
58 
Black 69 (52%) 
 
137 (22%) 
 
206 
Total 132 
 
 
619 
 
 
751 
Table 105 Cases of ascending infection by maternal ethnicity 
 
Black mothers delivered a significantly greater proportion of fetuses with ascending 
infection than any other ethnicity (z=7.046, p =<0.0001) and were 4.3 times more 
likely to have a case of ascending infection than white mothers (p<0.0001) 
 
Figure 83 Maternal ethnicity in cases of ascending infection and all other causes of death 
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Maternal Age 
Maternal Age (years) 
Number of cases with 
ascending Infection 
Number of 
cases with 
different cause 
of death 
Total 
Less than or equal to 35 130 (75%) 
 
40 (61%) 
 
170 
36-40 36 (21%) 
 
24 (36%) 
 
60 
>40 8 (5%) 
 
2 (3%) 
 
10 
Total:  174 
 
66 
 
240 
Table 106 Maternal age in cases with and without ascending infection 
 
 
Figure 84 Cases with ascending infection by maternal age groups 
The majority of mothers had an age of equal to or less than 35 years. There was no 
significant difference in the maternal age distribution between cases of ascending 
infection and all other deaths in the study population.  
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Maternal BMI 
Maternal BMI 
Number of cases 
with ascending 
infection 
Number of cases 
with a different 
cause of death 
Total 
<18 0 (0%) 
 
         16 (4%) 
 
 
16 (3%) 
20-24 30 (35%) 
 
112 (29%) 
 
142 (30%) 
25-30 30 (35%) 
 
132 (35%) 
 
162 (35%) 
30+ 25 (29%) 
 
121 (32%) 
 
146 (31%) 
Total:  85 
 
381 
 
466 
Table 107 Maternal BMI distribution for cases of ascending infection (91 cases excluded as no BMI 
given) 
In cases of ascending infection, there was an equal proportion of mothers with a 
normal and an overweight BMI and there was no significant difference in the BMIs 
of mothers who delivered fetuses with ascending infection compared to all other 
causes of death at autopsy.  
 
Figure 85 Maternal BMI in cases with and without ascending infection  
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Summary 
In cases of ascending infection: 
 The majority of cases were fresh intrapartum deaths and as such had no 
maceration, the death as a consequence of the ascending infection and severe 
preterm labour.  
 There were two gestational age peaks; one large at 22 weeks and another 
smaller at 40+ weeks. 
 Black mothers were significantly more likely to have deaths associated with 
ascending infection with an odds ratio of 4.3 compared to white mothers.   
 There was no association between maternal age or BMI and rates of 
ascending infection compared to other causes of death 
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7.2.5 Maternal vascular malperfusion 
Fetal Gestation 
Gestation (weeks) Number/Percentage of cases 
23 1 (2%) 
24 7 (17%) 
25 1 (2%) 
26 2 (5%) 
27 2 (5%) 
28 5 (12%) 
29 5 (12%) 
30 2 (5%) 
31 2 (5%) 
32 2 (5%) 
33 1 (2%) 
34 2 (5%) 
37 2 (5%) 
38 3 (7%) 
39 2 (5%) 
40 2 (5%) 
42 1 (2%) 
Total:  42 
    
Table 108 Fetal gestations in cases of maternal vascular malperfusion 
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Figure 86 Fetal gestation in cases of maternal vascular malperfusion   
There were two peaks of cases with histological evidence of maternal vascular 
malperfusion at 24 weeks gestation and a smaller peak at 28-29 weeks gestation. The 
frequency of typical maternal vascular malperfusion in term stillbirths (37+ weeks) 
was only 24%.  
Type of Death  
90% of maternal vascular malperfusion cases were intrauterine deaths with an 
intrauterine retention time of at least 24 hours (Table 109) 
Type of death Number/ percentage of cases 
Intrauterine death < 24 hours retension 4 (10%) 
Intrauterine death > 24 hours retention 38 (90%) 
Intrapartum death – known 0 (0%) 
Intrapartum death – fresh 0 (0%) 
Total: 42 
Table 109 Type of death in cases of maternal vascular malperfusion 
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Figure 87 Type of death in cases of maternal vascular malperfusion 
 
Fetal Maceration 
Fetal Maceration: Number of cases 
None 1(2%) 
Mild  4 (10%) 
Moderate 6 (15%) 
Severe  26 (63%) 
Other description 4 (10%) 
Total: (excluding not givens) 41 
Not given 1 
Table 110 Degree of fetal maceration in cases of maternal vascular malperfusion 
 
0 20 40 60 80 100
Intrauterine death < 24 hours
retension
Intrauterine death > 24 hours
retention
Intrapartum death - known
Intrapartum death - fresh
P
er
ce
n
ta
g
e 
o
f 
ca
se
s 
T
y
p
e 
o
f 
d
ea
th
 
% Of cases
Autopsy Investigation in Stillbirth 
 
232 
 
 
Figure 88 Degree of fetal maceration in cases of maternal vascular malperfusion 
 
98% of fetuses with maternal vascular malperfusion had some degree of maceration, 
with the majority being severely macerated; a finding in keeping with the fact the 
most cases had a prolonged intrauterine interval, death occurring in the absence of 
labour or other maternal symptoms. 
Maternal Ethnicity 
Mums Ethnic Group 
Number of cases 
with maternal 
vascular 
malperfusion 
Number of 
cases with a 
different cause 
of death 
Total 
White 27 (82%) 
 
 
442 (63%) 
 
 
469 (64%) 
Asian/Asian British Indian 1 (3%) 
 
 
57 (8%) 
 
 
58 (8%) 
Black 5 (15%) 
 
201 (29%) 
 
206 (28%) 
Total:  33 
 
700 
 
733 
Table 111 Maternal ethnicity in cases of maternal vascular malperfusion (excluding 9 unknowns) and 
other causes of death 
Mild
Moderate
Severe
Other description
None
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There were significantly more white mothers with a diagnosis of maternal vascular 
malperfusion than any other ethnicity (z=2.377, p=0.0175).  
Figure 89 Maternal ethnicity in cases of maternal vascular malperfusion 
Maternal Age 
The majority of mothers were less than or equal to 35 years old in cases of maternal 
vascular malperfusion and all other causes of death. There was no significant 
difference in the maternal age distribution between the two groups. 
Maternal Age 
(years) 
Number of cases with 
maternal vascular 
malperfusion 
Number of cases 
with a different 
cause of death 
Total 
Less than or equal 
to 35 32 (78%) 
 
766 (77%) 
 
798 (77%) 
36-40 4 (10%) 
 
189 (19%) 
 
193 (19%) 
>40 5 (12%) 
 
43 (4%) 
 
48 (5%) 
Total:  41 
 
998 
 
1039 
Table 112 Maternal Age for cases of maternal vascular malperfusion (excludes 1 case with no 
maternal age) and cases of all other causes of death.  
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Figure 90 Maternal Age for cases of maternal vascular malperfusion and other causes of death 
Maternal BMI 
Only 16 cases with maternal vascular malperfusion had a recorded maternal BMI 
and of those, the majority had a normal BMI. There was no significant difference in 
the distribution of BMI between cases of maternal vascular malperfusion and all 
other causes of death.  
Maternal BMI 
Number of cases 
with maternal 
vascular 
malperfusion 
Number of cases 
with a different 
cause of death 
Total 
Underweight 0 (0%) 
 
 
16 (4%) 
 
 
16 (3%) 
Normal 7 (44%) 
 
 
135 (30%) 
 
 
142 (30%) 
Overweight 5 (31%) 
 
 
157 (35%) 
 
 
162 (35%) 
Obese 4 (25%) 
 
 
142 (32%) 
 
 
146 (31%) 
Total 16 
 
450 
 
466 
Table 113 Maternal BMI for cases of maternal vascular malperfusion 
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Figure 91 Maternal BMI for cases of maternal vascular malperfusion and all other causes of death 
Summary 
In cases of maternal vascular malperfusion: 
 There were two gestational peaks, one at 24 weeks and the other at 28-29 
weeks 
 The majority of deaths were intrauterine antepartum with >24 hours of 
intrauterine retention and 98% of all maternal vascular malperfusion cases 
had some degree of maceration. 
 There were significantly more cases of maternal vascular malperfusion in 
white mothers compared to other ethnicities. 
 The majority of mothers with maternal vascular malperfusion were less than 
or equal to 35 years of age and had normal BMIs 
 There was no significant difference in the distribution of maternal age or 
maternal BMI between cases of maternal vascular malperfusion and other 
causes of death.  
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7.2.6 Other specific significant placental pathologies 
Maternal vascular malperfusion represented by far the largest proportion of placental 
abnormalities within the “placenta” cause of death category. However, there were 14 
other cases with specific histological abnormalities of the placenta including cases 
of; 
1. Fetal Vascular Occlusion 
2. Chronic Histiocytic Intervillositis 
3. Massive perivillous fibrin deposition 
Table 114 represents the clinical findings in these cases. The majority of the deaths 
(79%) were intrauterine with a retention time of > 24 hours and fetal maceration 
varied from mild to severe. The average fetal gestation for these cases was 32 weeks.  
Two thirds of the mothers were white; mothers had an average age of 31 years and 
50% of mothers (3 out of 6) were overweight. 
Placental 
Pathology:  Type of death 
Degree of 
maceration 
Fetal 
gestation 
Maternal 
ethnicity 
Maternal 
BMI 
Maternal 
age 
Fetal 
Vascular 
Occlusion             
Case 1 
Intrauterine 
death > 24 hours Moderate 37 White 
Not 
given 18 
Case 2 
Intrauterine 
death > 24 hours Other 41 White 51.1 28 
Case 3  
Intrauterine 
death > 24 hours Mild 25 Black 
Not 
given 29 
Case 4 
Intrauterine 
death > 24 hours Severe 29 White 23.1 40 
Case 5 
Intrauterine 
death > 24 hours Severe 38 White 23.2 30 
Chronic 
Histiocytic 
intervillositis             
Case 1 
Intrauterine 
death > 24 hours Other 26 White 24.5 39 
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Case 2 
Intrapartum 
death None 24 
Not 
given 
Not 
given 27 
Case 3  
Intrauterine 
death > 24 hours Moderate 29 Asian 
Not 
given 41 
Massive 
perivillous 
fibrin 
deposition             
Case 1 
Intrauterine 
death > 24 hours Mild 35 
Not 
given 
Not 
given 
Not 
given 
Case 2 
Intrauterine 
death < 24 hours None 17 Black 26.2 30 
Case 3  
Intrauterine 
death > 24 hours Severe 39 Asian 28 30 
Case 4 
Intrauterine 
death > 24 hours Severe 35 White 
Not 
given 20 
Case 5 
Intrauterine 
death < 24 hours Mild 27 White 
Not 
given 35 
Case 6 
Intrauterine 
death >24 hours Mild 41 White 
Not 
given 40 
Table 114 Case findings in cases of significant other placental pathology  
Cases of Chronic Histiocytic Intervillositis all occurred in the late second/early third 
trimester, whereas cases of Massive perivillous fibrin deposition affected all 
gestational ages from second trimester to post-term.  
7.2.7 Unexplained placental lesions 
There were 78 cases (16 early miscarriages, 5 late miscarriages and 57 stillbirths) in 
which there were histological findings/abnormalities of the placenta that were either 
not severe enough to be to be the likely cause of death, or whose significance was 
uncertain but which could not be completely discounted as having contributed to or 
be associated with death. These cases were labelled “unexplained, lesion placenta” 
and included abnormalities such as: 
 Isolated subjective increased syncytial knots/ accelerated maturation 
 Villitis of unknown aetiology (any) 
 Scattered fibrin thrombi (Perivillous /subchorionic/ intravascular)  
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 Focal areas of sclerotic villi with no other features of fetal thrombotic 
vasculopathy 
 Plasma cell deciduitis 
 Calcified thrombi in chorionic plate vessels with no downstream effects 
 Small peripheral infarcts/ ischaemic changes 
The majority of these unexplained deaths with placental lesions (72%) were 
intrauterine with a retention time of > 24 hours and 66% were severely macerated, 
very similar to results for totally unexplained unexplained deaths. The gestational 
age of unexplained placental lesion cases peaked at 35-40+ weeks gestation 
suggesting such abnormalities are either incidental and are more frequent with 
increasing gestational age or are associated with late stillbirths. The mothers were 
mostly between the ages of 26-30 years, were overweight and of white ethnicity. 
There was no significant difference in either the gestational age for unexplained 
placental lesion deaths or in the maternal age when comparing to cases of specific 
placental abnormalities (p=0.64 and p= 0.7884 respectively). However, when 
comparing to totally unexplained death, unexplained placental lesion deaths were 
delivered at a significantly more advanced gestation (median 32 weeks versus 
median 26 weeks) but there was no significant difference in the maternal age 
distributions between groups (Table 115).  
Unexplained lesion Placenta:  
Unexplained lesion 
Placenta  Unexplained Unexplained 
Type of death 
  
 
Intrauterine death < 24 hours 8 (10%) 
36 (12%) 
Intrauterine death > 24 hours 56 (72%) 
196 (67%) 
Intrapartum death -Known 2 (3%) 
10 (3%) 
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Intrapartum death - Fresh 12 (15%) 
50 (17%) 
Degree of maceration 
  
 
None 12 (16%) 
62 (22%) 
Mild  7 (9%) 
33 (12%) 
Moderate 2 (3%) 
20 (7%) 
Severe 49 (66%) 
120 (42%) 
Other 7 (9%) 
50 (18%) 
Not given 1 
7 
Fetal gestation 
  
 
15-23 weeks 21 (27%) 
122 (42%) 
24-30 weeks  20 (26%) 
49 (17%) 
31-34 weeks 5 (6%) 
22 (8%) 
35- term weeks 32 (41%) 
99 (34%) 
Maternal ethnicity 
  
 
White 40 (69%) 
133 (68%) 
Black 12 (21%) 
45 (23%) 
Asian 6 (10%) 
11 (6%) 
Mixed 0 
5 (3%) 
Chinese 0 
1 (1%) 
Not given 20 
97 
Maternal age 
  
 
<20 years 4 (5%) 
21 (7%) 
21-25 years 10 (13%) 
35 (12%) 
26-30 years 26 (34%) 
67 (24%) 
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31-35 years 19 (25%) 
101 (35%) 
35-40 years 15 (20%) 
50 (18%) 
40+ years 2 (3%) 
10 (4%) 
Not given 2 
8 
Maternal BMI 
  
 
Underweight 0 (0%) 
2 (2%) 
Normal 8 (35%) 
45 (46%) 
Overweight 10 (43%) 
47 (48%) 
Obese  5 (22%) 
3 (3%) 
Not given 55 
195 
Table 115 Case findings in unexplained placental lesions and unexplained unexplained cases 
7.3 Discussion 
In 946 stillbirth and miscarriage autopsies (89%) the placenta was also submitted for 
examination. Nearly one third of all placentas had entirely normal microscopic 
findings of the umbilical cord, membranes and placenta sections. Stillbirths, 
however, had a third of cases with some type of placental abnormality (a 
significantly greater proportion than miscarriages) and in 208 of these cases, the 
placental features could be directly linked to the cause of death, including those with 
diagnosis based mainly on clinical history, such as abruption. There was a significant 
difference in the placental weight between black and white mothers, however the 
placental weight was not adjusted for gestational age and it is known that black 
mothers had more frequent miscarriages than white mothers (Chapter 3) and this is 
therefore the likely cause for differences seen. Cord examination found that the 
majority were eccentrically inserted into the placenta and there was no significant 
difference in cord insertion between cases of miscarriage and stillbirth. Overall, 
determination of macroscopic features of the placenta, such as weight and cord 
Autopsy Investigation in Stillbirth 
 
241 
 
insertion site are of limited value in determining cause of death but macroscopic 
examination is important for cases of retroplacental haemorrhage/ abruption (in 
conjunction with the clinical features) and for the identification of focal lesions, such 
as infarcts, for sampling and subsequent histological examination.  
In total, 303 cases in the study population were attributed a cause of death related to 
placental abnormalities including; 
 Placental Abruption 
 Ascending Infection 
 IUGR 
 Specific placental histological abnormalities  
 Pre-eclampsia 
These deaths account for nearly one third of all causes of death in the study, second 
only to unexplained deaths (see Chapter 4) in keeping with other studies (151, 152). 
58% were ascending infection, almost always associated with miscarriage and 
intrapartum death, whilst 18% were related to specific histological abnormalities of 
the placenta; of which maternal vascular malperfusion accounted for the large 
majority (75%); nearly twice that reported in a previous large American study (215).  
In view of these findings cases of ascending infection and maternal vascular 
malperfusion were analysed in greater detail. 
Firstly, in cases of ascending infection the majority of deaths were fresh intrapartum 
deaths with no maceration. In comparison, the majority of maternal vascular 
malperfusion cases were intrauterine deaths with retention, 98% showing 
maceration.  
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The prevalence of these two conditions varies by gestational age; a recognised 
finding (144, 150, 215). Ascending infection frequency peaks at around 22 weeks, 
whilst maternal vascular malperfusion is most frequent at 24-29 weeks gestation. 
Black mothers were significantly more likely to be affected by cases of ascending 
infection with an odds ratio of four compared to white mothers. A previous 
American study reported that intrapartum and early gestational age stillbirths are 
more common in non-Hispanic black women compared to non-Hispanic white 
women and Hispanic women, in keeping with the findings of the present study (215). 
Conversely, white mothers were more likely to be affected by maternal vascular 
malperfusion than all other ethnicities. 
There were no differences in the maternal age or BMI distributions of ascending 
infection or maternal vascular malperfusion cases versus other causes of death. 
Cases with significant other specific placental pathologies causing death (14 of 1064, 
1%) were predominantly intrauterine deaths with a retention time of > 24 hours, at 
an average fetal gestation of 32 weeks, with some degree of maceration present.  The 
findings are similar to those found in cases of maternal vascular malperfusion.  
There was an additional group of cases (78 of 1064, 7%) in which the placenta 
showed some histological abnormality but which was not severe enough to be 
attributed as the cause of death or was of uncertain significance.  The majority of 
these otherwise unexplained deaths were also intrauterine with a retention time of > 
24 hours, with macerated and a similar gestational age, maternal age and ethnic 
distribution to the overall population, including a predominant occurrence at or near 
term. Several of these features, such as villitis of unknown aetiology (VUE) and 
abnormal villous maturation have been reported more frequently in clinically normal 
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pregnancies delivering at term and therefore have very low positive predictive values 
(216). At present there is no “gold standard” or objective test to determine whether 
in an individual case, such findings contributed directly or indirectly to the cause of 
fetal death and this is an important area of future research. 
In conclusion, the findings of this chapter demonstrate that ascending infection is the 
major cause of late second trimester miscarriage with intrapartum or fresh stillbirth, 
specially affecting women of black ethnic origin. Other placental histological 
abnormalities represent a significant cause of death for third trimester stillbirths, 
especially maternal vascular malperfusion and chronic histiocytic intervillositis in 
the early third trimester. A range of placental histological abnormalities of uncertain 
significance remain, particularly in the later third trimester stillbirth, the significance 
of which is uncertain. Placental examination remains an important contributor to 
determining cause of death in cases of intrauterine fetal death at all gestational ages, 
including routine histological sampling and assessment of cord, membranes and 
placental parenchyma, even when this appears normal macroscopically, since in 
many cases a specific histological diagnosis to explain the death may be possible.   
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8.0 Background 
It is recommended by The Royal College of Pathologists (UK) that fetal organs 
should be sampled for histological analysis in stillbirth autopsy but this is based on 
expert opinion rather than published data (159). Similarly, the Kennedy Guidelines 
for the investigation of  Sudden Unexpected Death in Infancy (SUDI) recommends 
autopsy procedures and guides pathologists on the tissue that should be taken for 
histological analysis based on opinion but limited data (217). Recent data suggest 
much more limited sampling in SUDI would not result in undetected causes of death 
(218). Stillbirth is 10 times more common than SUDI and yet there are no large scale 
published studies which evaluate the usefulness and/ or necessity of the histological 
analysis of specific organs in stillbirth (6). 
Although major organ sampling may theoretically lead to detection of specific 
congenital abnormalities, aiding clinicians in the relevance of these abnormalities for 
future pregnancies, the most commonly reported causes of death in stillbirth are, 
IUGR/SGA,  ascending infection and ‘unexplained’ deaths, all of which do not 
significantly rely on histological analysis of fetal internal organ tissue for their 
detection other than as an investigation “of exclusion” (5, 175, 194-197).  
The aim of this chapter is to therefore evaluate the usefulness of both the 
macroscopic and microscopic assessment of fetal internal organs.  Cases in which 
the histological analysis of tissue provided the definitive cause of death will be 
identified.  
8.1 Methods 
The Microsoft Access Autopsy Database was used to collate postmortem and 
antenatal details available for all stillbirths, early and late miscarriages from 2005 – 
2013 from Great Ormond Street Hospital and St George’s Hospital, London.  Data 
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was analysed through queries and statistical tests run using Microsoft Access, Excel, 
Graph Pad Prism and Stats Direct. Statistical test results can be viewed in detail in 
Appendix 3.  
8.2 Results 
There were 1064 cases within the total study population. Macroscopic and 
microscopic examinations of organs were completed in the majority of cases (see 
tables below) and were categorised into four main groups: 
1. Normal: no abnormalities found 
2. Abnormal BUT not contributed to death: e.g. congestion of tissue 
3. Abnormal and potentially contributed to death: e.g. Intraalveolar 
haemorrhage and aspirated squamous cells within lung tissue 
4. Abnormal and definitive cause of death: abnormalities directly provide cause 
of death e.g. CMV seen on lung histology  
Some cases were not consented for macroscopic and / or microscopic examination of 
organs and were categorised as ‘not examined’. Organs, which in the pathologist’s 
expert opinion did not require analysis, were also placed in this category. In some 
instances organs were ‘too autolysed’ for useful examination and thus were 
categorised as such.  
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Heart 
Heart Macro 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
 
Total: 
Normal 
234  
(95%) 
153  
(85%) 
480 
(75%) 
 
867 
(81%) 
Abnormal BUT not 
contributed to death 
4  
(2%) 
13 
 (7%) 
104 
(16%) 
 
121 
(11%) 
Abnormal and potentially 
contributed to death 
2 
 (1%) 
3 
 (2%) 
26 
 (4%) 
 
31 
 (3%) 
Abnormal and definitive 
cause of death 
0  
(0%) 
0 
 (0%) 
1 
 (<1%) 
 
1 
 (<1%) 
Not examined 
4 
 (2%) 
10 
 (6%) 
28  
(4%) 
 
42 
 (4%) 
Too autolysed 
2  
(1%) 
0  
(0%) 
0 
 (0%) 
 
2  
(<1%) 
Total: 246 179 639 
 
 
1064 
Table 116 Macroscopic heart findings in different death categories 
 
The majority of cases had a normal macroscopic appearance of the heart (81%).  
Stillbirths had the greatest proportion of macroscopic abnormalities of the heart but 
almost all were minor changes that did not directly contribute to death (99%). Only 
one case, a stillborn had a macroscopic cardiac abnormality that provided the 
definitive cause of death (see histology below).  
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Heart Histology 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
 
Total 
Normal 
240 
 (98%) 
160 
 (89%) 
546 
(85%) 
 
946  
(89%) 
Abnormal BUT not 
contributed to death 
0 
 (0%) 
5  
(3%) 
41 
 (6%) 
 
46  
(4%) 
Abnormal and potentially 
contributed to death 
0 
 (0%) 
0  
(0%) 
13 
 (2%) 
 
13 
 (1%) 
Abnormal and definitive 
cause of death 
0 
 (0%) 
0 
 (0%) 
1 
 (<1%) 
 
1 
 (<1%) 
Not examined 
4 
 (2%) 
12 
 (7%) 
32 
 (5%) 
 
48 
 (5%) 
Too autolysed 
2 
 (1%) 
2 
 (1%) 
5  
(1%) 
 
9 
 (1%) 
Presumed normal, histo 
taken, not in PM report 0 (0%) 0 (0%) 1 (<1%) 
 
1 
 (<1%) 
Total:  246 179 639 
 
1064 
Table 117 Microscopic heart findings in different death categories 
The majority of heart histology was normal (89%). Stillbirths had the greatest 
proportion of microscopic abnormalities of the heart but almost all were minor 
abnormalities that did not directly contribute to death (98%). Only one heart had a 
microscopic abnormality that provided a definitive cause of death, which was also 
seen macroscopically: 
1. Epstein anomaly of tricuspid valve enlarged dilated right atrium. The 
artrialised portion was extremely thin and almost transparent. There was 
marked displacement of the right atrioventricular valve into the right 
ventricle.  
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a. Cause of death given: Congenital abnormalities. (No antenatal details 
were provided in this case).  
 
Heart 
 
Early 
miscarriage 
Late 
miscarriage 
Stillbirth 
 
Normal macro, Histo Normal 
234  
(100%) 
148 
 (97%) 
446 
(93%) 
Normal macro, Histo abnormal and not 
COD 
0  
(0%) 
1 
 (1%) 
21  
(4%) 
Normal macro, Histo possibly related to 
COD 
0 
 (0%) 
0 
 (0%) 
5 
 (1%) 
Normal macro, Histo abnormal and COD 
0  
(0%) 
0 
 (0%) 
0 
 (0%) 
Normal macro, Histo not examined 
0 
 (0%) 
2 
 (1%) 
2  
(<1%) 
Normal macro, Histo too autolysed 
0  
(0%) 
2 
 (1%) 
5 
 (1%) 
Normal macro, Histo presumed normal, not 
in PM report 
0 
 (0%) 
0 
 (0%) 
1 
 (<1%) 
Total:  234 153 480 
Table 118 Microscopic histology findings when macroscopic findings normal 
The majority of cases (93-100%) had both a normal macroscopic and microscopic 
examination of the heart. Importantly, there were no cases in this large series of 
intrauterine deaths in which histological examination provided the cause of death 
when the macroscopic appearance of the heart was normal.  
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Figure 92 Microscopic findings in different death categories with normal macroscopic findings in the 
heart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
90
100
P
er
ce
n
ta
g
e 
o
f 
ca
se
s 
Heart findings 
% Early
miscarriage
% Late
miscarriage
% Stillbirth
Autopsy Investigation in Stillbirth 
 
251 
 
Lung 
Lung Macro 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
 
 
Total 
 
Normal 
235 
 (96%) 
159 
 (89%) 
448 
 (70%) 
 
842 
(79%) 
Abnormal BUT not contributed 
to death 
1 
 (<1%) 
6  
(3%) 
136 
 (21%) 
 
143 
(13%) 
Abnormal and potentially 
contributed to death 
4 
 (2%) 
3  
(2%) 
25 
 (4%) 
 
32 
 (3%) 
Abnormal and definitive cause 
of death 
0 
 (0%) 
1 
 (1%) 
2 
 (<1%) 
 
3 
(<1%) 
Not examined 
4 
 (2%) 
10 
 (6%) 
28 
 (4%) 
 
42 
 (4%) 
Too autolysed 
1 
 (<1%) 
0  
(0%) 
0 
(0%) 
 
1  
(<1%) 
Not given 
1  
(<1%) 
0  
(0%) 
0  
(0%) 
 
1  
(<1%) 
Total: 246 179 639 
 
 
1064 
Table 119 Macroscopic findings in the lung in different death categories 
 
The majority of cases had a normal macroscopic appearance of the lungs (79%).  
Stillbirths had the greatest proportion of macroscopic abnormalities of the lungs but 
almost all were minor changes that did not directly contribute to death (99%). In 
only three cases did the lungs have a macroscopic abnormality that provided a 
definitive cause of death (see histology below).  
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Lung Histology 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
 
Total: 
Normal 
198  
(80%) 
100 
 (56%) 
198  
(31%) 
 
   496 
(47%) 
Abnormal BUT not 
contributed to death 
25  
(10%) 
24 
 (13%) 
323  
(51%) 
 
372 
(35%) 
Abnormal and 
potentially contributed 
to death 
14 
 (6%) 
32 
 (18%) 
72 
 (11%) 
 
118 
(11%) 
Abnormal and definitive 
cause of death 
2 
 (1%) 
8 
 (4%) 
11 
 (2%) 
 
21 
(2%) 
Not examined 
5  
(2%) 
11 
 (6%) 
32 
 (5%) 
 
48 
(5%) 
Too autolysed 
2 
 (1%) 
4 
 (2%) 
3  
(<1%) 
 
9 
(1%) 
Total: 246 179 639 
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Table 120 Microscopic histological findings in different causes of death 
The majority of lung histology was normal (47%). Stillbirths had the greatest 
proportion of microscopic abnormalities of the lungs but almost all were minor 
abnormalities that did not directly contribute to death (97%). In 21 cases there were 
microscopic abnormalities of the lungs that provided a definitive cause of death 
including:  
 Eighteen cases of pneumonia indicating ascending infection 
o 14 had placentas submitted; all showed chorioamnionitis in the 
placenta and/or funisitis/angiitis of the cord.  
o 1 case had no placenta submitted but showed necrotizing funisitis of 
the cord 
 Two cases of Cytomegalovirus infection (CMV) 
o One case had no placenta submitted for examination 
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o One case showed evidence of choirioamnionitis but no CMV 
inclusions within the placenta 
 One case of congenital pulmonary airway malformation 
o The placental examination showed acute atherosis 
Twenty of the 21 cases had causes of death secondary to infection, which 
theoretically could have been identified on placental examination alone.  16 of the 21 
cases (76%) had placentas submitted for histological examination. Placental 
examination showed evidence of chorioamnionitis and/ or funisitis within the cord in 
all cases of ascedning infection in which a placenta was submitted (14 cases). One 
case of ascendign infection showed necrotising funisitis within the cord despite no 
placenta being submitted for examination. 
Of the two cases diagnosed with CMV, one case had no placenta submitted and the 
other showed chorioamnionitis but no CMV inclusions in the placenta. 
Placental examination in the case of congenital pulmonary airway malformation 
showed acute atherosis, hence the cause of the intrauterine death could have been 
primary placental disease rather than pulmonary related. 
These findings show that 15 of the 21 cases (71%) could have been diagnosed 
through placental examination alone. The findings also suggest that the if the other 
three cases of ascending infection had placentas submitted for examination, it would 
be very likely that they would show positive finindgs for chorioamnionitis, meaning 
up to 18 of the 21 cases (86%) could be diagnosed through placental examination 
only.  
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Lungs 
 
Early 
miscarriage 
Late 
miscarriage 
Stillbirth 
 
Normal macro, Histo Normal 196 (83%) 96 (60%) 
172 
(38%) 
Normal macro, Histo abnormal and not 
COD 25 (11%) 23 (14%) 
216 
(48%) 
Normal macro, Histo possibly related to 
COD 13 (6%) 28 (18%) 
50 
(11%) 
Normal macro, Histo abnormal and COD 2 (1%) 7 (4%) 5 (1%) 
Normal macro, Histo not examined 0 (0%) 2 (1%) 2 (<1%) 
Normal macro, Histo too autolysed 0 (0%) 3 (2%) 3 (1%) 
Total:  236 159 448 
Table 121 Microscopic findings when macroscopic findings are normal in different cases of death 
 
 
Figure 93 Microscopic findings in different death categories with normal macroscopic findings in the 
Lung 
 
The majority of cases had both a normal macroscopic and microsocpic appearance of 
the lungs. In 14 cases (2%) the macroscopic appearance of the lungs was normal but 
the histology was abnormal; 14 cases showed pneumonia and 1 case had CMV 
infection. The histology therefore gave a definitive cause of death. Howerer, 10 of 
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these cases had placentas submitted for histological examination; 9 cases showed 
evidence of chorioamnionitis within the placenta. The remianing case, despite 
showing chorioamnionitis, did not show CMV inclusions which was deemed the 
cause of death in that case.   
Liver 
Liver Macro 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
 
Total: 
Normal 
226  
(92%) 
159 
 (89%) 
530 
 (83%) 
 
915 
 (86%) 
Abnormal BUT not 
contributed to death 
10  
(4%) 
8  
(4%) 
70 
 (11%) 
 
88 
 (8%) 
Abnormal and 
potentially contributed 
to death 
1 
 (<1%) 
1 
 (1%) 
7  
(1%) 
 
9 
 (1%) 
Abnormal and 
definitive cause of 
death 
0 
 (0%) 
1 
 (1%) 
1 
 (<1%) 
 
2 
 (<1%) 
Not examined 
4 
 (2%) 
10 
 (6%) 
29 
 (5%) 
 
43 
 (4%) 
Too autolysed 
4  
(2%) 
0 
 (0%) 
2 
 (<1%) 
 
6  
(1%) 
Not given 
1 
 (<1%) 
0 
 (0%) 
0  
(0%) 
 
1 
 (<1%) 
Total:  246 179 639 
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Table 122 Macroscopic liver findings in different death categories 
The majority of cases had a normal macroscopic appearance of the liver (86%).  
Stillbirths had the greatest proportion of macroscopic abnormalities of the liver but 
almost all were minor changes that did not directly contribute to death (99%). In 
only two cases was the liver was found to have macroscopic abnormalities that 
provided a definitive cause of death (see histology below).  
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Liver Histology 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
 
Total: 
Normal 
226 
 (92%) 
151 
 (84%) 
494  
(77%) 
 
871  
(82%) 
Abnormal BUT not 
contributed to death 
6 
 (2%) 
13  
(7%) 
87 
 (14%) 
 
106 
 (10%) 
Abnormal and 
potentially contributed 
to death 
2  
(1%) 
1 
 (1%) 
9  
(1%) 
 
12 
 (1%) 
Abnormal and 
definitive cause of 
death 
0  
(0%) 
0 
 (0%) 
1 
 (<1%) 
 
1  
(<1%) 
Not examined 
6  
(2%) 
12  
(7%) 
35 
 (3%) 
 
53 
 (5%) 
Too autolysed 
6 
 (2%) 
2 
 (1%) 
13 
 (2%) 
 
21 
 (2%) 
Total:  246 179 639 
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Table 123 Microscopic Liver findings in different death categories 
The majority of liver histology was normal (82%). Stillbirths had the greatest 
proportion of microscopic abnormalities of the liver but almost all were minor 
abnormalities that did not directly contribute to death (99%). There was only one 
case in which microscopic examination of the liver provided the definitive cause of 
death, however in this case the diagnosis would have been made by examination of 
the lung and/or the brain. 
1. Numerous abscesses with multiple gram positive bacilli  
a. Cause of death given: Infection 
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Liver 
Early 
miscarriage 
Late 
miscarriage Stillbirth 
Normal macro, Histo Normal 
217 
 (96%) 
144  
(91%) 
448 
(85%) 
Normal macro, Histo abnormal and 
not COD 
5 
 (2%) 
11 
 (7%) 
61 
 (12%) 
Normal macro, Histo possibly related 
to COD 
0 
 (0%) 
0  
(0%) 
5  
(1%) 
Normal macro, Histo abnormal and 
COD 
0  
(0%) 
0  
(0%) 
0 
 (0%) 
Normal macro, Histo not examined 
1 
 (<1%) 
2  
(1%) 
5 
 (1%) 
Normal macro, Histo too autolysed 
3 
 (1%) 
2 
 (1%) 
11 
 (2%) 
Total:  226 159 530 
Table 124 Microscopic liver findings when macroscopic findings normal in different causes of death 
 
Figure 94 Microscopic findings in different death categories with normal macroscopic findings in the 
Liver 
The majority of all cases had both a normal macroscopic and microscopic 
appearance of the liver. There were no cases with a normal macroscopic appearance 
with abnormal histology that was a definite cause of death.  
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Kidney 
Kidney Macro 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
 
Total:  
Normal 
231 
(94%) 
164 
(92%) 
484 
(76%) 
 
879  
(83%) 
Abnormal BUT not 
contributed to death 
3 
(1%) 
3 
(2%) 
114 
(18%) 
 
120  
(11%) 
Abnormal and potentially 
contributed to death 
5 
(2%) 
2 
(1%) 
8  
(1%) 
 
15  
(1%) 
Abnormal and definitive 
cause of death 
1 
(<1%) 
0 
(0%) 
2 
(<1%) 
 
3  
(<1%) 
Not examined 
4 
(2%) 
10 
(6%) 
30 
(5%) 
 
44  
(4%) 
Too autolysed 
2 
(1%) 
0 
(0%) 
1 
(<1%) 
 
3  
(<1%) 
Total:  246 179 639 
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Table 125 Macroscopic findings in the kidney for different death categories 
The majority of cases had a normal macroscopic appearance of the kidneys (83%).  
Stillbirths had the greatest proportion of macroscopic abnormalities of the kidneys 
but almost all were minor changes that did not directly contribute to death (95%). In 
only 3 cases the kidney was found to have macroscopic abnormalities that provided a 
definitive cause of death, including one case of bilateral renal agenesis (see histology 
below).  
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Kidney Histology 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
 
Total: 
Normal 
228  
(93%) 
132  
(74%) 
487 
(76%) 
 
847 
(80%) 
Abnormal BUT not 
contributed to death 
8 
 (3%) 
26 
 (15%) 
98 
(15%) 
 
132 
(12%) 
Abnormal and potentially 
contributed to death 
2  
(1%) 
6  
(3%) 
8  
(1%) 
 
16 
 (2%) 
Abnormal and definitive 
cause of death 
0 
 (0%) 
0  
(0%) 
5 
 (1%) 
 
5 
 (<1%) 
Not examined 
6 
 (2%) 
13 
 (7%) 
36 
 (6%) 
 
55  
(5%) 
Too autolysed 
2 
 (1%) 
2 
 (1%) 
5  
(1%) 
 
9 (1%) 
Total:  246 179 639 
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Table 126 Microscopic findings in the kidney for different death categories 
The majority of kidney histology was normal (80%). Stillbirths had the greatest 
proportion of microscopic abnormalities of the kidneys but almost all were minor 
abnormalities that did not directly contribute to death (95%). There were five cases 
in which a microscopic abnormality in the kidney provided the definitive cause of 
death: 
1.  Absent kidneys with only a small amount of renal tissue on the left. 
a. Cause of death given: Congenital abnormalities (mother had no 
antenatal care; no history of scans) 
 
2. Large mass, up to 7cm diameter, right kidney, consistent with mesoblastic 
nephroma.  
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a. Cause of death given: Congenital abnormalities (seen on antenatal 
scan) 
 
3. The right kidney showed patchy, mainly non-occlusive focally calcified 
laminated thrombus within the renal vein and its teributary intrarenal 
branches, suggestive of a fetal thrombotoic tendancy (fetal thrombotic 
vasculopathy FTV).  
a. Cause of death given: Placenta 
 
4. Right kidney shows a focally calcified laminated thrombus in the renal vein 
and its tributary intrarenal branches, indicating the likely presence of a fetal 
thrombophilia. 
a. Cause of death given: Placenta 
 
5. Scattered cytomegalic cells containing nuclear inclusions 
a. Cause of death given: Infection (also detected on Lung histology) 
Kidney  
Early 
miscarriage 
Late 
miscarriage Stillbirth 
Normal macro, Histo Normal 
221 
 (96%) 
129 
 (79%) 
401 
(83%) 
Normal macro, Histo abnormal and not 
COD 
8 
 (3%) 
24  
(15%) 
68  
(14%) 
Normal macro, Histo possibly related to 
COD 
0 
 (0%) 
6 
 (4%) 
4 
 (1%) 
Normal macro, Histo abnormal and COD 
0 
 (0%) 
0 
 (0%) 
2 
 (<1%) 
Normal macro, Histo not examined 
1  
(<1%) 
3  
(2%) 
5 
 (1%) 
Normal macro, Histo too autolysed 
1  
(<1%) 
2  
(1%) 
4 
 (1%) 
 Total:  231 164 484 
Table 127 Microscopic findings in the kidney with normal macroscopic findings for different death 
categories 
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Figure 95 Microscopic findings in different death categories with normal macroscopic findings in the 
kidney 
The majority of cases (79-96%) had both a normal macroscopic and microscopic 
appearance of the kidneys. Only two cases had a normal macroscopic appearance 
and an abnormal histological appearance which was directly linked to the cause of 
death. On both occasions the cause of death was linked to fetal thrombosis. 
However, both cases showed extensive placental FTV and the underlying diagnosis 
would have been identified without fetal histological sampling.  
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Brain 
Brain Macro 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
 
Total:  
Normal 
185  
(75%) 
124 
 (69%) 
339  
(53%) 
 
648 
(61%) 
Abnormal BUT not contributed 
to death 
16  
(7%) 
25 
 (14%) 
200 
 (31%) 
 
241 
(23%) 
Abnormal and potentially 
contributed to death 
5 
 (2%) 
6 
 (3%) 
35  
(5%) 
 
46 
(4%) 
Abnormal and definitive cause 
of death 
0  
(0%) 
0  
(0%) 
6 
 (1%) 
 
6 
(1%) 
Not examined 
15  
(6%) 
13 
 (7%) 
49 
 (8%) 
 
77 
(7%) 
Too autolysed 
25 
 (10%) 
11 
 (6%) 
10 
 (2%) 
 
46 
(4%) 
Total:  246 179 639 
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Table 128 Macroscopic findings in the brain for different death categories 
The majority of cases had a normal macroscopic appearance of the brain (61%).  
Stillbirths had the greatest proportion of macroscopic abnormalities of the brain but 
almost all were minor changes that did not directly contribute to death (98%). In six 
cases the brain was found to have macroscopic abnormalities that provided a 
definitive cause of death (see histology below).  
 
 
 
 
 
Autopsy Investigation in Stillbirth 
 
263 
 
Brain Histology 
Early 
Miscarriage 
Late 
miscarriage Stillbirth 
 
Total:  
Normal 
184 
 (75%) 
126  
(70%) 
298  
(47%) 
 
608 
(57%) 
Abnormal BUT not contributed 
to death 
10 
 (4%) 
23  
(13%) 
206 
 (32%) 
 
239 
(22%) 
Abnormal and potentially 
contributed to death 
3 
 (1%) 
7 
 (4%) 
52 
 (8%) 
 
62 
(6%) 
Abnormal and definitive cause 
of death 
0 
 (0%) 
0 
 (0%) 
3 
 (1%) 
 
3 
(<1%) 
Not examined 
22  
(9%) 
16 
 (9%) 
61 
 (10%) 
 
99 
(9%) 
Too autolysed 
26 
 (11%) 
7 
 (4%) 
16 
 (3%) 
 
49 
(5%) 
Not given 1 (<1%) 0 (0%) 0 (0%) 
 
1 
(<1%) 
Pres norm, "PM histo" taken 
but organ NOT reported 0 (0%) 0 (0%) 2 (<1%) 
 
2 
(<1%) 
No information provided 0 (0%) 0 (0%) 1 (<1%) 
 
1 
(<1%) 
Total:  246 179 639 
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Table 129 Microscopic findings in the brain for different death categories 
The majority of brain histology was normal (57%). Stillbirths had the greatest 
proportion of microscopic abnormalities of the brain but almost all were minor 
abnormalities that did not directly contribute to death (99%). There were three cases 
in which histological examination of the brain provided a definitive cause of death: 
1. Massive subdural and subarachnoid haemorrhage. Some focal white matter 
cortical haemorrhage in cerebellum. 
a. Cause of death given: Congenital abnormalities 
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2. Massive fresh haemorrhage including the germinal matrix and periventricular 
white matter with microscopic fresh haemorrhage in the white matter. 
a. Cause of death given: Congenital abnormalities 
 
3. Fibrinopurulent leptomeningitis and purulent ventriculitis. Gram positive 
organisms present. (abnormalities of infection also seen on histology of lung 
and liver) 
a. Cause of death given: Infection 
The intracerebral bleeds could have been visualised on a postmortem MRI and the 
case of infection showed evidence of infection within the lung and liver tissue also.  
Brain 
Early 
miscarriage 
Late 
miscarriage Stillbirth 
Normal macro, Histo Normal 
168  
(91%) 
107 
 (86%) 
220 
(65%) 
Normal macro, Histo abnormal and 
not COD 
4 
 (2%) 
11 
 (9%) 
82 
(24%) 
Normal macro, Histo possibly related 
to COD 
0 
 (0%) 
2 
(2%) 
17  
(5%) 
Normal macro, Histo abnormal and 
COD 
0 
 (0%) 
0 
 (0%) 
0 
 (0%) 
Normal macro, Histo not examined 
2  
(1%) 
3 
 (2%) 
9 
 (3%) 
Normal macro, Histo too autolysed 
10  
(5%) 
1 
 (1%) 
9 
 (3%) 
Not given 
1  
(1%) 
0 
(0%) 
0 
(0%) 
Total:  185 124 337 
Table 130 Microscopic findings in the Brain with normal macroscopic findings for different death 
categories (excludes 2 cases with inadequate documentation) 
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Figure 96 Microscopic findings in different death categories with normal macroscopic findings in the 
Brain 
 
The majority of cases had both a normal macroscopic and microscopic appearance of 
the brain. There were no cases in which the macroscopic appearance was normal 
with the microscopic examination providing the definitive cause of death. 
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Adrenal Glands 
Adrenal Macro 
Early 
Miscarriage 
Late 
miscarriage Stillbirth 
 
Total 
Normal 
239 
(97%) 
166 
(93%) 
533 
(83%) 
 
938 
(88%) 
Abnormal BUT not contributed 
to death 
0 
(0%) 
2 
(1%) 
70 
(11%) 
 
72 
(7%) 
Abnormal and potentially 
contributed to death 
1 
(<1%) 
1 
(1%) 
4 
(1%) 
6 
(1%) 
Abnormal and definitive cause 
of death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Not examined 
4 
(2%) 
10 
(6%) 
30 
(5%) 
44 
(4%) 
Too autolysed 
2 
(1%) 
0 
(0%) 
2 
(<1%) 
4( 
<1%) 
Not given 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Total:  246 179 639 
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Table 131 Macroscopic findings in the adrenal glands for different death categories 
The majority of cases had a normal macroscopic appearance of the adrenal glands 
(88%).  Stillbirths had the greatest proportion of macroscopic abnormalities of the 
adrenal glands and all were minor changes that did not directly contribute to death. 
There were no cases in which abnormal macroscopic abnormalities of the adrenal 
glands provided a definitive cause of death. 
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Adrenal Histology 
Early 
Miscarriage 
Late 
miscarriage Stillbirth 
 
Total 
Normal 
227 
(92%) 
143 
(80%) 
422 
(66%) 
792 
(74%) 
Abnormal BUT not contributed 
to death 
8 
(3%) 
18 
(10%) 
153 
(24%) 
179 
(17%) 
Abnormal and potentially 
contributed to death  
2 
(1%) 
3 
(2%) 
17 
(3%) 
22 
(2%) 
Abnormal and definitive cause 
of death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Not examined 
7 
(3%) 
12 
(7%) 
38 
(6%) 
57 
(5%) 
Too autolysed 
2 
(1%) 
3 
(2%) 
9 
(1%) 
14 
(1%) 
Not given 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Total:  246 179 639 
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Table 132 Microscopic findings in the adrenal glands for different death categories 
The majority of adrenal histology was normal (74%). Stillbirths had the greatest 
proportion of microscopic abnormalities of the adrenal glands and all were minor 
abnormalities that did not directly contribute to death. There were no cases in which 
a microscopic abnormality in the adrenal gland provided the definitive cause of 
death: 
Adrenal 
Early 
miscarriage 
Late 
miscarriage Stillbirth 
Normal macro, Histo Normal 
226  
(95%) 
141 
(85%) 
396 
(74%) 
Normal macro, Histo abnormal and 
not COD 
8 
(3%) 
17 
(10%) 
111 
(21%) 
Normal macro, Histo possibly related 
to COD 
1 
(<1%) 
3 
(2%) 
13 
(2%) 
Normal macro, Histo abnormal and 
COD 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Normal macro, Histo not examined 
3 
(1%) 
2 
(1%) 
6 
(1%) 
Normal macro, Histo too autolysed 
1 
(<1%) 
3 
(2%) 
7 
(1%) 
Total:  239 166 533 
Table 133 Microscopic findings in the adrenal glands with normal macroscopic findings for different 
death categories 
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Figure 97 Microscopic findings in different death categories with normal macroscopic findings in the 
adrenal glands 
The majority of cases had both a normal macroscopic and microscopic appearance of 
the adrenal glands. There were no cases in which the macroscopic appearance was 
normal with the microscopic examination providing the definitive cause of death. 
Spleen 
Spleen Macro 
Early 
Miscarriage 
Late 
miscarriage Stillbirth 
 
Total 
Normal 
219 
(89%) 
168 
(94%) 
584 
(91%) 
971 
(91%) 
Abnormal BUT not contributed to 
death 
4 
(2%) 
1 
(1%) 
23 
(4%) 
28 
(3%) 
Abnormal and potentially 
contributed to death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Abnormal and definitive cause of 
death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Not examined 
7 
(3%) 
10 
(6%) 
30 
(5%) 
47 
(4%) 
Too autolysed 
15 
(6%) 
0 
(0%) 
2 
(<1%) 
17 
(2%) 
Not given 
1 
(<1%) 
0 
(0%) 
0 
(0%) 
1 
(<1%) 
Total:  246 179 639 
 
1064 
Table 134 Macroscopic findings in the spleen for different death categories 
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The majority of cases had a normal macroscopic appearance of the spleen (91%).  
Stillbirths had the greatest proportion of macroscopic abnormalities of the spleen and 
all were minor changes that did not directly contribute to death. There were no cases 
in which abnormal macroscopic abnormalities of the spleen provided a definitive 
cause of death. 
 
Spleen Histology 
Early 
Miscarriage 
Late 
miscarriage Stillbirth 
 
Total 
Normal 
219 
(89%) 
158 
(88%) 
512 
(80%) 
889 
(84%) 
Abnormal BUT not contributed 
to death 
3 
(1%) 
4 
(2%) 
50 
(8%) 
57 
(5%) 
Abnormal and potentially 
contributed to death 
1 
(<1%) 
0 
(0%) 
3 
(<1%) 
4 
(<1%) 
Abnormal and definitive cause of 
death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Not examined 
13 
(5%) 
14 
(8%) 
37 
(6%) 
64 
(6%) 
Too autolysed 
10 
(4%) 
3 
(2%) 
37 
(6%) 
50 
(5%) 
Not given 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Total:  246 179 639 
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Table 135 Microscopic findings in the spleen for different death categories 
The majority of spleen histology was normal (84%). Stillbirths had the greatest 
proportion of microscopic abnormalities of the spleen and all were minor 
abnormalities that did not directly contribute to death. There were no cases in which 
a microscopic abnormality in the spleen provided the definitive cause of death. 
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Spleen 
Early 
miscarriage 
Late 
miscarriage Stillbirth 
Normal macro, Histo Normal 
211 
(96%) 
160 
(95%) 
497 
(85%) 
Normal macro, Histo abnormal and 
not COD 
3 
(1%) 
3 
(2%) 
43 
(7%) 
Normal macro, Histo possibly related 
to COD 
1 
(<1%) 
0 
(0%) 
3 
(1%) 
Normal macro, Histo abnormal and 
COD 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Normal macro, Histo not examined 
3 
(1%) 
3 
(0%) 
7 
(1%) 
Normal macro, Histo too autolysed 
1 
(<1%) 
2 
(1%) 
34 
(6%) 
Not given 
1 
(<1%) 
0 
(0%) 
0 
(0%) 
 Total:  219 168 584 
Table 136 Microscopic findings in the spleen with normal macroscopic findings for different death 
categories 
 
 
Figure 98 Microscopic findings in different death categories with normal macroscopic findings in the 
spleen 
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The majority of cases had both a normal macroscopic and microscopic appearance of 
the spleen. There were no cases in which the macroscopic appearance was normal 
with the microscopic examination providing the definitive cause of death. 
Thymus 
Thymus Macro 
Early 
Miscarriage 
Late 
miscarriage Stillbirth 
 
Total 
Normal 
235 
(96%) 
169 
(94%) 
550 
(86%) 
954 
(90%) 
Abnormal BUT not 
contributed to death 
1 
(<1%) 
0 
(0%) 
58 
(9%) 
59 
(6%) 
Abnormal and potentially 
contributed to death 
0 
(0%) 
0 
(0%) 
1 
(<1%) 
1 
(<1%) 
Abnormal and definitive 
cause of death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Not examined 
5 
(2%) 
10 
(6%) 
30 
(5%) 
45 
(4%) 
Too autolysed 
4 
(2%) 
0 
(0%) 
0 
(0%) 
4 
(<1%) 
Not given 
1 
(<1%) 
0 
(0%) 
0 
(0%) 
1 
(<1%) 
Total:  246 179 639 
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Table 137 Macroscopic findings in the thymus for different death categories 
The majority of cases had a normal macroscopic appearance of the thymus (90%).  
Stillbirths had the greatest proportion of macroscopic abnormalities of the thymus 
and all were minor changes that did not directly contribute to death. There were no 
cases in which abnormal macroscopic abnormalities of the thymus provided a 
definitive cause of death. 
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Thymus Histology 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
Total 
Normal 
203 
(83%) 
116 
(65%) 
409 
(64%) 
 
730 
(69%) 
Abnormal BUT not 
contributed to death 
28 
(11%) 
42 
(23%) 
173 
(27%) 
243 
(23%) 
Abnormal and potentially 
contributed to death 
4 
(2%) 
7 
(4%) 
18 
(3%) 
29 
(3%) 
Abnormal and definitive 
cause of death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Not examined 
9 
(4%) 
12 
(7%) 
35 
(5%) 
56 
(5%) 
Too autolysed 
2 
(1%) 
2 
(1%) 
4 
(1%) 
8 
(1%) 
Not given 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Total:  246 179 639 
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Table 138 Microscopic findings in the thymus for different death categories 
The majority of thymus gland histology was normal (69%). Stillbirths had the 
greatest proportion of microscopic abnormalities of the thymus gland and all were 
minor abnormalities that did not directly contribute to death. There were no cases in 
which a microscopic abnormality in the thymus gland provided the definitive cause 
of death. 
Thymus 
Early 
miscarriage 
Late 
miscarriage Stillbirth 
Normal macro, Histo Normal 
201 
(86%) 
116 
(69%) 
390 
(71%) 
Normal macro, Histo abnormal and not 
COD 
28 
(12%) 
42 
(25%) 
134 
(24%) 
Normal macro, Histo possibly related to 
COD 
4 
(2%) 
7 
(4%) 
17 
(3%) 
Normal macro, Histo abnormal and COD 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Normal macro, Histo not examined 
2 
(1%) 
2 
(1%) 
5 
(1%) 
Normal macro, Histo too autolysed 
0 
(0%) 
2 
(1%) 
4 
(1%) 
 Total:  235 169 550 
Table 139 Microscopic findings in the thymus with normal macroscopic findings for different death 
categories 
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Figure 99 Microscopic findings in different death categories with normal macroscopic findings in the 
thymus 
The majority of cases had both a normal macroscopic and microscopic appearance of 
the thymus. There were no cases in which the macroscopic appearance was normal 
with the microscopic examination providing the definitive cause of death. 
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Intestines 
Intestine Macro 
Early 
Miscarriage 
Late 
miscarriage Stillbirth 
 
Total 
Normal 
230 
(93%) 
163 
(91%) 
581 
(91%) 
974 
(92%) 
Abnormal BUT not contributed 
to death 
6 
(2%) 
1 
(1%) 
10 
(2%) 
17 
(2%) 
Abnormal and potentially 
contributed to death 
4 
(2%) 
3 
(2%) 
13 
(2%) 
20 
(2%) 
Abnormal and definitive cause of 
death 
0 
(0%) 
1 
(1%) 
2 
(<1%) 
3 
(<1%) 
Not examined 
4 
(2%) 
10 
(6%) 
29 
(5%) 
43 
(4%) 
Too autolysed 
2 
(1%) 
1 
(1%) 
4 
(1%) 
7 
(1%) 
Not given 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Total:  246 179 639 
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Table 140 Macroscopic findings in the intestines for different death categories 
The majority of cases had a normal macroscopic appearance of the intestines (92%).  
Stillbirths had the greatest proportion of macroscopic abnormalities of the intestines 
but almost all were minor changes that did not directly contribute to death (82%). 
There were 3 cases in which abnormal macroscopic abnormalities of the intestines 
provided a definitive cause of death: 
1. Intestinal malrotation; the large and small intestine, together with the 
mesentery had herniated through a traumatic defect in the left flank beneath 
the left costal margin..  
a. Cause of death: Congenital abnormalities (no abnormalities noted in 
antenatal history) 
 
2. Meconium peritonitis secondary to (spontaneous) perforation of the small 
bowel.  
a. Cause of death: Unexplained lesion, baby (no evidence of 
abnormalities in antenatal history) 
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3. Patent urachus and small intestine is present attached to the umbilicus and 
malrotation with a small mesentery and a huge blind ending rectum is present 
in the upper pelvis.  
a. Cause of death: Congenital abnormalities (mother had no antenatal 
care) 
Intestinal histology was not taken in the majority of cases (67%). 
Intestine Histology 
Early 
Miscarriage 
Late 
miscarriage Stillbirth 
Yes 
46 
(19%) 
27 
(15%) 
278 
(44%) 
No 
200 
(81%) 
152 
(85%) 
361 
(56%) 
Total:  246 179 639 
Table 141 The number and percentage of cases in which intestines examined microscopically 
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Pancreas  
Pancreas Macro 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
 
Total 
Normal 
225 
(91%) 
163 
(91%) 
587 
(92%) 
 
975 
(92%) 
Abnormal BUT not 
contributed to death 
0 
(0%) 
0 
(0%) 
10 
(2%) 
 
10 
(1%) 
Abnormal and potentially 
contributed to death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
 
0 
(0%) 
Abnormal and definitive 
cause of death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
 
0 
(0%) 
Not examined 
9 
(4%) 
15 
(8%) 
33 
(5%) 
 
57 
(5%) 
Too autolysed 
10 
(4%) 
1 
(1%) 
5 
(1%) 
 
16 
(2%) 
Not given 
2 
(1%) 
0 
(0%) 
4 
(1%) 
 
6 
(1%) 
Total:  246 179 639 
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Table 142 Macroscopic findings in the pancreas for different death categories 
The majority of cases had a normal macroscopic appearance of the pancreas (92%).  
Stillbirths had the greatest proportion of macroscopic abnormalities of the pancreas 
and all were minor changes that did not directly contribute to death. There were no 
cases in which abnormal macroscopic abnormalities of the pancreas provided a 
definitive cause of death. 
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Pancreas Histology 
 
Early 
Miscarriage 
Late 
miscarriage 
Stillbirth 
 
 
Total 
Normal 
219 
(89%) 
152 
(85%) 
423 
(66%) 
 
794 
(75%) 
Abnormal BUT not 
contributed to death 
1 
(<1%) 
8 
(4%) 
8 
(1%) 
 
17 
(2%) 
Abnormal and potentially 
contributed to death 
0 
(0%) 
0 
(0%) 
2 
(<1%) 
 
2 
(<1%) 
Abnormal and definitive 
cause of death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
 
0 
(0%) 
Not examined 
16 
(7%) 
18 
(10%) 
47 
(7%) 
 
81 
(8%) 
Too autolysed 
10 
(4%) 
1 
(1%) 
159 
(25%) 
 
170 
(16%) 
Total: 246 179 639 
 
 
1064 
Table 143 Microscopic findings in the pancreas for different death categories 
The majority of pancreas histology was normal (79%). Stillbirths had the greatest 
proportion of microscopic abnormalities of the pancreas and all were minor 
abnormalities that did not directly contribute to death. There were no cases in which 
a microscopic abnormality in the pancreas provided the definitive cause of death. 
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Pancreas Early miscarriage Late miscarriage Stillbirth 
Normal macro, Histo 
Normal 
219 
(97%) 
135 
(83%) 
415 
(71%) 
Normal macro, Histo 
abnormal and not COD 
1 
(<1%) 
7 
(4%) 
7 
(1%) 
Normal macro, Histo 
possibly related to COD 
0 
(0%) 
0 
(0%) 
2 
(<1%) 
Normal macro, Histo 
abnormal and COD 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Normal macro, Histo not 
examined 
4 
(2%) 
20 
(12%) 
12 
(2%) 
Normal macro, Histo too 
autolysed 
1 
(<1%) 
1 
(1%) 
151 
(26%) 
 Total:  225 163 587 
Table 144 Microscopic findings in the pancreas with normal macroscopic findings for different death 
categories 
 
 
Figure 100 Microscopic findings in different death categories with normal macroscopic findings in 
the pancreas 
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The majority of cases had both a normal macroscopic and microscopic appearance of 
the pancreas. There were no cases in which the macroscopic appearance was normal 
with the microscopic examination providing the definitive cause of death. 
 
Thyroid 
Thyroid Macro 
Early 
miscarriage 
Late 
miscarriage Stillbirth Total 
Normal 
213 
 (87%) 
144 
 (80%) 
550  
(86%) 
907 
(85%) 
Abnormal BUT not 
contributed to death 
0 
 (0%) 
0  
(0%) 
11 
 (2%) 11 (1%) 
Abnormal and potentially 
contributed to death 
0 
 (0%) 
0 
 (0%) 
0 
 (0%) 0 (0%) 
Abnormal and definitive 
cause of death 
0  
(0%) 
0 
 (0%) 
0  
(0%) 0 (0%) 
Not examined 
31  
(13%) 
35  
(20%) 
78  
(12%) 
144 
(14%) 
Too autolysed 
1  
(<1%) 
0 
 (0%) 
0 
 (0%) 
1  
(<1%) 
Not given 1 0  0 1 
Total 246 179 639 1064 
Table 145 Macroscopic findings in the thyroid for different death categories 
The majority of cases had a normal macroscopic appearance of the thyroid gland 
(85%).  Stillbirths had the greatest proportion of macroscopic abnormalities of the 
thyroid and all were minor changes that did not directly contribute to death. There 
were no cases in which abnormal macroscopic abnormalities of the thyroid provided 
a definitive cause of death. 
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Thyroid Histology 
Early 
miscarriage 
Late 
miscarriage Stillbirth Total 
Normal 
182 
(74%) 
118 
(66%) 
493 
(77%) 
793 
(75%) 
Abnormal BUT not 
contributed to death 
0 
(0%) 
0 
(0%) 
9 
(1%) 
9 
(1%) 
Abnormal and potentially 
contributed to death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Abnormal and definitive 
cause of death 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Not examined 
63 
(26%) 
59 
(33%) 
132 
(21%) 
254 
(24%) 
Too autolysed 
1 
(<1%) 
2 
(1%) 
5 
(1%) 
8 
(1%) 
Total 246 179 639 1064 
Table 146 Microscopic findings in the thyroid for different death categories 
The majority of thyroid gland histology was normal (75%). Stillbirths had the 
greatest proportion of microscopic abnormalities of the thymus gland and all were 
minor abnormalities that did not directly contribute to death. There were no cases in 
which a microscopic abnormality in the thymus gland provided the definitive cause 
of death. 
Thyroid 
Early 
miscarriage 
Late 
miscarriage Stillbirth Total 
Normal macro, Histo Normal 
181 
(85%) 
118 
(82%) 
483 
(88%) 
782 
(86%) 
Normal macro, Histo abnormal 
and not COD 
0 
(0%) 
0 
(0%) 
7 
(1%) 
7 
(1%) 
Normal macro, Histo possibly 
related to COD 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Normal macro, Histo abnormal 
and COD 
0 
(0%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
Normal macro, Histo not 
examined 
32 
(15%) 
25 
(17%) 
55 
(10%) 
112 
(12%) 
Normal macro, Histo too autolysed 
0 
(0%) 
1 
(1%) 
5 
(1%) 
6 
(1%) 
Total 213 144 550 907 
Table 147 Microscopic findings in the thyroid with normal macroscopic findings for different death 
categories 
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Figure 101 Microscopic findings in different death categories with normal macroscopic findings in 
the thyroid 
 
The majority of cases had both a normal macroscopic and microscopic appearance of 
the thyroid. There were no cases in which the macroscopic appearance was normal 
with the microscopic examination providing the definitive cause of death. 
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8.3 Discussion 
The majority of all fetuses in this study had normal macroscopic and microscopic 
appearances of their internal organs. Cases of stillbirth showed a greater proportion, 
on average, of abnormal macroscopic or microscopic appearances but almost all 
were nonspecific and  did not provide the cause of death. The same was true for 
miscarriages (Table 148 and Figure 102).   
Organ 
 
Abnormal Histology 
and Cause of death 
Abnormal Histology but 
NOT cause of death 
Total: 
Heart 1 (3%) 58 (4%) 
 
59 (4%) 
Lung 21 (68%) 489 (34%) 
 
510 (35%) 
Liver 1 (3%) 118 (8%) 
 
119 (8%) 
Brain 3 (10%) 301 (21%) 
 
304 (21%) 
Kidney 5 (16%) 149 (10%) 
 
154 (10%) 
Spleen 0 (0%) 53 (4%) 
 
53 (4%) 
Adrenal 0 (0%) 70 (5%) 
 
70 (5%) 
Thymus 0 (0%) 191 (13%) 
 
191 (13%) 
Pancreas 0 (0%) 10 (1%) 
 
10 (1%) 
Thyroid 0 (0%) 7 (<1%) 
 
7 (<1%) 
Total: 31 1446 
 
1477 
Table 148 Histological abnormalities in organs (1 case had histological abnormalities of the liver, 
the lungs and the brain and another case had abnormalities in the kidney and the lungs; 28 individual 
cases therefore had abnormal histology that was directly linked to the cause of death) Note: 
Percentages within this table represent column percentages not row percentages. 
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Figure 102 Comparison in percentage of organ histological abnormalities between those that directly 
provided the cause of death and those that did not directly provide the cause of death.  
Thirty-one organs had abnormal histological findings that directly contributed to the 
cause of death. However, one case had histological abnormalities of the liver, the 
lungs and the brain and another case had abnormalities in the kidney and the lungs 
therefore 28 individual cases, of more than 1,000 intrauterine deaths, had abnormal 
microscopic findings that directly provided the cause of death (for the following 
discussion the two cases with multiple abnormal organs have been placed in the 
abnormal lung histology group).  
The majority of all histological abnormalities (68%) were seen in lung tissue; a 
similar finding to the histological abnormalities found in cases of Sudden 
Unexpected Death in Infancy (SUDI) where 43% of histological abnormalities are 
found in lung tissue (218).  
14 cases with abnormal lung histology also had chorioamnionitis on placental 
histological examination which could have provided the same cause of death. Four 
cases of ascending infection with abnormal lung histology would most likely also 
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have had abnormal placental histology, if a placenta had been submitted for 
examination. Of the remaining ten cases with abnormal histology that directly 
provided the cause of death there were: 
 Two cases of histological abnormalities in the kidneys (thrombi) could have 
been given the same cause of death through examination of the placenta 
(Fetal Thrombotic Vasculopathy) 
 One heart, one lung and two kidney cases had macroscopically identifiable 
congenital abnormalities which could have been diagnosed using 
postmortem Magnetic Resonance Imaging as could the two intracerebral 
bleeds.  
 The two cases with cytomegalovirus (CMV) infection were diagnosed in 
fetal lung and kidney tissue, but not seen in placental tissue (however one 
case had no placental tissue submitted for examination), suggesting it was 
only possible to diagnose the CMV after invasive autopsy in at least one of 
these two cases.  
27 cases with histological abnormalities therefore had the potential to be diagnosed 
with the same cause of death without the need for microscopic examination of fetal 
organs.  Indeed published work (albeit from small a small study) has found that 
postmortem MRI, together with investigations such as placental histology, external 
fetal examination, cytogenetics and plain film radiography can provide the 
equivalent information to that of a complete invasive autopsy (214).  One study, of 
intrauterine fetal deaths greater than 20 weeks gestation,  reported that the most 
valuable test to help determine the cause of fetal death was examination of the 
placenta (219). Furthermore, placental examination, without autopsy, has also been 
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reported to provide a cause of death in nearly 50% of intrauterine, intrapartum and 
neonatal deaths (220). 
There were no cases in the present study in which histology of the spleen, adrenal 
glands, thyroid, thymus or pancreas provided the cause a death; a finding similarly 
demonstrated in the histological examination of organs in cases of SUDI (218). 
Of the total 1,064 cases there were only 16 cases with organs which had a normal 
macroscopic appearance but abnormal histology that directly gave the cause of 
death. All 16 cases have been discussed above; 14 lung abnormalities with ascending 
infection (nine of which had chorioamniontis in the placenta, one CMV infection and 
the remaining four had no placenta submitted for examination), and 2 cases of fetal 
thrombotic vasculopathy with abnormalities in the kidney, which also had 
abnormalities within the placenta that could have provided the same cause of death. 
These findings suggest that if fetal macroscopic organ examination is normal, there 
is very little benefit in histological examination in intrauterine deaths. This differs 
from results found in the investigation of SUDI, where 26% of lungs, 2% of hearts 
and 1% of livers had reported normal macroscopic results but significant findings on 
histological examination (218).  
As there are no other large scale published studies providing an in depth review of 
histological abnormalities at autopsy, it must be recommended that further studies 
are completed to corroborate these findings; it is clear, however, that routine 
histological examination of all organs in stillbirth and miscarriage is of limited value 
in providing the accurate cause of death.  
Several caveats should be noted regarding these data and their interpretation. First, 
this only applies to predominantly structurally normal intrauterine deaths, not 
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terminations of pregnancy for anomalies, since in such a population, targeted 
histological sampling may be essential for diagnosis. Secondly, the interpretation 
here was limited to findings that influenced directly the final cause of death. 
Therefore, some abnormalities, such as finding subtle brain changes suggestive of 
ischaemia, may indeed add to our understanding of the process of intrauterine death, 
but their presence of absence will not alter the final cause of death in the absence of 
other significant findings such as placental pathology, etc. Finally, it should be 
recognised that this interpretation is based on routine histological assessment. It is 
possible that in future, novel investigations may be introduced which require organ 
specific fetal tissue, such as various omic approaches, which would provide 
additional rationale for invasive evaluation and sampling.     
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9. Thymus Histology 
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9.0 Background 
The thymus is an organ that develops embryologically from the third and fourth pair 
of pharyngeal pouches and at birth usually weighs between 10-35g (221).  The 
thymus gland can involute in response to either stress or age and involution is more 
complex than a single negative exponential function of age alone (222). 
Histologically, involution of the thymus is characterised by karyorrhexis of 
lymphocytes with active phagocytosis by macrophages – creating the typical “starry 
sky” appearance of the cortex which then progressively thins until the 
corticomedullary ratio is reversed (223).  
 
Figure 103 Thymus gland histology at x10 magnification with evidence of involution  
Histological examination of the thymus gland is typically undertaken in stillbirth 
autopsies to assess for accelerated involution which has been suggested to be an 
indicator of prenatal stress (171, 172). Existing data indicates that the degree of 
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thymic involution varies with many factors such as maternal diabetes mellitus or 
fetal cause of death such as chorioamnionitis (210, 224, 225).  Involution is graded 
using the Van Baarlen Grading scale (Figure 104). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 104 Van Baarlen Grading of thymic involution (173) 
However, the assessment of thymic involution is essentially subjective and relies on 
consistent reporting from perinatal pathologists making judgements on the degree of 
lymphodepletion and shrinkage of the cortex without the use of measurements. 
Comments regarding thymic histological appearances derived from pathology 
reports are also unreliable due to the absence of blinding of the pathologist to the 
clinical features, introducing the potential for significant bias.  
Grade 0: The resting state, ie, a clear cortex-medulla distinction with a high 
density of lymphocytes in the cortex. The thymic lobules closely packed together 
and separated only by delicate connective tissue septa. Lymphophagocytosis in the 
cortex was absent. 
Grade 1: Identical to grade 0, except for the presence of some 
lymphophagocytosis in the cortex. 
Grade 2: More pronounced lymphophagocytosis in the cortex, with a "starrysky" 
aspect. In addition, early signs of shrinkage of the cortex and some separation of 
the thymic lobules. In other aspects, the histologic picture is similar to that of 
grade 0 or 1.  
Grade 3: Loss of distinction between cortex and medulla at low magnification 
due to advanced lymphophagocytosis, resulting in irregular narrowing of the 
cortex, loci of lymphodepletion, and increasing separation of thymic lobules. 
Grade 4: More pronounced lymphodepletion of the cortex. This often presents a 
"reverse" picture, lymphocyte density being higher in the medulla than in the 
cortex. Most often, the distinction between cortex and medulla is lost. There is a 
relative prominence of interstitium and blood vessels (perivascular areas). 
Advanced shrinkage and separation of the thymic lobules observed. 
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Since thymic involution is most often used as a potential marker for fetal IUGR, this 
chapter aims to assess whether evidence of thymic involution can be performed in a 
more objective manner and blinded to clinical features and as a result whether 
evaluation of thymic involution in cases of stillbirth is reliably associated with 
different causes of death, in particular IUGR. Table 149 highlights current published 
literature about thymic involution in which the majority only use subjective criteria 
to assess thymic involution and as such their results are likely confounded by 
observer bias. 
Author Cases Methods Results 
Van 
Baarlen et 
al.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
234 cases 
(fetuses and 
young children) 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Age of cases:  20 weeks 
gestation to 17 years.  
 
Duration of acute illness: 
0 hours - 12 months. 
 
Grading of thymic 
involution: Van Baarlen 
grading (blinded).  
 
Morphological 
assessment of thymus: 
Projection microscope. 
 
 
 
   
Thymus weight and 
volume percentages 
of interstitium, cortex 
and medulla were 
significantly related 
to prenatal or 
postnatal status and 
the age of patient. 
The thymus weight 
related to duration of 
illness in prenatal 
patients. The 5 Van 
Baarlen gardes were 
significantly 
correlated with the 
duration of acute 
illness. 
 
 
 
  
 
Bancalari 
et al.  
 
 
 
 
 
 
 
 
30 cases (all 
neonatal deaths) 
 
 
 
 
 
 
 
 
Morphological 
assessment of Thymus: 
Macroscopic and 
microscopic assessment 
was correlated with 
clinical and radiological 
data. 
 
 
 
Malformations, 
severe asphyxia and 
hyaline disease 
showed a moderate 
decrease in thymus 
weight and slight 
depletion of cortical 
lymphocytes. 
Newborns with 
severe infection had 
Autopsy Investigation in Stillbirth 
 
291 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pronounced 
decreased thymic 
weight and severe 
depletion of cortical 
lymphocytes. There 
was no correlation 
between radiological 
and postmortem 
findings.  
Agapitos et 
al.  
 
 
 
 
 
 
 
 
 
300 cases (all 
perinatal deaths) 
 
 
 
 
 
 
 
 
 
Grading of thymic 
involution: 5 groups (1. 
normal -mature thymus, 2. 
involutionary changes - 
"starry sky", 3. 
involutionary changes - 
intense lymphocyte 
depletion, 4. hypoplasia - 
aplasia, 5. agenesis).  
 
Classification of deaths: 
Wigglesworth 
classification system  
 
A strong correlation 
was reported between 
thymic weight and 
gestational age, birth 
weight and 
histological features 
as well as 
histological features 
of the thymus and 
cause of death.  
 
 
 
 
Toti et al.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 cases (30 
cases with 
chorioamnionitis
/ sepsis; 20 
controls)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age of cases: 16 weeks 
gestation to term.  
 
Grading of Thymic 
involution: 1-3 (1: resting 
state;  2: early signs of 
shrinkage, some 
separation of thymic 
lobules and relative 
prominence in interstitium 
and blood vessels, cortex 
partly devoid of 
lymphocytes; 3: extensive 
lymphodepletion, irregular 
narrowing of the cortex 
(sometimes completely 
disappeared) (blinded) 
 
Morphological 
assessment of thymus: 
Non- parametric test point 
analysis at low and high 
power fractal analysis and 
immunohistochemistry  
 
Cases of 
chorioamnionitis 
showed decreased 
thymic volume, 
reduced 
corticomedullary 
ratio, significant 
changes in the 
relationship between 
thymic parenchyma 
and thymic 
insterstital tissue with 
resulting organ 
complexity, severe 
reduction in 
thymocytes and other 
degenerative 
processes such as 
monocyte/macrophag
e infiltration of 
Hassall's Bodies.  
 
The 
corticomedullarty 
ratio in controls was 
reported as 1.46-
3.46.  
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The main conclusion 
drawn was that 
chorioamnionitis 
with or without 
sepsis was associated 
with significant 
morphological 
changes of the 
thymus.  
 
Glavina-
Durdov et 
al.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
100 cases 
(perterm and 
term fetal 
deaths) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Age of cases: 21-41 
weeks gestation with death 
ranging from <1 hour to 
28 days after birth.   
 
Grading of Thymic 
involution: Van Baarlen 
grading system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
25 of 38 neonates 
who lived <12 hours 
had a Grade 0 
Thymus. In 13 of the 
38 neontaes who 
lived < 12 hours 
involution suggested 
prenatal stress. 
 
The grade of thymic 
involution 
significantly related 
to duration of illness. 
Placental 
inflammation was 
significantly 
associated with 
thymic involution 
and pre-term 
newborns with 
infection were 
significantly more 
associated with acute 
thymic involution 
than cases of 
respiratory distress. 
A significant increase 
in peripheral blood 
lymphocyte count in 
grade 0-2 was 
reported and a 
decrease in 
peripheral blood 
lymphocytes in 
grades 2-4. 
Edwards et 
al.  
 
 
23 cases 
(matched pairs 
of stillbirths) 
 
Age of cases: 24 - 41 
weeks gestation.  
 
Type of maternal 
In maternal diabetes 
the thymus was small 
with a starry sky 
appearance in 11 of 
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Diabetes: Any form of 
diabetes mellitus or no 
diabetes mellitus.  
 
Morphological 
assessment of thymus:  
Cortical lymphocyte 
depletion and hassalls 
corpuscles used as 
markers of hypoxic stress.  
 
20 cases compared to 
4 of 22 in controls 
and these findings 
were associated with 
a low placental 
weight. 
 
 
 
 
 
 
 
Jacques et 
al.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 cases  (8 
stillbirths; 2 
neonatal deaths)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age of cases: Third 
trimester fetuses that died 
during or very close to 
their time of delivery.  
 
Grading of thymic 
involution: Van Baarlen 
grading system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recent brain injury 
was found in nine 
cases. Thymic 
involution was 
present in eight 
cases; five mild and 
three severe (grade 
3/4).  
 
Myocardial infarcts 
were reported in two 
cases, intrathoracic 
petechiae in five 
cases and ascites or 
pleural effusions in 
six cases. 
 
Severe thymic 
involution and 
myocradial infarcts 
correlated with 
established brain 
injury. Increased 
nucleated red blood 
cells or villous 
hypervascularity was 
reported in five cases 
and correlated with 
established brain 
injury.  
 
Acute 
chorioamnionitis 
with funisitis was 
present in one case 
and chronic 
inflammatory 
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placental lesion in six 
cases.   
 
 
Table 149 Summary of published literature about Thymic involution. (171-173, 210, 224-226) 
 
9.1 Methods 
The Microsoft Access Autopsy Database was used to collate postmortem and 
antenatal details available for all stillbirths, early and late miscarriage from 2005 – 
2013 from Great Ormond Street Hospital and St George’s Hospital, London.  Three 
different groups of cases were selected for further thymic analysis and gathered 
using Microsoft Access queries and Microsoft Excel. The three groups included; 
1. Controls (20 cases): Unexplained unexplained deaths with no associated 
findings at autopsy, of normal birthweight and with no abnormalities of the 
placenta (either definitive or of uncertain significance).  
2. IUGR (14 cases): Cases that were either known antenatal IUGR or cases 
found to be SGA based on delta birthweight values (Chapter 5) all of whom 
also had significantly abnormal placentas with evidence of maternal vascular 
malperfusion.  
3. SGA (12 cases): Cases with no history of IUGR but found to be SGA based 
on delta birthweight values (Chapter 5) all of whom showed no placental 
abnormalities (likely physiological SGA rather than pathological IUGR)  
 
46 cases in total were selected for analysis. There was no statistical difference in the 
gestational age of the fetuses between each group. Each case had a 4 micrometer 
Haemotoxylin and Eosin stained microscopic slide of the thymus gland that was then 
digitally scanned using the NanoZoomer Hamamatsu Scanner (Digital Pathology 
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Software; NDP. Scan 2.5, NDP.view2). The slide scanner allowed for good quality 
images to be obtained of each entire case for subsequent independent analysis of the 
microscopic features. Each case was recorded using a study number assigned to the 
case, which allowed cases to be blinded during analysis but identified at the end of 
the study. 
Sections were objectively assessed over four different representative areas for 
changes described in thymic involution. These included: 
1. Corticomedullary ratio: A representative lobule was measured in square 
millimeters in one field of view at x2 magnification in each case. The 
medulla was then measured in the same way. The area of the medulla was 
subtracted from the area of the lobule to calculate the area of the cortex. The 
corticomedullary ratio (of the area) could then be calculated.  
2. Number of Hassall’s Corpuscles: The number of corpuscles were counted in 
six randomly selected fields at x4 magnification in each case. 
3. Distance between lobules: The distance was measured in millimeters 
between two lobules in six randomly selected fields at x4 magnification in 
each case and an average distance between lobules was calculated. 
4. Number of tingible body macrophages: The number of tingible body 
macrophages were counted in one representative high power field in each 
case. 
The cases were also graded subjectively using the Vann Baarlen grading system by a 
single pathologist. During the examination of images the cases were blinded and 
only unblinded for statistical analysis of differences between groups. Statistical tests 
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were completed in Graph Pad Prism and Stats Direct and can be viewed in detail in 
Appendix 3.  
9.2 Results  
A complete table of all measurements taken can be found in Appendix 6. When 
comparing the control group to the IUGR/SGA group, or the IUGR versus SGA 
groups there were no significant differences in: 
1. The number of Hassall’s corpuscles per field (p= 0.9931, p=0.483, p=0.486).  
2. The number of tingible body macrophages per field (p=0.9638, p=0.3021, 
p=0.3266).  
3. The average distance between lobules (p= 0.6165, p=0.6939, p=0.9798) 
 
Figure 105 Number of Hassall’s Corpuscles (HCs) and Tingible body macrophages (TBM) in each 
group where group 1 is the control group, group 2 is IUGR with abnormal placentas and group 3 is 
SGA with normal placentas. No significant differences were found between the groups. 
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Figure 106 Distance between lobules (micrometres) in each group where group 1 is the control 
group, group 2 is IUGR with abnormal placentas and group 3 is SGA with normal placentas. No 
significant differences were found between the groups. 
 
 
Figure 107 Corticomedullary ratios (square mm) in each group where group 1 is the control group, 
group 2 is IUGR with abnormal placentas and group 3 is the SGA with normal placentas. IUGR 
cases with abnormal placentas (group 2) had significantly smaller corticomedullary ratios than 
controls (group 1) (p= 0.0221). (Excludes 4 cases, 1 of which was too autolysed for assessment and 3 
were too high grade to differentiate the cortex from the medulla) 
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The only significant finding was that cases with IUGR had significantly reduced 
corticomedullary ratios than controls indicating a significantly smaller cortex (p= 
0.0221: Median 1.63 (range 1.18-4.17) versus median 3.32 (range 0.91 – 6.27), 
median difference -1.24 (95% CI -2.38 to 0.20)). However, using ROC statistics the 
most useful cut off of corticomedullary ratio in the differentiation of cases with 
IUGR and controls is 2.13 with a sensitivity of 64% and specificity of 78% (Table 
150). However, it must be noted that the distributions of corticomedullary ratios in 
all three groups overlap massively and therefore using a specific ratio, as a 
diagnostic tool in IUGR, is likely to be inaccurate. 
 
Corticomedullary ratio Cut 
Off Sensitivity % Specificity % 
1.05 0 94 
2.13 64 78 
3.16 71 50 
4.13 92 33 
5.06 100 17 
Table 150 Sensitivity and specificity for the differentiation of IUGR against control cases using 
specific corticomedullary ratio cut offs. 
  
There was no difference in the corticomedullary ratio between normal controls and 
the SGA group, supporting the concept that stillbirths with body weight below the 
10
th
 centile but no placental features of maternal vascular malperfusion are likely 
artefactually or physiologically small and do not indicate pathological IUGR as the 
likely cause of death. 
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9.2.1 Van Baarlen Grading 
Van 
Baarle
n 
Grade 
Controls  
 
 
IUGR Abnormal 
placenta  
 
SGA Normal 
placentas 
 
Total 
1 
(Low) 1 (5%) 0 (0%) 1 (8%) 
 
2 (4%) 
2 
(Low) 12 (60%) 9 (64%) 9 (75%) 
 
30 (65%) 
3 
(High) 6 (30%) 3 (21%) 2 (17%) 
 
11 (24%) 
4 
(High) 1(5%) 2 (14%) 0 (0%) 
 
3 (7%) 
Total:  20 14 12 
 
46 
Table 151 Number and percentage of cases that were assigned each Van Baarlen Grade.  
The majority of cases (65%) had a low Van Baarlen grade and there were no 
significant differences in the distribution of low and high grade cases between any of 
the groups. Furthermore, within each of the separate groups, there were no 
significant differences in the number of cases that would be expected (by chance) to 
have a low or high Van Baarlen Grade and those that were observed to have a low or 
high Von Baarlen Grade (p=0.3373, 0.3625 and 0.083). These finding suggest that 
the Van Baarlen grading method is no more accurate at differentiating the degree of 
thymic involution than if chance alone was to assign the degree of involution and 
that the grading system does not help differentiate between different mechanisms or 
causes of death in stillbirth when assessed blindly.  Importantly, there is a marked 
variation in grade even in controls, making the test of limited value in clinical 
practise.  
9.3 Discussion 
This chapter aimed to assess whether thymic involution could be objectively 
assessed and used as a tool to help provide a definitive cause of death in stillbirth, in 
particular to distinguish IUGR due to maternal vascular malperfusion form other 
causes. The results demonstrate that, when assessed blinded to all clinical history 
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from scanned images, there was no significant difference in the number of tinigible 
body macrophages, Hassall’s corpuscles or the average distance between lobules 
between groups. There was a significant statistical reduction in coricomedullary ratio 
in the IUGR case group, but with extensive overlap of all distributions. Furthermore, 
the Van Baarlen Grading system, when assessed blindly, was not associated with and 
particular cause of death group in stillbirth.  
These findings are in keeping with the suggestion that overall, with typical IUGR 
there may be slightly reduced overall thymic size and weight (see Chapter 6) with 
increased thymic involution, as evidenced by reduced corticomedullary ratio but 
subjective assessment is of limited value as a reliable tool to help determine the level 
of intrauterine “stress” and therefore cause of fetal demise, in individual cases due to 
the large overlap in distributions. 
There were some technical difficulties in assessing these thymic microscopic 
features which should be mentioned. Firstly, some of the images, despite the use of a 
high quality digital scanner, were of poor quality (compared to traditional 
microscopy slide assessment) for high power assessment of tingible body 
macrophages and Hassall’s corpuscles. Secondly, in some high grade cases the 
distinction between the cortex and medulla was indistinct, making corticomedullay 
ratio calculation difficult. Lastly, when trying to assess the distance between lobules 
the use of a 2D image of a 3D structure means that the true angle between lobules 
may vary, with the effects of distance; again this applied equally to all cases. 
Chapter 6 in this thesis examined the relationship between the Body:Thymus weight 
ratio, fetal SGA and cause of death. Results showed significant differences between 
SGA and non SGA groups and SGA cases with and without placental causes of 
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death. A Body:Thymus weight ratio of 855.5 could be used to differentiate  “true” 
IUGR from SGA cases without  significant placental pathology with 50% sensitivity 
and 75% specificity. Furthermore, a Body:Thymus weight ratio cut off of 671.7 
could be used to define “true IUGR” from all other causes of death with a sensitivity 
of 61% and specificity of 79%.  
 In conclusion, these findings demonstrate that there is evidence for statistical 
reduced thymic size and “involution” in stillbirth with IUGR and maternal vascular 
malperfusion using blinded morphometric assessments. However, due to the large 
overlap of distributions, variation within groups, and difficulties of subjective 
evaluations, the Van Baarlen grading system is an inaccurate tool in the assessment 
of thymic involution and this assessment is of limited use in clinical practise.   
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10.3 Discussion 
 
 
 
 
 
10. Proteomics of formalin 
fixed, paraffin embedded 
archival material from 
stillbirths 
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10.0 Background 
Proteomics is the study of the protein complement of samples such as body fluids or 
tissues; their identification; modification; quantification and localisation (227). 
Developments in protein ionization methods have facilitated the use of mass 
spectrometry in proteomic analysis, and this is now the main method in use (228).  A 
mass spectrometer is composed of an ion source, an analyser that measures mass-to 
charge ratio (m/z) and a detector that recognizes the number of ions at each m/z 
value (228).  Liquid-based chromatography, used in conjunction with electrospray 
ionization (ESI) can be used to produce ions from a solution of protein extracted 
from tissues, which is then analysed by mass spectrometry for mass and quantity 
determination (227-229).  
Two different approaches can be used to prepare proteins for mass spectrometry 
analysis. Firstly, bottom-up (or shot-gun) proteomics is a technique in which proteins 
are digested (usually with Trypsin) prior to mass spectrometry analysis and the 
resulting peptide masses are used to sequence and identify all specific proteins 
present in the sample (227, 230-232). Alternatively, top-down proteomics uses intact 
proteins and their fragments to identify specific proteins in the sample (227).  
It was long assumed that formalin fixed paraffin embedded (FFPE) human tissue 
was too problematic for use in proteomics due to issues with formalin-induced cross-
linking and modifications (Figure 108). However, with technical advances it is now 
possible to reliably derive protein form such tissue (233-238). 
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Figure 108 Reaction mechanism for formaldehyde cross-linking of proteins. Reaction [1] creates a 
hydroxymethyl-methylol adduct with a + 30 Da mass shift. Reaction [2] is a water elimination to form 
a Schiff base and a total + 12 mass shift. Reaction [3] is a cross-linking reaction where nucleophilic 
attack on the methylene carbon of the Schiff base by a nucleophile in the amino acid residue results in 
a methylene bridge (238). (This research was originally published in Journal of Biological Chemistry 
(239)) 
 
However, there are no published studies which examine the potential use of fetal 
FFPE tissue from intrauterine deaths for use in proteomics. The primary aim of this 
Chapter is to therefore explore the feasibility of extracting protein from routine 
archival FFPE samples of fetal tissue, from cases of stillbirth, and therefore assess 
the possible use of proteomics as a future investigative tool in stillbirth causation and 
clinical investigation. If applicable, the use of a validated database with well-
characterised populations of intrauterine deaths, such as from the present study, will 
allow identification of numerous distinct subgroups for further targeted analysis and 
hence provide a resource for future studies of stillbirth mechanisms.  
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10.1 Methods 
The Microsoft Access Autopsy Database was used to collate postmortem and 
antenatal details available for all stillbirths, early and late miscarriage from 2005 – 
2013 from Great Ormond Street Hospital and St George’s Hospital, London. Queries 
were run through Microsoft Access and Excel to establish a list of cases (consented 
for research) that had chroioamnionitis with and without funisitis on histological 
examination of the placenta but normal liver histology and a separate group of 
control cases of unexplained deaths with normal histology of the placenta and liver. 
The Haematoxylin and Eosin stained microscopic slides were assessed for any tissue 
autolysis and their paraffin blocks were reviewed to ensure there was adequate 
material available for proteomic sampling. Using complex laboratory techniques and 
mass spectrometry (detailed below), proteins were extracted and analysed from 
formalin fixed placental and liver tissue from each case. Such cases were chosen to 
represent clear and definite pathologies regarding cause of death in whom no 
histological liver changes are reported, to determine proof of principle that liver 
proteomic assessment could be used to determine mechanism of death. 
10.1.1 Laboratory Methods 
Case Selection 
Following formalin fixation and paraffin embedding, 50 microns of tissue was 
obtained (five rolls of tissue, 10 microns thick were cut) and stored in eppendorfs. 
The samples were cleaned with incubation in heptane, followed by protein 
solubilisation with 300mM of Tris-HCL, 2% Sodium Dodecyl Sulfate and 2-
Mercaptoethanol, heated to 100 ⁰C for 20 minutes and then 80 ⁰C for 2 hours. 
Following centrifugation at 4⁰C for 20 minutes, the supernatant was removed with 
subsequent protein quantification with a modified BCA assay (Pierce™ BCA Protein 
Assay Kit, ThermoFisher Scientific, UK).  
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Protein precipitation and preparation for 1D-PAGE 
From each sample, 100ug of protein was obtained from each sample and precipitated 
out into a pellet with chloroform/methanol (at a ratio of 1:3). The samples were 
washed with ethanol and then the centrifuged at 9000g for 2 minutes. The pellet was 
air-dried briefly and then re-suspended in 20ul of SDS-PAGE buffer, 10ul of DTE 
(300mM in H2) and 20ul of H20. The sample was alkylated with 3ul of 
iodoacetamide (36mg in 1 ml of H2O) for 45 minutes followed by addition of an 
extra 20ul of SDS-PAGE buffer to make a final volume of 60ul.  30ul 
(approximately 50ug) of sample was loaded into a well of an Any kD™ Mini-
PROTEAN TGX™ precast protein gel (Bio-Rad Laboratories, UK), along with a 
full range rainbow marker (Amersham ECL PLex™fluorescent Rainbow Marker, 
GE Healthcare Life Sciences, UK). Isoelectric focusing was carried out using the 
Mini-PROTEAN Tetra Cell system (Bio-Rad Laboratories, UK) at 200V for 30 
minutes. 
Protein staining and in-gel digestion 
The gels were stained with 0.1% coomassie, 40% methanol and 7.5% acetic acid 
before being counter stained with 40% methanol and 7.5% acetic acid. From each 
lane, the gels were divided into two gel bands and placed into eppendorfs. The 
coomassie stain was removed with 50% methanol and 0.1% acetic acid. Gel bands 
were washed twice with 50mM ammonium bicarbonate at ph7.8 before being 
dehydrated in acetonitrile and then in a speed vacuum (Eppendorf Concentrator 
Plus™, Eppendorf, UK) for 30 minutes. Protein digestion was undertaken with 60ul 
of 25ng/ul of sequencing grade modified porcine Trypsin (Promega, UK), 
reconstituted in 50mM ammonium bicarbonate, pH 7.8 with subsequent incubation 
at 37 ⁰C for 12 hours.  
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Digested peptides were extracted from the gel bands using washes of 1% formic 
acid, followed by extraction with 50% acetonitrile and 1% formic acid. To this final 
wash, 1% formic acid was added and the final supernatant was freeze-dried and then 
reconstituted in 50ul of 3% acetonitrile with 0.1% formic acid.  
Electrospray QTOF MS analysis 
The samples were analysed with a SYNAPT G2-Si HDMS Q-TOF mass 
spectrometer (mass acquisition range of 50 to 2000 Da), coupled to a 
nanoACQUITY UPLC system via a nanospray (ZSpray™) source (SYNAPT, 
nanoACQUITY and ZSpray from Waters Ltd, UK).  
19ul of each sample was vialed and spiked with 1ul (1nmol/ml) of S. cerevisiae yeast 
enolase (Sigma-Aldrich, UK)). 1ul of sample was loaded onto the nanoAcquity 
column (ACQUITY UPLC™ Peptide BEH C18 nanoACQUITY Column 10K psi, 
130A, 1.7µm, 75µm x 100mm, Waters Ltd, UK). The samples were analysed over 
60 minutes, utilising a linear gradient of mobile phase A (H2O with 0.1% formic 
acid) and mobile phase B (acetonitrile with 0.1% formic acid) with the initial 
gradient changing from 3 to 40% of mobile phase B over 40 minutes, followed by 40 
to 85% for 2 minutes and then a subsequent decrease to 3%  over 1 minute and for 
the remainder of the run, with a flow rate of 300nL/minute. 
The peptides were analysed in positive mode electrospray ionisation with data 
collected through alternating 1.5 second scans of low (4eV) or high (15-40eV) 
collision energies. Post-calibration of data files were corrected using the doubly 
charged precursor ion of [Glu1]--fibrinopeptide B (785.8426 m/z).  
Data analysis 
All data was processed and analysed using Progenesis QI for Proteomics software 
2.0 (Nonlinear Dynamics, UK). Fragment ions in the first 5 minutes and the last 5 
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minutes of each run were excluded. Protein identifications were obtained by 
searching the Homo sapiens proteome database (including canonical sequences and 
isoforms) from Uniprot (obtained on 01/03/2015 from www.uniprot.org), to which 
the sequence of yeast enolase and porcine trypsin was added manually. The spectra 
obtained from each sample was analysed using the following search parameters; the 
enzyme was trypsin (up to 2 missed cleavages), fixed modifications of 
carbamidomethylation of cysteine and variable modification of oxidation of 
methionine. Peptide and protein matching required two fragment ions per peptide, 
three fragment ions per protein and more than one peptide per protein. Quantification 
was performed using the spiked standard of yeast enolase (S. cerevisiae). The false 
detection rate was 1% 
Protein function and pathway analysis was performed using the PANTHER (Protein 
Analysis Through Evolutionary Relationships) classification system.  
10.2 Results 
As a proof of principle study only, seven cases were selected for proteomic analysis 
with research consent. Cases analysed included liver and placental samples from: 
 Two cases of Chroioamnionitis with funisitis (fetal systemic response) and 
normal liver histology 
o Gestation: 22 and 23 weeks  
o Intrauterine Interval: 1 day and 0 days respectively 
o Postmortem  Interval: 8 days and 10 days respectively 
 Two cases of Chorioamnionitis without funisitis (no fetal systemic response) 
and normal liver histology 
o Gestation: 20 and 22 weeks  
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o Intrauterine Interval: 1 day for each case  
o PostMortem Interval: 7 days for each case 
 Three control cases of unexplained deaths with both normal placental and 
liver histology 
o Gestation: 17, 20 and 22 weeks  
o Intrauterine Interval: Uncertain, 0 days and 1 day respectively 
o Postmortem Interval: 13 days, 2 days and 3 days respectively. 
10.2.1 The Placenta 
Using the methods above, in total, 305 unique proteins were extracted from placental 
tissue, demonstrating that protein can be successfully extracted from FFPE placental 
tissue in cases of stillbirth with varying mechanisms of death (Appendix 7). 
A wide variety of proteins were obtained including 25 different classes of protein 
(Figure 109) and proteins with nine different types of molecular functions (Figure 
110).  
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Figure 109 25 different classes of proteins found of which cytoskeletal protein (accession PC00085) 
had the greatest percentage of gene hits against protein class hits (18%) 
 
 
Figure 110 Proteins with nine different molecular functions were found of which Catalytic activity 
had the greatest percentage of gene hits against the total number of function hits (32.9%) 
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Four proteins were present in significantly different amounts between the case 
(funisitis and no funisitis) and control groups, despite peptide counts being small 
(Table 152). 
Protein 
Peptide 
count 
Unique 
peptides 
Anova 
(p) 
Highest 
mean 
condition 
Lowest 
mean 
condition 
Peptidyl-prolyl cis-trans isomerase B 
OS=Homo sapiens GN=PPIB PE=1 
SV=2 
15 12 0.004 
No 
Funisitis Funisitis 
Peptidyl-prolyl cis-trans isomerase A 
OS=Homo sapiens GN=PPIA PE=1 
SV=2 
15 10 0.01 Funisitis 
No 
Funisitis 
Probable phosphoglycerate mutase 4 
OS=Homo sapiens GN=PGAM4 PE=2 
SV=1 
5 3 0.02 
No 
Funisitis Funisitis 
40S ribosomal protein S4, X isoform 
OS=Homo sapiens GN=RPS4X PE=1 
SV=2 
3 3 0.03 Control 
No 
Funisitis 
Table 152 Proteins found to be present in significantly different amplitudes between case groups 
during proteomic analysis in placental tissue. 
 
These findings suggest that protein expression differs more significantly between 
cases of Chorioamnionitis with and without funisitis than between control cases and 
cases of Chrorioamnionitis. This is also highlighted by the differences in normalized 
abundance between the three different case groups (Figure 111). 
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 Figure 111 Normalized abundance of proteins with significantly different amplitudes between case 
groups 
10.2.2 The Liver 
Using the methods above, 250 unique proteins were extracted from the liver tissue. 
There were 25 different protein classes of which nucleic acid binding (accession 
PC00171 was the most dominant (15.7%) and 9 different molecular functions, of 
which catalytic activity was similarly the most prominent (32.6%).  
Two proteins were present in significantly different amounts between the case 
groups, despite peptide counts being small (Table 153). 
Protein 
Peptide 
count 
Unique 
peptides 
Anova 
(p) 
Highest mean 
condition 
Lowest 
mean 
condition 
3-ketoacyl-CoA thiolase, 
peroxisomal  10 1 0.043553 Chorioamnionitis Funisitis 
Neurofilament medium polypeptide  9 8 0.041746 Funisitis Control 
Table 153 Proteins found to be present in significantly different amplitudes between case groups 
during proteomic analysis in liver tissue. 
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10.3 Discussion 
Results from this chapter have demonstrated that it is possible to extract proteins 
from routinely collected, archival FFPE stillbirth tissue, both fetal and placental, and 
that there are significant differences in protein amounts between different case 
groups and in different organs.  
In total, 305 proteins were successfully extracted from FFPE placental tissue and 250 
proteins from liver tissue however, some of the proteins extracted in this small study 
could not be identified which could be secondary to the process of maceration, 
autolysis of tissue or post-translational modifications (i.e. the process of 
glycosylation of proteins within the endoplasmic reticulum (240)). Four placental 
proteins and two liver proteins were expressed in significantly different amounts 
between case groups.  However, studies which used fresh tissue with multiple 
fractions have found yields of up to 4000 proteins and  37 - 171 significantly 
different proteins between case groups and controls (in cases of intrahepatic 
cholestasis and pre-eclampsia) (241-243).  This highlights the continued complexity 
of extracting protein from FFPE and as such fresh frozen tissue remains the gold 
standard for use in clinical proteomics at the present time (244). 
The findings of this chapter do however prove, in principle, that proteins can be 
derived from fetal tissue in stillbirth and that there are some significant differences 
between cause of death groups. This could be an important step in the investigation 
of cause of death in stillbirth; if proteomics can highlight cases of infection (for 
example) that may have been indistinguishable from “unremarkable” cases 
microscopically, we may find that previously unexplained causes of death have a 
pathological cause, particularly with regard to “ischaemic” mechanisms. Future work 
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needs to further develop proteomic techniques with larger scale studies and more 
diverse case groups using both fresh and FFPE fetal tissue.  
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11.0 Conclusions 
Maternal demographics 
Known associations to stillbirth and miscarriage were confirmed such as increasing 
maternal age, increased maternal BMI (with raised maternal BMI being associated 
with both miscarriage and stillbirth), maternal ethnicity, diabetes mellitus and 
hypertension, allowing for comparison of the results within this study to other 
stillbirth and miscarriage research. This chapter also highlighted that white mothers 
were significantly overrepresented in stillbirth and black mothers were significantly 
overrepresented in miscarriage. Mothers who were primigravida were also found to 
be overrepresented in the stillbirth group however; mothers with an obstetric history 
of vaginal bleeding during pregnancy, uterine fibroids and in vitro fertilization were 
overrepresented in miscarriages.  
Cause of Death 
Two thirds of the study population had an unexplained cause of death using strict 
criteria applied for this project: 27% of these deaths had no associated clinical, fetal 
or placental lesions. Black and Asian ethnicities were found to be significantly more 
associated with ascending infection in miscarriages than white mothers. Mothers 
over the age of 40 years had significantly more deaths associated with placental 
pathology than younger mothers. Fetuses with unexplained death were significantly 
more macerated than non-macerated fetuses suggesting a possible association 
between the degree of maceration and the ability to assign a specific cause of death. 
Re-classifying deaths using the ReCoDe classification system found that 36% of 
cases were SGA and 35% were unexplained, highlighting the difficulty of comparing 
classification systems. Internal examination alone provided a definitive cause of 
death in only 1% of cases; 19% of the overall causes of death could have been 
diagnosed from review of the clinical circumstances and a further 18% by placental 
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macroscopic and microscopic examination. However, 62% of deaths remained 
unexplained, around half of whom were associated with either maternal risk factors 
or placental/histological changes of uncertain significance, suggesting current 
autopsy practise is of limited utility to identify causes of death and newer approaches 
are required for more reliable death investigation. There is great variation in cause of 
death allocation according to subjective interpretation of findings of uncertain 
significance. 
Intrauterine Growth restriction and Small for Gestational age fetuses 
Around 35% of stillbirths were SGA based purely on unadjusted birthweight 
centiles. The majority of SGA fetuses had no identifiable cause of death at autopsy 
and of the total number of unexplained deaths, 27% were SGA. The most common 
specific finding in cases with known IUGR or SGA was an abnormality of the 
placenta, mainly changes suggestive of maternal vascular malperfusion. A 
significant association was found between increasing maceration and SGA and the 
longer the intrauterine interval, the greater the degree of fetal maceration and the 
greater the delta birthweight decrease. In addition, on average, fetuses lost 12% of 
their birthweight in the interval between delivery and autopsy. Without adjusting for 
such factors, using birthweight or bodyweight alone will erroneously significantly 
overestimate the role of SGA as an underlying factor in stillbirth causation. 
Organ weights 
Organ weights were significantly affected by maternal factors as well as the process 
of fetal maceration, the cause of death and the underlying mechanism for demise. 
The Brain:Liver weight ratio can be erroneously increased simply due to the effects 
of maceration rather than underlying pathology and hence such post death changes 
must be accounted for in clinical practise; on average the Brain:Liver weight ratio 
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should be reduced by 1 unit to account for the artefactual effects of maceration 
where present. The Brain:Liver weight ratio was significantly greater in cases of 
SGA with a placental cause of death compared to cases with birthweight < 10
th
 
centile but with no pathological placental findings or with another cause of death. A 
Brain:Liver weight ratio of 5 can identify ‘pathological’ placental IUGR compared 
to other causes of death with a sensitivity of 73% and a specificity of 85%. A ratio of 
6 improves specificity to 92% but reduces sensitivity to 55%. ‘Pathological’ IUGR 
can be distinguished from SGA cases with no placental abnormalities using a 
Brain:Liver weight ratio of 6 with a sensitivity of 53% and a specificity of 80%. 
Although of some use, the sensitivity and specificity of Body:Thymus weight ratios 
are not as effective as Brain:Liver weight ratios for the detection of ‘pathological’ 
IUGR. 
Histology 
The majority of fetuses had normal macroscopic and microscopic appearances of 
their internal organs after accounting for maceration and autolytic change. Cases of 
stillbirth showed a greater proportion of abnormal macroscopic or microscopic 
appearances but in the vast majority of cases, histological examination of internal 
organs did not provide the cause of death. The same was true for miscarriages.  Less 
than 3% of deaths had abnormal microscopic findings that directly provided the 
cause of death and the majority of all histological abnormalities (68%) were seen in 
lung tissue. There were no cases in which histology of the spleen, adrenal glands, 
thyroid, thymus or pancreas provided the cause of death. 
The Placenta 
The placenta was submitted for examination in 946 (89%) of stillbirth and 
miscarriage autopsies. Nearly one third of all placentas had entirely normal 
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microscopic findings of the umbilical cord, membranes and placenta. In 208 
stillbirths the placenta was abnormal (a significantly greater proportion than that 
seen in miscarriages) and could be directly linked to the cause of death (including 
those with diagnosis based mainly on clinical history, such as abruption). Nearly one 
third of all causes of death in the study were primarily placental; of these, 58% were 
ascending infection, almost always associated with midtrimester miscarriage and 
fresh intrapartum death, whilst 18% were related to specific histological 
abnormalities of the placental parenchyma; of which maternal vascular malperfusion 
accounted for the large majority (75%). Ascending infection was the major cause of 
late second trimester miscarriage with intrapartum or fresh stillbirth, specifically 
affecting women of black ethnic origin. Other placental histological abnormalities 
represented a significant cause of death for third trimester stillbirths, especially 
maternal vascular malperfusion and other specific lesions in the early third trimester. 
In an additional group of cases (78 of 1064, 7%) the placenta showed some 
histological findings that were abnormal but not considered severe enough to be 
attributed as the cause of death or were of uncertain significance (example patchy 
mild villitis).  The majority of these otherwise unexplained deaths were macerated 
and had a similar gestational age, maternal age and ethnic distribution to the overall 
stillbirth population, including a predominant occurrence at or near term. 
Thymus Histology and IUGR 
This chapter assessed whether thymic involution could be objectively assessed and 
used to distinguish IUGR due to maternal vascular malperfusion form other causes. 
The Van Baarlen Grading system, when assessed blindly, was not associated with 
any particular cause of death group in stillbirth and was thus deemed an inaccurate 
tool in the assessment of IUGR. When assessed blind to all clinical history from 
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scanned images, there was no significant difference in the number of tingible body 
macrophages, Hassall’s corpuscles or the average distance between lobules between 
groups. There was a significant statistical reduction in thymic weight and 
corticomedullary ratio, suggesting some evidence of accelerated thymic involution, 
in the IUGR case group, but with extensive overlap of all distributions.  
Proteomics 
In total, 305 proteins were successfully extracted from FFPE placental tissue and 250 
proteins from liver tissue however; some of the proteins extracted could not be 
identified. Four placental proteins and two liver proteins were expressed in 
significantly different amounts between case groups. These protein yields are much 
smaller than those from fresh tissue and as such further research needs to continue to 
develop proteomic techniques in FFPE tissue. This Chapter does, however prove that 
proteins can be derived from fetal tissue in stillbirth and significant differences can 
be found between different case groups. 
11.1 Limitations and Criticisms 
One of the main limitations of this study was related to the retrospective nature of 
the dataset and hence intrinsic limitations regarding the extent of details of the 
antenatal history provided with autopsy reports. Some cases were submitted with no 
details of ultrasound scans or fetal birthweight and in others there was no maternal 
ethnicity or BMI provided. Such issues are common to all retrospective data series 
but this limited the number of cases that could be analysed within these categories 
and the effects of some risk factors may therefore have been over or underestimated. 
However, these issues were offset by the large size of the study; this study is the 
largest of its kind and therefore such effects on the study population are likely to be 
minimal. This study has highlighted that in 19% of cases, the cause of death was 
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clear on review of the clinical findings and external examination of the fetus. Within 
this study the aim was to use data and information that is currently available to 
assess the components of autopsy practise. However these findings suggest that if 
more information was provided it is possible that the proportion of unexplained 
deaths may be reduced. In view of this it is recommended that these study data be 
used as evidence to support possible changes in practise based on the findings of a 
future study to review the accuracy and completeness of clinical information 
provided within post-mortem packs compared to the original clinical notes. 
Furthermore, review of unexplained cases with full clinical information is required to 
determine whether this information affects the proportion of unexplained deaths or 
any other category of death.  
In addition, a major strength is the use of predefined, objective definitions for all 
criteria used to ensure standardisation of interpretation. Where possible all data 
recorded was of findings present independent of the opinion of the reporting 
pathologist at the time. All classifications were performed identically for all cases. In 
addition, cases were included throughout the gestational age range from miscarriages 
through to post-term intrauterine deaths.  
Cases were entered onto the database by one observer to further limit any effects of 
observer bias. All causes of death were reviewed by myself and my supervising 
Professor and allocated an objective cause of death thus limiting the subjective 
interpretation of the original autopsy findings by different pathologists and ensuring 
consistency.  
Chapter 5 examined growth restriction and the effects of being small for gestational 
age in stillbirth. World Health Organisation (WHO) fetal growth charts were used as 
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a control measure of fetal birthweight. This provided some restrictions in the 
analysis of cases. Firstly, the WHO charts were not adjusted for the effects of 
maternal factors such as height or ethnicity, hence neither were the cases within this 
study. Secondly, the gestational age on the charts ranged from 23- 42 weeks and thus 
a percentage of cases within this study could not have a delta birthweight calculated 
as they were delivered prior to 23 weeks gestation. Growth charts are in existence 
that take into account maternal factors, (customised) however they are not freely 
available and detailed maternal demographic data were not available in all cases in 
this series. 
In order to assess histology objectively, the images used to analyse thymic involution 
in Chapter 9, were scanned and hence of slightly poorer quality (compared to 
traditional microscopy slide assessment) for high power assessment of features such 
as tingible body macrophages, despite the use of a high quality digital scanner. In 
some high grade cases the distinction between the cortex and medulla was also 
impossible, making corticomedullay ratio calculation less reliable and when trying to 
assess the distance between lobules, the true angle would inevitably be different to 
that recorded due to the use of a 2D image of a 3D structure.  
11.2 Evidence based guidance 
Results from the present study can be incorporated into the six areas of current Royal 
College guidelines for autopsy investigation in fetal and perinatal death, providing 
the first evidence based guidance for stillbirth autopsy practise in the United 
Kingdom (159).  
1. External examination: Current Royal College guidance recommended with 
the addition that the effects of maceration (its presence or absence), 
intrauterine interval and postmortem interval should be taken into 
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consideration when measuring body weight and assessing for SGA (Chapter 
5).  
 
2. Internal examination: Current Royal College guidance recommended with 
the understanding that the brain, liver, thymus, heart, lungs, adrenal glands 
and thyroid weights will be significantly affected by the process of 
maceration and intrauterine interval. The weights of the liver, spleen and 
thymus will be significantly affected in cases of SGA. Liver and thymus 
weights will also be significantly affected by placental causes of death. 
Brain:Liver weight ratio calculation is advised when assessing for the 
presence of true, pathological SGA, taking into consideration the effects of 
maceration, intrauterine interval and postmortem interval. In cases consented 
for limited autopsy only, Body:Thymus weight ratio can be used to assess for 
true pathological SGA with the knowledge that this, although useful, is less 
reliable than Brain:Liver weight ratio (Chapter 6).  
 
3. Placental Examination: Placental examination remains a key investigation 
in stillbirth autopsy and current guidance should be followed. (NB: cord 
insertion site is of no particular significance and should not be over-
interpreted by the reporting pathologist) (Chapter 7). 
 
4. Histology: If consented for examination and a cause of death is not apparent 
from the clinical history or examination of the placenta, at most it may be 
suggested that one block of tissue should be taken of each lung and kidney, 
the heart, the liver and the brain.  Histology of the spleen, adrenal glands, 
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pancreas and thyroid do not require routine histological examination as there 
is no evidence to support that such analysis will provide a cause of death 
(Chapter 8). There is little benefit in assessing for accelerated thymic 
involution (Chapter 9).  
 
5. Special procedures and investigations: Current Royal College guidance 
recommended.  
 
6. Autopsy reports: Current Royal College guidance recommended with 
consideration of the effects of maceration, intrauterine interval and 
postmortem interval on body and organ weights, particularly in the 
assessment of true, pathological SGA (Chapters 5-6). An objective cause of 
death should be sought to aid in the classification of deaths and comparison 
of deaths between centres (Chapters 4-9). 
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Figure 112 Summary of evidence based approach to stillbirth autopsy practise 
Detailed review of clinical/ 
antenatal history 
Pathological examination of the placenta 
and external examination of fetus and 
imaging to exclude internal structural 
abnormalities 
Proceed to internal examination of the 
fetus with histological sampling of tissues 
following new evidence based guidelines. 
Cause of death diagnosed. 
No internal examination 
required. 
No cause of death. Advise 
parents current autopsy 
techniques provide a cause 
of death in only a minority of 
such cases.  
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11.3 Future studies 
This study has utilised a unique and objective database to evaluate current stillbirth 
autopsy practise. Cases were predominantly third trimester stillbirths but also 
included a proportion of miscarriages to allow for the assessment of pathologies and 
associations over a range of gestational ages. It is the largest study of its kind and has 
provided statistical evidence for the improvement of clinical practise.  
Nearly two thirds of all deaths were unexplained and nearly half of these deaths had 
no associated maternal, clinical or placental abnormalities. Of those deaths with 
associated abnormalities, little is known about the extent to which these 
abnormalities contribute to fetal demise and highlights the need for further research 
into the mechanisms of death in stillbirth. There is much debate about the relevance 
of IUGR and SGA in stillbirth and results from this study emphasise the importance 
of interpreting body and organ weights in light of fetal maceration, intrauterine 
interval and postmortem interval; findings that ideally need to be reproduced in other 
large scale studies.   
The difficulty in classifying causes of death in stillbirth and the importance of 
remaining objective when diagnosing a cause of death was evident in this study. 
Further attempts must be made to unify classification systems in stillbirth in order to 
correlate findings not only between hospitals in this country but globally. The use of 
a united database for such deaths would prove beneficial for research, allowing for 
collaborations between centres of excellence as well as smaller centres where data 
may otherwise be poorly utilised.  
Protein can now be successfully extracted from formalin fixed paraffin embedded 
(FFPE) tissue in stillbirths. Technical and genomic advances allow for the extraction 
of good quality proteins yields and for the analysis of protein function. 
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Histopathology departments hold huge collections of FFPE tissue, which if 
consented for research, could be a great resource of data collection both 
retrospectively and prospectively. Much research is needed on the usefulness and 
reproducibility of such investigations as well as interpretation of the findings and 
their relevance to mechanisms of death in stillbirth. The major area of future research 
in stillbirth investigation must focus on development of novel investigations to allow 
objective determination of cause or mechanism of death in the majority of cases 
which remain unexplained using current approaches. This is likely to require 
development of additional multiomic approaches.  
The role of less invasive methods of investigation after death including post-mortem 
Magnetic Resonance Imaging (MRI) must also be highlighted. It has recently been 
reported that based on post-mortem MRI and non-invasive investigations; has a 95% 
accuracy compared to full standard autopsy; can reliably differentiate livebirths from 
stillbirths in relation to lung aeration; is able to provide accurate images of fetuses 
greater than 500g; is an accurate investigation for diagnosing significant 
neuropathology, even in cases in which tissue autolysis would usually prevent 
accurate neuropathological examination; and can identify clinically significant 
cardiac lesions and renal abnormalities (245-249). PMMRI is also favoured by 
parents as being more accepted than conventional autopsy (99% vs 60%) making it a 
useful investigation in stillbirth, particularly in parents who decline a traditional 
autopsy (250). Advances in PMMRI are likely to continue, highlighting the need for 
a continued multidisciplinary approach to stillbirth autopsy in which clinicians and 
researchers work together to strive for improved determination of cause of death in 
stillbirth. 
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